Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
NM_004964.3(HDAC1):c.461A>G (p.Asn154Ser)	HDAC1	N154S	Inborn genetic diseases	VCV000208751	1	32792645	1	32327044	208751	205221	rs797044931	NC_000001.11:32327043:A:G	single nucleotide variant	missense variant	Likely pathogenic	Apr 2, 2013	criteria provided, single submitter							
NM_002524.5(NRAS):c.449A>G (p.Gln150Arg)	NRAS	Q150R	Noonan syndrome 6	VCV001320232	1	115252191	1	114709570	1320232	1310477	rs2101738598	NC_000001.11:114709569:T:C	single nucleotide variant	missense variant	Likely pathogenic	Oct 2, 2021	criteria provided, single submitter							
NM_002524.5(NRAS):c.204A>T (p.Arg68Ser)	NRAS	R68S	Noonan syndrome	VCV000981556	1	115256507	1	114713886	981556	969622		NC_000001.11:114713885:T:A	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_002524.5(NRAS):c.182A>C (p.Gln61Pro)	NRAS	Q61P	not provided	VCV000280409	1	115256529	1	114713908	280409	263939	rs11554290	NC_000001.11:114713907:T:G	single nucleotide variant	missense variant	Pathogenic	Mar 22, 2016	criteria provided, single submitter							
NM_002524.5(NRAS):c.182A>G (p.Gln61Arg)	NRAS	Q61R	Noonan syndrome 6|Non-small cell lung carcinoma|not provided|Large congenital melanocytic nevus|Neoplasm	VCV000013900	1	115256529	1	114713908	13900	28939	rs11554290	NC_000001.11:114713907:T:C	single nucleotide variant	missense variant	Pathogenic	Oct 7, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_002524.5(NRAS):c.179G>A (p.Gly60Glu)	NRAS	G60E	RASopathy|NRAS-related disorder|Cardiovascular phenotype|not provided|Noonan syndrome 6	VCV000013903	1	115256532	1	114713911	13903	28942	rs267606920	NC_000001.11:114713910:C:T	single nucleotide variant	missense variant	Pathogenic	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002524.5(NRAS):c.178G>A (p.Gly60Arg)	NRAS	G60R	not provided	VCV000561786	1	115256533	1	114713912	561786	552485	rs1557982817	NC_000001.11:114713911:C:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_002524.5(NRAS):c.176C>A (p.Ala59Asp)	NRAS	A59D	Noonan syndrome|Anemia	VCV000812886	1	115256535	1	114713914	812886	800975		NC_000001.11:114713913:G:T	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_002524.5(NRAS):c.173C>T (p.Thr58Ile)	NRAS	T58I	not provided|RASopathy|Noonan syndrome and Noonan-related syndrome|Colorectal cancer	VCV001070042	1	115256538	1	114713917	1070042	1058378	rs2101742052	NC_000001.11:114713916:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_002524.5(NRAS):c.149C>T (p.Thr50Ile)	NRAS	T50I	RASopathy	VCV000013902	1	115256562	1	114713941	13902	28941	rs267606921	NC_000001.11:114713940:G:A	single nucleotide variant	missense variant	Pathogenic	Sep 17, 2024	reviewed by expert panel							
NM_002524.5(NRAS):c.108A>G (p.Ile36Met)	NRAS	I36M	Noonan syndrome 6	VCV001335888	1	115258674	1	114716053	1335888	1326906	rs2101743991	NC_000001.11:114716052:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 27, 2022	criteria provided, single submitter							
NM_002524.5(NRAS):c.101C>T (p.Pro34Leu)	NRAS	P34L	Epidermal nevus	VCV000039647	1	115258681	1	114716060	39647	48246	rs397514553	NC_000001.11:114716059:G:A	single nucleotide variant	missense variant	Pathogenic	Apr 1, 2012	no assertion criteria provided							
NM_002524.5(NRAS):c.71T>A (p.Ile24Asn)	NRAS	I24N	RASopathy	VCV000222971	1	115258711	1	114716090	222971	224691	rs869025573	NC_000001.11:114716089:A:T	single nucleotide variant	missense variant	Likely pathogenic	Sep 17, 2024	reviewed by expert panel							
NM_002524.5(NRAS):c.38G>T (p.Gly13Val)	NRAS	G13V	Cardiovascular phenotype	VCV000375876	1	115258744	1	114716123	375876	362755	rs121434596	NC_000001.11:114716122:C:A	single nucleotide variant	missense variant	Likely pathogenic	Jul 2, 2018	criteria provided, single submitter							
NM_002524.5(NRAS):c.38G>A (p.Gly13Asp)	NRAS	G13D	not provided|Autoimmune lymphoproliferative syndrome type 4|Noonan syndrome 6|Acute megakaryoblastic leukemia in down syndrome|RASopathy|Neoplasm	VCV000013901	1	115258744	1	114716123	13901	28940	rs121434596	NC_000001.11:114716122:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 24, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_002524.5(NRAS):c.37G>C (p.Gly13Arg)	NRAS	G13R	Noonan syndrome 6|not provided	VCV000013899	1	115258745	1	114716124	13899	28938	rs121434595	NC_000001.11:114716123:C:G	single nucleotide variant	missense variant	Likely pathogenic	Nov 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_002524.5(NRAS):c.34_35delinsTT (p.Gly12Phe)	NRAS	G12F	NRAS-related disorder	VCV003029607	1	115258747 - 115258748	1	114716126 - 114716127	3029607	3189473		NC_000001.11:114716125:CC:AA	Indel	missense variant	Likely pathogenic	Jan 10, 2024	no assertion criteria provided							
NM_002524.5(NRAS):c.35G>C (p.Gly12Ala)	NRAS	G12A	Noonan syndrome and Noonan-related syndrome|RASopathy|Myelodysplastic syndrome progressed to acute myeloid leukemia|not provided	VCV000219097	1	115258747	1	114716126	219097	216786	rs121913237	NC_000001.11:114716125:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002524.5(NRAS):c.35G>T (p.Gly12Val)	NRAS	G12V	Noonan syndrome|RASopathy|not provided|Neoplasm	VCV000040470	1	115258747	1	114716126	40470	48940	rs121913237	NC_000001.11:114716125:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 22, 2023	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_002524.5(NRAS):c.35G>A (p.Gly12Asp)	NRAS	G12D	RASopathy|NRAS-related disorder|Noonan syndrome and Noonan-related syndrome|not provided|Cardiovascular phenotype|Autoimmune lymphoproliferative syndrome type 4|Noonan syndrome 6	VCV000039648	1	115258747	1	114716126	39648	48247	rs121913237	NC_000001.11:114716125:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_002524.5(NRAS):c.34G>A (p.Gly12Ser)	NRAS	G12S	RASopathy|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 6|not provided|Neoplasm	VCV000177778	1	115258748	1	114716127	177778	172332	rs121913250	NC_000001.11:114716126:C:T	single nucleotide variant	missense variant	Pathogenic	Sep 11, 2023	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_002524.5(NRAS):c.34G>C (p.Gly12Arg)	NRAS	G12R	Increased nuchal translucency|not provided|Noonan syndrome 6	VCV000040469	1	115258748	1	114716127	40469	48939	rs121913250	NC_000001.11:114716126:C:G	single nucleotide variant	missense variant	Pathogenic	Jan 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002524.5(NRAS):c.34G>T (p.Gly12Cys)	NRAS	G12C	not provided|Neoplasm	VCV000040468	1	115258748	1	114716127	40468	48938	rs121913250	NC_000001.11:114716126:C:A	single nucleotide variant	missense variant	Pathogenic	Jun 2, 2012	criteria provided, single submitter				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_019032.6(ADAMTSL4):c.2237G>A (p.Arg746His)	ADAMTSL4	R707H, R769H, R746H	not provided	VCV001457756	1	150530480	1	150558004	1457756	1471323	rs754966903	NC_000001.11:150558003:G:A	single nucleotide variant	missense variant	Pathogenic	Feb 1, 2024	criteria provided, single submitter							
NM_019032.6(ADAMTSL4):c.2594G>A (p.Arg865His)	ADAMTSL4	R865H, R826H, R888H	Ectopia lentis 2, isolated, autosomal recessive|Ectopia lentis et pupillae|Ectopia lentis et pupillae|Ectopia lentis 2, isolated, autosomal recessive|not provided	VCV000381746	1	150531472	1	150558996	381746	364468	rs781691587	NC_000001.11:150558995:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1A>G (p.Met1Val)	LMNA	M1V	Cardiovascular phenotype	VCV003229277	1	156084710	1	156114919	3229277	3391194		NC_000001.11:156114918:A:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|intron variant	Pathogenic	Dec 12, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.1A>T (p.Met1Leu)	LMNA	M1L	Charcot-Marie-Tooth disease type 2	VCV001076704	1	156084710	1	156114919	1076704	1058424	rs2102816719	NC_000001.11:156114918:A:T	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic	Feb 20, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.2T>A (p.Met1Lys)	LMNA	M1K	not provided|Cardiovascular phenotype	VCV002488942	1	156084711	1	156114920	2488942	2470608		NC_000001.11:156114919:T:A	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|intron variant	Pathogenic	Jul 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.3G>A (p.Met1Ile)	LMNA	M1I	Charcot-Marie-Tooth disease type 2|not provided|See cases	VCV000488705	1	156084712	1	156114921	488705	481568	rs794728598	NC_000001.11:156114920:G:A	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.3G>C (p.Met1Ile)	LMNA	M1I	not provided	VCV000245838	1	156084712	1	156114921	245838	244206	rs794728598	NC_000001.11:156114920:G:C	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic	Apr 28, 2017	criteria provided, single submitter							
NM_170707.4(LMNA):c.3G>T (p.Met1Ile)	LMNA	M1I	Charcot-Marie-Tooth disease type 2|not provided	VCV000200949	1	156084712	1	156114921	200949	196446	rs794728598	NC_000001.11:156114920:G:T	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic/Likely pathogenic	Apr 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.11C>G (p.Pro4Arg)	LMNA	P4R	Charcot-Marie-Tooth disease type 2	VCV000066795	1	156084720	1	156114929	66795	77692	rs267607620	NC_000001.11:156114928:C:G	single nucleotide variant	missense variant	Pathogenic	Jul 18, 2018	criteria provided, single submitter							
NM_170707.4(LMNA):c.28A>T (p.Thr10Ser)	LMNA|LOC129931597	T10S	Charcot-Marie-Tooth disease type 2	VCV003612170	1	156084737	1	156114946	3612170	3738402		NC_000001.11:156114945:A:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely pathogenic	Jun 9, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.28A>C (p.Thr10Pro)	LMNA|LOC129931597	T10P	Charcot-Marie-Tooth disease type 2	VCV001943785	1	156084737	1	156114946	1943785	1995326		NC_000001.11:156114945:A:C	single nucleotide variant	missense variant	Likely pathogenic	Oct 13, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.29C>G (p.Thr10Ser)	LMNA|LOC129931597	T10S	Charcot-Marie-Tooth disease type 2	VCV003633621	1	156084738	1	156114947	3633621	3770377		NC_000001.11:156114946:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely pathogenic	May 11, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.29C>T (p.Thr10Ile)	LMNA|LOC129931597	T10I	Familial partial lipodystrophy, Dunnigan type|not provided|Inborn genetic diseases	VCV000066888	1	156084738	1	156114947	66888	77785	rs57077886	NC_000001.11:156114946:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 15, 2016	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.73C>T (p.Arg25Cys)	LMNA|LOC129931597	R25C	Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype|Dilated cardiomyopathy 1A	VCV000066929	1	156084782	1	156114991	66929	77826	rs58327533	NC_000001.11:156114990:C:T	single nucleotide variant	missense variant	Likely pathogenic	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.73C>G (p.Arg25Gly)	LOC129931597|LMNA	R25G	Charcot-Marie-Tooth disease type 2|not provided|Cardiovascular phenotype	VCV000066928	1	156084782	1	156114991	66928	77825	rs58327533	NC_000001.11:156114990:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.74G>A (p.Arg25His)	LMNA|LOC129931597	R25H	Charcot-Marie-Tooth disease type 2	VCV002756520	1	156084783	1	156114992	2756520	2909921		NC_000001.11:156114991:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely pathogenic	Dec 15, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.74G>C (p.Arg25Pro)	LMNA|LOC129931597	R25P	Charcot-Marie-Tooth disease type 2	VCV000066932	1	156084783	1	156114992	66932	77829	rs61578124	NC_000001.11:156114991:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 30, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.80C>T (p.Thr27Ile)	LMNA|LOC129931597	T27I	Dilated cardiomyopathy 1A|Congenital muscular dystrophy due to LMNA mutation|Charcot-Marie-Tooth disease type 2	VCV000804298	1	156084789	1	156114998	804298	792654	rs863225270	NC_000001.11:156114997:C:T	single nucleotide variant	missense variant	Likely pathogenic	Oct 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.82C>G (p.Arg28Gly)	LMNA|LOC129931597	R28G	Inborn genetic diseases	VCV000225065	1	156084791	1	156115000	225065	226866	rs59914820	NC_000001.11:156114999:C:G	single nucleotide variant	missense variant	Likely pathogenic	Dec 28, 2012	criteria provided, single submitter							
NM_170707.4(LMNA):c.82C>T (p.Arg28Trp)	LMNA|LOC129931597	R28W	Charcot-Marie-Tooth disease type 2	VCV000066946	1	156084791	1	156115000	66946	77843	rs59914820	NC_000001.11:156114999:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 24, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.83G>A (p.Arg28Gln)	LOC129931597|LMNA	R28Q	not provided|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Charcot-Marie-Tooth disease type 2	VCV000285468	1	156084792	1	156115001	285468	269705	rs886043109	NC_000001.11:156115000:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.91G>A (p.Glu31Lys)	LMNA|LOC129931597	E31K	Charcot-Marie-Tooth disease type 2|not provided	VCV000573778	1	156084800	1	156115009	573778	556955	rs1228406418	NC_000001.11:156115008:G:A	single nucleotide variant	missense variant	Pathogenic	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.92A>G (p.Glu31Gly)	LMNA|LOC129931597	E31G	Charcot-Marie-Tooth disease type 2	VCV000944168	1	156084801	1	156115010	944168	921664	rs1649709575	NC_000001.11:156115009:A:G	single nucleotide variant	missense variant	Pathogenic	Aug 26, 2019	criteria provided, single submitter							
NM_170707.4(LMNA):c.94A>G (p.Lys32Glu)	LMNA|LOC129931597	K32E	Charcot-Marie-Tooth disease type 2|Congenital muscular dystrophy due to LMNA mutation	VCV000476837	1	156084803	1	156115012	476837	447227	rs1553261891	NC_000001.11:156115011:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.95A>C (p.Lys32Thr)	LMNA|LOC129931597	K32T	Congenital muscular dystrophy due to LMNA mutation	VCV002503449	1	156084804	1	156115013	2503449	2668630		NC_000001.11:156115012:A:C	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Pathogenic	Apr 1, 2023	no assertion criteria provided							
NM_170707.4(LMNA):c.98A>G (p.Glu33Gly)	LMNA|LOC129931597	E33G	Charcot-Marie-Tooth disease type 2	VCV000066962	1	156084807	1	156115016	66962	77859	rs267607614	NC_000001.11:156115015:A:G	single nucleotide variant	missense variant	Pathogenic	Jul 12, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.99G>C (p.Glu33Asp)	LMNA|LOC129931597	E33D	not provided	VCV000066964	1	156084808	1	156115017	66964	77861	rs57966821	NC_000001.11:156115016:G:C	single nucleotide variant	missense variant	Likely pathogenic	Aug 24, 2019	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.104T>C (p.Leu35Pro)	LMNA|LOC129931597	L35P	not provided|Muscular dystrophy|Charcot-Marie-Tooth disease type 2	VCV000066765	1	156084813	1	156115022	66765	77662	rs267607644	NC_000001.11:156115021:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.112C>G (p.Leu38Val)	LMNA	L38V	Charcot-Marie-Tooth disease type 2	VCV001067826	1	156084821	1	156115030	1067826	1054742	rs2102817550	NC_000001.11:156115029:C:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 1, 2021	criteria provided, single submitter							
NM_170707.4(LMNA):c.115A>G (p.Asn39Asp)	LMNA	N39D	Charcot-Marie-Tooth disease type 2	VCV002202857	1	156084824	1	156115033	2202857	1928507		NC_000001.11:156115032:A:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 14, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.115A>C (p.Asn39His)	LMNA	N39H	Charcot-Marie-Tooth disease type 2	VCV000935833	1	156084824	1	156115033	935833	930061	rs267607627	NC_000001.11:156115032:A:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.116A>T (p.Asn39Ile)	LMNA	N39I	Charcot-Marie-Tooth disease type 2	VCV000649203	1	156084825	1	156115034	649203	626904	rs57983345	NC_000001.11:156115033:A:T	single nucleotide variant	missense variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.116A>G (p.Asn39Ser)	LMNA	N39S	not provided|LMNA-related disorder|Charcot-Marie-Tooth disease type 2	VCV000066791	1	156084825	1	156115034	66791	77688	rs57983345	NC_000001.11:156115033:A:G	single nucleotide variant	missense variant	Pathogenic	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.117T>A (p.Asn39Lys)	LMNA	N39K	Charcot-Marie-Tooth disease type 2	VCV002098082	1	156084826	1	156115035	2098082	2146938		NC_000001.11:156115034:T:A	single nucleotide variant	missense variant	Pathogenic	Jul 13, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.121C>T (p.Arg41Cys)	LMNA	R41C	Charcot-Marie-Tooth disease type 2	VCV002733990	1	156084830	1	156115039	2733990	2898323		NC_000001.11:156115038:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Pathogenic	Jul 31, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.122G>C (p.Arg41Pro)	LMNA	R41P	not provided	VCV000806240	1	156084831	1	156115040	806240	794448	rs1060502215	NC_000001.11:156115039:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jul 1, 2017	criteria provided, single submitter							
NM_170707.4(LMNA):c.122G>A (p.Arg41His)	LMNA	R41H	not provided|Charcot-Marie-Tooth disease type 2	VCV000408994	1	156084831	1	156115040	408994	390827	rs1060502215	NC_000001.11:156115039:G:A	single nucleotide variant	missense variant	Pathogenic	Mar 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.125T>C (p.Leu42Ser)	LMNA	L42S	Charcot-Marie-Tooth disease type 2	VCV001479657	1	156084834	1	156115043	1479657	1439380	rs2102817644	NC_000001.11:156115042:T:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 17, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.128C>A (p.Ala43Glu)	LMNA	A43E	Charcot-Marie-Tooth disease type 2	VCV001457766	1	156084837	1	156115046	1457766	1471333	rs2102817667	NC_000001.11:156115045:C:A	single nucleotide variant	missense variant	Pathogenic	Sep 4, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.134A>G (p.Tyr45Cys)	LMNA	Y45C	Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Charcot-Marie-Tooth disease type 2	VCV000066807	1	156084843	1	156115052	66807	77704	rs58436778	NC_000001.11:156115051:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.139G>T (p.Asp47Tyr)	LMNA	D47Y	not provided	VCV002571950	1	156084848	1	156115057	2571950	2736896		NC_000001.11:156115056:G:T	single nucleotide variant	5 prime UTR variant|intron variant|missense variant	Pathogenic	Jan 9, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.142C>G (p.Arg48Gly)	LMNA	R48G	Charcot-Marie-Tooth disease type 2	VCV001386753	1	156084851	1	156115060	1386753	1357880	rs769977710	NC_000001.11:156115059:C:G	single nucleotide variant	missense variant	Likely pathogenic	Dec 23, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.143G>A (p.Arg48His)	LMNA	R48H	Charcot-Marie-Tooth disease type 2	VCV002873499	1	156084852	1	156115061	2873499	3032214		NC_000001.11:156115060:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely pathogenic	Jul 20, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.143G>T (p.Arg48Leu)	LMNA	R48L	Charcot-Marie-Tooth disease type 2	VCV000655012	1	156084852	1	156115061	655012	626907	rs1572332235	NC_000001.11:156115060:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 26, 2025	criteria provided, single submitter							
NM_170707.4(LMNA):c.143G>C (p.Arg48Pro)	LMNA	R48P	not provided|Charcot-Marie-Tooth disease type 2	VCV000646027	1	156084852	1	156115061	646027	626906	rs1572332235	NC_000001.11:156115060:G:C	single nucleotide variant	missense variant	Pathogenic	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.149G>C (p.Arg50Pro)	LMNA	R50P	not provided	VCV000066840	1	156084858	1	156115067	66840	77737	rs60695352	NC_000001.11:156115066:G:C	single nucleotide variant	missense variant	Pathogenic	May 3, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.154C>G (p.Leu52Val)	LMNA	L52V	Primary dilated cardiomyopathy	VCV000048042	1	156084863	1	156115072	48042	57206	rs397517895	NC_000001.11:156115071:C:G	single nucleotide variant	missense variant	Likely pathogenic	Mar 2, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.158A>G (p.Glu53Gly)	LMNA	E53G	not provided|Charcot-Marie-Tooth disease type 2	VCV000424915	1	156084867	1	156115076	424915	413249	rs60290646	NC_000001.11:156115075:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 9, 2018	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.164A>G (p.Glu55Gly)	LMNA	E55G	Hutchinson-Gilford syndrome	VCV001308669	1	156084873	1	156115082	1308669	1298938	rs2102817930	NC_000001.11:156115081:A:G	single nucleotide variant	missense variant	Likely pathogenic	Nov 1, 2021	criteria provided, single submitter							
NM_170707.4(LMNA):c.168C>G (p.Asn56Lys)	LMNA	N56K	Congenital muscular dystrophy due to LMNA mutation|Heart-hand syndrome, Slovenian type|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Dilated cardiomyopathy 1A|Hutchinson-Gilford syndrome|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Familial partial lipodystrophy, Dunnigan type	VCV001341358	1	156084877	1	156115086	1341358	1332566	rs2102817952	NC_000001.11:156115085:C:G	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_170707.4(LMNA):c.169G>C (p.Ala57Pro)	LMNA	A57P	Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome	VCV000014506	1	156084878	1	156115087	14506	29545	rs28928903	NC_000001.11:156115086:G:C	single nucleotide variant	missense variant	Pathogenic	Feb 15, 2009	no assertion criteria provided							
NM_170707.4(LMNA):c.176T>G (p.Leu59Arg)	LMNA	L59R	Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome	VCV000018457	1	156084885	1	156115094	18457	33496	rs58922911	NC_000001.11:156115093:T:G	single nucleotide variant	missense variant	Pathogenic	Feb 15, 2009	no assertion criteria provided							
NM_170707.4(LMNA):c.178C>G (p.Arg60Gly)	LMNA	R60G	Familial partial lipodystrophy, Dunnigan type|Dilated cardiomyopathy 1A	VCV000014479	1	156084887	1	156115096	14479	29518	rs28928900	NC_000001.11:156115095:C:G	single nucleotide variant	missense variant	Pathogenic	Aug 27, 2002	no assertion criteria provided							
NM_170707.4(LMNA):c.179G>A (p.Arg60His)	LMNA	R60H	Charcot-Marie-Tooth disease type 2	VCV002722945	1	156084888	1	156115097	2722945	2888172		NC_000001.11:156115096:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.184C>T (p.Arg62Cys)	LMNA	R62C	Charcot-Marie-Tooth disease type 2	VCV000570592	1	156084893	1	156115102	570592	558140	rs56793579	NC_000001.11:156115101:C:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 9, 2021	criteria provided, single submitter							
NM_170707.4(LMNA):c.184C>G (p.Arg62Gly)	LMNA	R62G	Familial partial lipodystrophy, Dunnigan type|not provided|Charcot-Marie-Tooth disease type 2	VCV000066868	1	156084893	1	156115102	66868	77765	rs56793579	NC_000001.11:156115101:C:G	single nucleotide variant	missense variant	Pathogenic	Jun 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.185G>T (p.Arg62Leu)	LMNA	R62L	Charcot-Marie-Tooth disease type 2	VCV000971606	1	156084894	1	156115103	971606	952090	rs1649721643	NC_000001.11:156115102:G:T	single nucleotide variant	missense variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.194A>T (p.Glu65Val)	LMNA	E65V	Charcot-Marie-Tooth disease type 2	VCV002003305	1	156084903	1	156115112	2003305	2055224		NC_000001.11:156115111:A:T	single nucleotide variant	missense variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.194A>G (p.Glu65Gly)	LMNA	E65G	Charcot-Marie-Tooth disease type 2	VCV001074127	1	156084903	1	156115112	1074127	1058426	rs2102818172	NC_000001.11:156115111:A:G	single nucleotide variant	missense variant	Pathogenic	Aug 15, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.203A>T (p.Glu68Val)	LMNA	E68V	Charcot-Marie-Tooth disease type 2	VCV001412639	1	156084912	1	156115121	1412639	1344620	rs2102818240	NC_000001.11:156115120:A:T	single nucleotide variant	missense variant	Pathogenic	Jul 13, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.215G>C (p.Arg72Pro)	LMNA	R72P	Congenital muscular dystrophy due to LMNA mutation	VCV002882128	1	156084924	1	156115133	2882128	3042731		NC_000001.11:156115132:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely pathogenic	Feb 5, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.234G>T (p.Lys78Asn)	LMNA	K78N	Arrhythmogenic right ventricular dysplasia 9	VCV000444011	1	156084943	1	156115152	444011	437672	rs727505038	NC_000001.11:156115151:G:T	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_170707.4(LMNA):c.244G>A (p.Glu82Lys)	LMNA	E82K	Charcot-Marie-Tooth disease type 2|not provided|Primary dilated cardiomyopathy	VCV000066882	1	156084953	1	156115162	66882	77779	rs59270054	NC_000001.11:156115161:G:A	single nucleotide variant	missense variant	Pathogenic	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.245A>G (p.Glu82Gly)	LMNA	E82G	Charcot-Marie-Tooth disease type 2	VCV002089379	1	156084954	1	156115163	2089379	2144709		NC_000001.11:156115162:A:G	single nucleotide variant	missense variant	Likely pathogenic	Oct 5, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.254T>A (p.Leu85His)	LMNA	L85H	Charcot-Marie-Tooth disease type 2	VCV000242004	1	156084963	1	156115172	242004	238146	rs28933090	NC_000001.11:156115171:T:A	single nucleotide variant	missense variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.265C>G (p.Arg89Gly)	LMNA	R89G	Charcot-Marie-Tooth disease type 2	VCV000959029	1	156084974	1	156115183	959029	941492	rs267607559	NC_000001.11:156115182:C:G	single nucleotide variant	missense variant	Likely pathogenic	Mar 23, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.265C>T (p.Arg89Cys)	LMNA	R89C	Heart-hand syndrome, Slovenian type	VCV000066883	1	156084974	1	156115183	66883	77780	rs267607559	NC_000001.11:156115182:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 1, 2022	no assertion criteria provided							
NM_170707.4(LMNA):c.266G>T (p.Arg89Leu)	LMNA	R89L	Charcot-Marie-Tooth disease type 2	VCV000066884	1	156084975	1	156115184	66884	77781	rs59040894	NC_000001.11:156115183:G:T	single nucleotide variant	missense variant	Pathogenic	Sep 21, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.274C>T (p.Leu92Phe)	LMNA	L92F	Cardiovascular phenotype|not provided|Primary familial dilated cardiomyopathy	VCV000066885	1	156084983	1	156115192	66885	77782	rs267607560	NC_000001.11:156115191:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.275T>C (p.Leu92Pro)	LMNA	L92P	Charcot-Marie-Tooth disease type 2	VCV001071935	1	156084984	1	156115193	1071935	1058427	rs2102818731	NC_000001.11:156115192:T:C	single nucleotide variant	missense variant	Pathogenic	Jun 24, 2021	criteria provided, single submitter							
NM_170707.4(LMNA):c.280T>C (p.Ser94Pro)	LMNA	S94P	Charcot-Marie-Tooth disease type 2	VCV001357086	1	156084989	1	156115198	1357086	1348516	rs2102818745	NC_000001.11:156115197:T:C	single nucleotide variant	missense variant	Pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.296G>C (p.Arg99Pro)	LMNA	R99P	Primary familial dilated cardiomyopathy	VCV000684819	1	156085005	1	156115214	684819	672372	rs1572332762	NC_000001.11:156115213:G:C	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_170707.4(LMNA):c.308A>G (p.Gln103Arg)	LMNA	Q103R	not provided	VCV001299837	1	156085017	1	156115226	1299837	1289889	rs2102818914	NC_000001.11:156115225:A:G	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_170707.4(LMNA):c.317T>C (p.Leu106Pro)	LMNA	L106P	not provided|Charcot-Marie-Tooth disease type 2	VCV002098083	1	156085026	1	156115235	2098083	2146939		NC_000001.11:156115234:T:C	single nucleotide variant	missense variant	Pathogenic	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.331G>A (p.Glu111Lys)	LMNA	E111K	Hutchinson-Gilford syndrome	VCV002572315	1	156085040	1	156115249	2572315	2737261		NC_000001.11:156115248:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely pathogenic	Jun 30, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.331G>C (p.Glu111Gln)	LMNA	E111Q	Dilated cardiomyopathy 1A	VCV000048060	1	156085040	1	156115249	48060	57224	rs61726475	NC_000001.11:156115248:G:C	single nucleotide variant	missense variant	Likely pathogenic	Dec 21, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.354_355delinsAG (p.Arg119Gly)	LMNA	R119G	Conduction system disorder	VCV000222695	1	156085063 - 156085064	1	156115272 - 156115273	222695	224179	rs869025458	NC_000001.11:156115271:GC:AG	Indel	missense variant	Likely pathogenic	Mar 11, 2015	criteria provided, single submitter							
NM_170707.4(LMNA):c.397C>G (p.Arg133Gly)	LMNA|LOC126805877	R34G, R52G, R21G, R133G	Charcot-Marie-Tooth disease type 2	VCV002733992	1	156100448	1	156130657	2733992	2898325		NC_000001.11:156130656:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely pathogenic	Dec 21, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.398G>C (p.Arg133Pro)	LMNA|LOC126805877	R133P, R52P, R21P	Charcot-Marie-Tooth disease type 2	VCV000014508	1	156100449	1	156130658	14508	29547	rs60864230	NC_000001.11:156130657:G:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 26, 2020	criteria provided, single submitter							
NM_170707.4(LMNA):c.398G>T (p.Arg133Leu)	LMNA|LOC126805877	R133L, R21L, R52L	Charcot-Marie-Tooth disease type 2	VCV000014488	1	156100449	1	156130658	14488	29527	rs60864230	NC_000001.11:156130657:G:T	single nucleotide variant	missense variant	Pathogenic	Jul 5, 2020	criteria provided, single submitter							
NM_170707.4(LMNA):c.401T>C (p.Leu134Pro)	LMNA|LOC126805877	L134P, L22P, L35P, L53P	Dilated cardiomyopathy 1A	VCV002505337	1	156100452	1	156130661	2505337	2670301		NC_000001.11:156130660:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely pathogenic	Jun 1, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.412G>A (p.Glu138Lys)	LMNA|LOC126805877	E138K, E26K, E57K	not provided	VCV000066897	1	156100463	1	156130672	66897	77794	rs267607649	NC_000001.11:156130671:G:A	single nucleotide variant	missense variant	Pathogenic	Oct 24, 2016	criteria provided, single submitter							
NM_170707.4(LMNA):c.419T>C (p.Leu140Pro)	LMNA|LOC126805877	L140P, L28P, L59P	Charcot-Marie-Tooth disease type 2	VCV000066898	1	156100470	1	156130679	66898	77795	rs60652225	NC_000001.11:156130678:T:C	single nucleotide variant	missense variant	Pathogenic	Sep 6, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.419T>G (p.Leu140Arg)	LMNA|LOC126805877	L140R, L28R, L59R	Hutchinson-Gilford progeria syndrome, childhood-onset	VCV000014507	1	156100470	1	156130679	14507	29546	rs60652225	NC_000001.11:156130678:T:G	single nucleotide variant	missense variant	Pathogenic	Aug 9, 2003	no assertion criteria provided							
NM_170707.4(LMNA):c.422T>C (p.Leu141Pro)	LMNA|LOC126805877	L141P, L29P, L60P	Charcot-Marie-Tooth disease type 2	VCV001364147	1	156100473	1	156130682	1364147	1386086	rs2102865805	NC_000001.11:156130681:T:C	single nucleotide variant	missense variant	Pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.427T>C (p.Ser143Pro)	LOC126805877|LMNA	S143P, S31P, S62P	Charcot-Marie-Tooth disease type 2|not provided|Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A	VCV000066899	1	156100478	1	156130687	66899	77796	rs61661343	NC_000001.11:156130686:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.428C>T (p.Ser143Phe)	LOC126805877|LMNA	S143F, S31F, S62F	Congenital muscular dystrophy due to LMNA mutation	VCV000014510	1	156100479	1	156130688	14510	29549	rs58912633	NC_000001.11:156130687:C:T	single nucleotide variant	missense variant	Pathogenic	Dec 1, 2007	no assertion criteria provided							
NM_170707.4(LMNA):c.431A>C (p.Lys144Thr)	LMNA|LOC126805877	K63T, K32T, K45T, K144T	Charcot-Marie-Tooth disease type 2	VCV002151903	1	156100482	1	156130691	2151903	1891983		NC_000001.11:156130690:A:C	single nucleotide variant	missense variant	Pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.433G>A (p.Glu145Lys)	LMNA|LOC126805877	E145K, E33K, E64K	Hutchinson-Gilford progeria syndrome, atypical	VCV000014502	1	156100484	1	156130693	14502	29541	rs60310264	NC_000001.11:156130692:G:A	single nucleotide variant	missense variant	Pathogenic	May 15, 2003	no assertion criteria provided							
NM_170707.4(LMNA):c.443T>C (p.Leu148Pro)	LMNA|LOC126805877	L148P, L36P, L67P	not provided	VCV000245752	1	156100494	1	156130703	245752	244216	rs879253929	NC_000001.11:156130702:T:C	single nucleotide variant	missense variant	Likely pathogenic	Apr 23, 2015	criteria provided, single submitter							
NM_170707.4(LMNA):c.448A>C (p.Thr150Pro)	LMNA|LOC126805877	T150P, T38P, T69P	Charcot-Marie-Tooth disease type 2|Inborn genetic diseases|Primary dilated cardiomyopathy	VCV000048067	1	156100499	1	156130708	48067	57231	rs58917027	NC_000001.11:156130707:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.481G>A (p.Glu161Lys)	LMNA|LOC126805877	E161K, E80K, E49K	not provided|Long QT syndrome|Cardiomyopathy|Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Cardiovascular phenotype|Charcot-Marie-Tooth disease type 2	VCV000014504	1	156100532	1	156130741	14504	29543	rs28933093	NC_000001.11:156130740:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.485T>C (p.Leu162Pro)	LMNA|LOC126805877	L162P, L50P, L81P	Primary dilated cardiomyopathy	VCV000048068	1	156100536	1	156130745	48068	57232	rs267607594	NC_000001.11:156130744:T:C	single nucleotide variant	missense variant	Likely pathogenic	Apr 2, 2009	no assertion criteria provided							
NM_170707.4(LMNA):c.497G>C (p.Arg166Pro)	LOC126805877|LMNA	R166P, R85P, R54P	Charcot-Marie-Tooth disease type 2|not provided|Cardiovascular phenotype|Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy	VCV000066901	1	156100548	1	156130757	66901	77798	rs267607570	NC_000001.11:156130756:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.568C>T (p.Arg190Trp)	LMNA	R190W, R109W, R78W	not provided|Primary dilated cardiomyopathy|LMNA-related disorder|Cardiovascular phenotype|Charcot-Marie-Tooth disease type 2	VCV000066908	1	156104248	1	156134457	66908	77805	rs59026483	NC_000001.11:156134456:C:T	single nucleotide variant	missense variant	Pathogenic	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.569G>A (p.Arg190Gln)	LMNA	R190Q, R109Q, R78Q	Dilated cardiomyopathy 1A|Charcot-Marie-Tooth disease type 2|not provided|Cardiomyopathy|Cardiovascular phenotype|Primary dilated cardiomyopathy	VCV000066910	1	156104249	1	156134458	66910	77807	rs267607571	NC_000001.11:156134457:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.575A>T (p.Asp192Val)	LMNA	D192V, D111V, D80V	Dilated cardiomyopathy 1A	VCV000066912	1	156104255	1	156134464	66912	77809	rs57045855	NC_000001.11:156134463:A:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 23, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.585C>G (p.Asn195Lys)	LMNA	N195K, N114K, N83K	Charcot-Marie-Tooth disease type 2|Primary dilated cardiomyopathy|not provided	VCV000014483	1	156104265	1	156134474	14483	29522	rs28933091	NC_000001.11:156134473:C:G	single nucleotide variant	missense variant	Pathogenic	Oct 27, 2021	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.590T>C (p.Leu197Pro)	LMNA	L116P, L85P, L197P	Charcot-Marie-Tooth disease type 2	VCV000939069	1	156104270	1	156134479	939069	930065	rs1651348222	NC_000001.11:156134478:T:C	single nucleotide variant	missense variant	Likely pathogenic	Aug 26, 2019	criteria provided, single submitter							
NM_170707.4(LMNA):c.593A>C (p.Gln198Pro)	LMNA	Q117P, Q86P, Q198P	Charcot-Marie-Tooth disease type 2	VCV001472188	1	156104273	1	156134482	1472188	1385336	rs2102878915	NC_000001.11:156134481:A:C	single nucleotide variant	missense variant	Likely pathogenic	Jul 25, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.607G>A (p.Glu203Lys)	LMNA	E203K, E91K, E122K	not provided|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype	VCV000048070	1	156104287	1	156134496	48070	57234	rs61195471	NC_000001.11:156134495:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.608A>T (p.Glu203Val)	LMNA	E203V, E91V, E122V	Charcot-Marie-Tooth disease type 2|Primary familial dilated cardiomyopathy	VCV000066915	1	156104288	1	156134497	66915	77812	rs28933092	NC_000001.11:156134496:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.608A>G (p.Glu203Gly)	LMNA	E203G, E122G, E91G	Charcot-Marie-Tooth disease type 2|Primary dilated cardiomyopathy	VCV000014484	1	156104288	1	156134497	14484	29523	rs28933092	NC_000001.11:156134496:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.611T>G (p.Leu204Arg)	LMNA	L204R, L123R, L92R	Dilated cardiomyopathy 1A	VCV000520416	1	156104291	1	156134500	520416	511002	rs1553265180	NC_000001.11:156134499:T:G	single nucleotide variant	missense variant	Likely pathogenic	Nov 27, 2017	criteria provided, single submitter							
NM_170707.4(LMNA):c.618C>A (p.Phe206Leu)	LMNA	F206L, F94L, F125L	Charcot-Marie-Tooth disease type 2|not provided	VCV000636395	1	156104298	1	156134507	636395	624159	rs267607629	NC_000001.11:156134506:C:A	single nucleotide variant	missense variant	Likely pathogenic	Mar 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.618C>G (p.Phe206Leu)	LMNA	F206L, F125L, F94L	Charcot-Marie-Tooth disease type 2|not provided|Cardiovascular phenotype	VCV000066916	1	156104298	1	156134507	66916	77813	rs267607629	NC_000001.11:156134506:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.644T>C (p.Leu215Pro)	LMNA	L215P, L103P, L134P	Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype	VCV000065764	1	156104600	1	156134809	65764	76672	rs61295588	NC_000001.11:156134808:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.646C>T (p.Arg216Cys)	LMNA	R216C, R135C, R104C	Primary familial dilated cardiomyopathy|Atrioventricular block|Charcot-Marie-Tooth disease type 2|Primary dilated cardiomyopathy|not provided|Primary dilated cardiomyopathy|Laminopathy|Cardiovascular phenotype	VCV000200938	1	156104602	1	156134811	200938	196467	rs794728591	NC_000001.11:156134810:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.656A>C (p.Lys219Thr)	LMNA	K219T, K138T, K107T	not provided|Charcot-Marie-Tooth disease type 2	VCV000066922	1	156104612	1	156134821	66922	77819	rs267607584	NC_000001.11:156134820:A:C	single nucleotide variant	missense variant	Likely pathogenic	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.664C>T (p.His222Tyr)	LMNA	H222Y, H141Y, H110Y	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	VCV000014492	1	156104620	1	156134829	14492	29531	rs28928901	NC_000001.11:156134828:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 1, 2000	no assertion criteria provided							
NM_170707.4(LMNA):c.674G>C (p.Arg225Pro)	LMNA	D4H, R113P, R126P, R144P, R225P, R39P	Charcot-Marie-Tooth disease type 2	VCV002413543	1	156104630	1	156134839	2413543	1946881		NC_000001.11:156134838:G:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.674G>T (p.Arg225Leu)	LMNA	R225L, R113L, R144L	Charcot-Marie-Tooth disease type 2	VCV001364825	1	156104630	1	156134839	1364825	1409306	rs199474724	NC_000001.11:156134838:G:T	single nucleotide variant	missense variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.688G>A (p.Asp230Asn)	LMNA	D230N, D118N, D149N	Familial partial lipodystrophy, Dunnigan type	VCV000014518	1	156104644	1	156134853	14518	29557	rs61214927	NC_000001.11:156134852:G:A	single nucleotide variant	missense variant	Pathogenic	Feb 1, 2007	no assertion criteria provided							
NM_170707.4(LMNA):c.689A>C (p.Asp230Ala)	LMNA	D131A, D118A, D230A, D44A, D149A, T9P	Charcot-Marie-Tooth disease type 2	VCV003633629	1	156104645	1	156134854	3633629	3770385		NC_000001.11:156134853:A:C	single nucleotide variant	missense variant	Pathogenic	Jun 14, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.694G>A (p.Gly232Arg)	LMNA	G232R, G120R, G151R	not provided|Charcot-Marie-Tooth disease type 2	VCV000285122	1	156104650	1	156134859	285122	269359	rs267607609	NC_000001.11:156134858:G:A	single nucleotide variant	missense variant	Pathogenic	Nov 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.694G>C (p.Gly232Arg)	LMNA	G232R, G120R, G151R	Charcot-Marie-Tooth disease type 2	VCV000066924	1	156104650	1	156134859	66924	77821	rs267607609	NC_000001.11:156134858:G:C	single nucleotide variant	missense variant	Likely pathogenic	Dec 26, 2019	criteria provided, single submitter							
NM_170707.4(LMNA):c.695G>A (p.Gly232Glu)	LMNA	G232E, G151E, G120E	Charcot-Marie-Tooth disease type 2|Emery-Dreifuss muscular dystrophy 2, autosomal dominant	VCV000066925	1	156104651	1	156134860	66925	77822	rs57207746	NC_000001.11:156134859:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 25, 2019	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.725C>A (p.Ala242Glu)	LMNA	A242E, A130E, A143E, A56E, A161E	Charcot-Marie-Tooth disease type 2	VCV002776047	1	156104681	1	156134890	2776047	2936339		NC_000001.11:156134889:C:A	single nucleotide variant	missense variant|synonymous variant	Likely pathogenic	Jul 20, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.727G>T (p.Asp243Tyr)	LMNA	D243Y, D131Y, D162Y	Dilated cardiomyopathy 1A	VCV000634638	1	156104683	1	156134892	634638	622303	rs1165819867	NC_000001.11:156134891:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2019	criteria provided, single submitter							
NM_170707.4(LMNA):c.734T>A (p.Leu245Gln)	LMNA	L59Q, L133Q, L146Q, C24S, L245Q, L164Q	Charcot-Marie-Tooth disease type 2	VCV002709822	1	156104690	1	156134899	2709822	2874720		NC_000001.11:156134898:T:A	single nucleotide variant	missense variant	Likely pathogenic	Jan 20, 2025	criteria provided, single submitter							
NM_170707.4(LMNA):c.744_745delinsTT (p.Arg249Trp)	LMNA	R137W, R168W, R249W	Charcot-Marie-Tooth disease type 2	VCV000543181	1	156104700 - 156104701	1	156134909 - 156134910	543181	515161	rs1553265342	NC_000001.11:156134908:GC:TT	Indel	missense variant	Pathogenic	Nov 19, 2017	criteria provided, single submitter							
NM_170707.4(LMNA):c.745C>G (p.Arg249Gly)	LMNA	R249G, R137G, R168G	Laminopathy|Charcot-Marie-Tooth disease type 2	VCV000048077	1	156104701	1	156134910	48077	57241	rs121912496	NC_000001.11:156134909:C:G	single nucleotide variant	missense variant	Likely pathogenic	May 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.745C>T (p.Arg249Trp)	LMNA	R249W, R137W, R168W	not provided|Congenital muscular dystrophy due to LMNA mutation|LMNA-related disorder|Charcot-Marie-Tooth disease type 2	VCV000014524	1	156104701	1	156134910	14524	29563	rs121912496	NC_000001.11:156134909:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.746G>C (p.Arg249Pro)	LMNA	R168P, R249P, G28R, R137P, R63P, R150P	Charcot-Marie-Tooth disease type 2	VCV003633630	1	156104702	1	156134911	3633630	3770386		NC_000001.11:156134910:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jul 19, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.746G>A (p.Arg249Gln)	LMNA	R249Q, R168Q, R137Q	Abnormality of the musculature|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Charcot-Marie-Tooth disease type 2B1|not provided|Charcot-Marie-Tooth disease type 2|Congenital muscular dystrophy due to LMNA mutation|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Charcot-Marie-Tooth disease type 2B1|Mandibuloacral dysplasia with type A lipodystrophy|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Dilated cardiomyopathy 1A|Familial partial lipodystrophy, Dunnigan type|Restrictive dermopathy 2|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Heart-hand syndrome, Slovenian type|Hutchinson-Gilford syndrome|Congenital muscular dystrophy|Cardiomyopathy|Dilated cardiomyopathy 1A|Muscular dystrophy	VCV000066931	1	156104702	1	156134911	66931	77828	rs59332535	NC_000001.11:156134910:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.771_772delinsTT (p.Glu257_Gln258delinsAspTer)	LMNA	S36I	Charcot-Marie-Tooth disease type 2	VCV002831514	1	156104727 - 156104728	1	156134936 - 156134937	2831514	3001114		NC_000001.11:156134935:GC:TT	Indel	nonsense|missense variant	Pathogenic	May 19, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.776A>G (p.Tyr259Cys)	LMNA	Y147C, Y178C, Y259C	Abnormality of the musculature	VCV001180818	1	156104732	1	156134941	1180818	1170138	rs2102881813	NC_000001.11:156134940:A:G	single nucleotide variant	missense variant	Likely pathogenic	Jul 10, 2021	criteria provided, single submitter							
NM_170707.4(LMNA):c.784G>A (p.Glu262Lys)	LMNA	E150K, E181K, E262K	Hutchinson-Gilford syndrome	VCV001698456	1	156104740	1	156134949	1698456	1690834	rs397517909	NC_000001.11:156134948:G:A	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_170707.4(LMNA):c.799T>C (p.Tyr267His)	LMNA	Y267H, Y186H, Y155H	Cardiovascular phenotype|Charcot-Marie-Tooth disease type 2|not provided|Primary dilated cardiomyopathy	VCV000048084	1	156104755	1	156134964	48084	57248	rs267607593	NC_000001.11:156134963:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.810G>C (p.Lys270Asn)	LMNA	K270N, K189N, K158N	Abnormality of the musculature	VCV000636306	1	156104766	1	156134975	636306	624113	rs267607631	NC_000001.11:156134974:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jul 10, 2021	criteria provided, single submitter							
NM_170707.4(LMNA):c.827A>C (p.Gln276Pro)	LMNA	Q164P, Q276P, Q195P, S55R, Q177P, Q90P	Charcot-Marie-Tooth disease type 2	VCV002759749	1	156104994	1	156135203	2759749	2924802		NC_000001.11:156135202:A:C	single nucleotide variant	missense variant	Pathogenic	Oct 19, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.832G>A (p.Ala278Thr)	LMNA	A166T, A197T, A278T	not provided|Charcot-Marie-Tooth disease type 2|LMNA-related disorder	VCV000995175	1	156104999	1	156135208	995175	982360	rs1553265433	NC_000001.11:156135207:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.832G>C (p.Ala278Pro)	LMNA	A278P, A197P, A166P	Charcot-Marie-Tooth disease type 2|Muscular dystrophy	VCV000435769	1	156104999	1	156135208	435769	427648	rs1553265433	NC_000001.11:156135207:G:C	single nucleotide variant	missense variant	Pathogenic	Nov 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.833C>T (p.Ala278Val)	LMNA	A197V, A278V, A166V, A179V, A92V	Charcot-Marie-Tooth disease type 2	VCV003683466	1	156105000	1	156135209	3683466	3812192		NC_000001.11:156135208:C:T	single nucleotide variant	missense variant|synonymous variant	Likely pathogenic	Jan 31, 2025	criteria provided, single submitter							
NM_170707.4(LMNA):c.851T>C (p.Leu284Pro)	LMNA	L284P, L172P, L203P	Charcot-Marie-Tooth disease type 2|Congenital muscular dystrophy due to LMNA mutation	VCV000285938	1	156105018	1	156135227	285938	270175	rs886043260	NC_000001.11:156135226:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.863C>G (p.Ala288Gly)	LMNA	A288G, A176G, A207G	Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease type 2	VCV000048089	1	156105030	1	156135239	48089	57253	rs397517911	NC_000001.11:156135238:C:G	single nucleotide variant	missense variant	Likely pathogenic	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.869A>T (p.Glu290Val)	LMNA	E178V, E209V, E290V	Charcot-Marie-Tooth disease type 2	VCV001025696	1	156105036	1	156135245	1025696	1002175	rs1651453317	NC_000001.11:156135244:A:T	single nucleotide variant	missense variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.871G>A (p.Glu291Lys)	LMNA	E291K, E210K, E179K	Dilated cardiomyopathy 1A|not provided	VCV000200942	1	156105038	1	156135247	200942	196473	rs794728594	NC_000001.11:156135246:G:A	single nucleotide variant	missense variant	Pathogenic	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.872A>T (p.Glu291Val)	LMNA	E105V, E179V, E192V, E210V, E291V, S70C	Dilated cardiomyopathy 1A	VCV002502156	1	156105039	1	156135248	2502156	2534366		NC_000001.11:156135247:A:T	single nucleotide variant	missense variant	Likely pathogenic	Apr 20, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.884C>A (p.Ser295Ter)	LMNA	R74S, S183*, S109*, S196*, S214*, S295*	Charcot-Marie-Tooth disease type 2	VCV002718218	1	156105051	1	156135260	2718218	2880461		NC_000001.11:156135259:C:A	single nucleotide variant	nonsense|missense variant	Pathogenic	Jun 17, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.898G>A (p.Asp300Asn)	LMNA	D300N, D188N, D219N	Dilated cardiomyopathy 1A|Charcot-Marie-Tooth disease type 2|Lipodystrophy	VCV000066952	1	156105065	1	156135274	66952	77849	rs267607591	NC_000001.11:156135273:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.899A>G (p.Asp300Gly)	LMNA	D300G, D188G, D219G	Hutchinson-Gilford progeria syndrome, atypical	VCV000217451	1	156105066	1	156135275	217451	214091	rs79907212	NC_000001.11:156135274:A:G	single nucleotide variant	missense variant	Pathogenic	Jul 1, 2013	no assertion criteria provided							
NM_170707.4(LMNA):c.917T>C (p.Leu306Pro)	LMNA	L306P, L225P, L194P	Dilated cardiomyopathy 1A|not provided	VCV000245950	1	156105084	1	156135293	245950	244222	rs730882262	NC_000001.11:156135292:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 12, 2017	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.917T>G (p.Leu306Arg)	LMNA	L306R, L225R, L194R	Right ventricular cardiomyopathy|Hutchinson-Gilford progeria syndrome, childhood-onset	VCV000183362	1	156105084	1	156135293	183362	181469	rs730882262	NC_000001.11:156135292:T:G	single nucleotide variant	missense variant	Pathogenic	Mar 2, 2015	no assertion criteria provided							
NM_170707.4(LMNA):c.937-2A>G	LMNA	Q104R	Cardiovascular phenotype	VCV001766724	1	156105690	1	156135899	1766724	1824967		NC_000001.11:156135898:A:G	single nucleotide variant	missense variant|splice acceptor variant	Likely pathogenic	Aug 31, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.949G>A (p.Glu317Lys)	LMNA	E317K, E236K, E205K	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A|Cardiomyopathy|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype|not specified|Primary familial dilated cardiomyopathy|not provided	VCV000048093	1	156105704	1	156135913	48093	57257	rs56816490	NC_000001.11:156135912:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.991C>G (p.Arg331Gly)	LMNA	R145G, R232G, R250G, R219G, R123G, R331G	Charcot-Marie-Tooth disease type 2	VCV003689505	1	156105746	1	156135955	3689505	3827585		NC_000001.11:156135954:C:G	single nucleotide variant	missense variant	Likely pathogenic	Oct 1, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.992G>T (p.Arg331Leu)	LMNA	R219L, R250L, R331L	Dilated cardiomyopathy 1A	VCV001077066	1	156105747	1	156135956	1077066	1065711	rs59301204	NC_000001.11:156135955:G:T	single nucleotide variant	missense variant	Likely pathogenic	Apr 27, 2021	no assertion criteria provided							
NM_170707.4(LMNA):c.992G>C (p.Arg331Pro)	LMNA	R331P, R219P, R250P	not provided|Charcot-Marie-Tooth disease type 2	VCV000066963	1	156105747	1	156135956	66963	77860	rs59301204	NC_000001.11:156135955:G:C	single nucleotide variant	missense variant	Likely pathogenic	Apr 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.992G>A (p.Arg331Gln)	LMNA	R331Q, R250Q, R219Q	not provided|Dilated cardiomyopathy 1A|Cardiomyopathy|Charcot-Marie-Tooth disease type 2|LMNA-related disorder|Cardiovascular phenotype|Primary dilated cardiomyopathy|See cases|Primary familial dilated cardiomyopathy	VCV000048098	1	156105747	1	156135956	48098	57262	rs59301204	NC_000001.11:156135955:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp)	LMNA	R335W, R223W, R254W	LMNA-related disorder|Left ventricular noncompaction|Primary dilated cardiomyopathy|Cardiomyopathy|Primary dilated cardiomyopathy|Laminopathy|Primary familial dilated cardiomyopathy|Dilated cardiomyopathy 1A|Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy|Congenital muscular dystrophy due to LMNA mutation|Restrictive dermopathy 2|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Mandibuloacral dysplasia with type A lipodystrophy|Familial partial lipodystrophy, Dunnigan type|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Charcot-Marie-Tooth disease type 2B1|Hutchinson-Gilford syndrome|Heart-hand syndrome, Slovenian type|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Dilated cardiomyopathy 1A|Charcot-Marie-Tooth disease type 2|not provided	VCV000036473	1	156105758	1	156135967	36473	45135	rs386134243	NC_000001.11:156135966:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1069G>C (p.Asp357His)	LMNA	D357H, D245H, D276H	Charcot-Marie-Tooth disease type 2	VCV000066769	1	156105824	1	156136033	66769	77666	rs267607567	NC_000001.11:156136032:G:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 5, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.1072G>A (p.Glu358Lys)	LMNA	E358K, E246K, E277K	Emery-Dreifuss muscular dystrophy|Muscular dystrophy|Charcot-Marie-Tooth disease type 2|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|not provided	VCV000014525	1	156105827	1	156136036	14525	29564	rs60458016	NC_000001.11:156136035:G:A	single nucleotide variant	missense variant	Pathogenic	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1073A>G (p.Glu358Gly)	LMNA	E358G, E246G, E277G	Arrhythmogenic right ventricular dysplasia 9	VCV000265834	1	156105828	1	156136037	265834	260506	rs1114167345	NC_000001.11:156136036:A:G	single nucleotide variant	missense variant	Likely pathogenic	May 1, 2016	no assertion criteria provided							
NM_170707.4(LMNA):c.1081G>A (p.Glu361Lys)	LMNA	E361K, E249K, E280K	Charcot-Marie-Tooth disease type 2|Muscular dystrophy	VCV000066772	1	156105836	1	156136045	66772	77669	rs267607634	NC_000001.11:156136044:G:A	single nucleotide variant	missense variant	Pathogenic	Jan 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1110C>A (p.Asp370Glu)	LMNA	D162E, D271E, D258E, D184E, D370E, D289E	Charcot-Marie-Tooth disease type 2	VCV003677001	1	156105865	1	156136074	3677001	3807034		NC_000001.11:156136073:C:A	single nucleotide variant	missense variant	Pathogenic	Nov 19, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.1110C>G (p.Asp370Glu)	LMNA	D370E, D258E, D289E	Laminopathy	VCV000228270	1	156105865	1	156136074	228270	228276	rs876657649	NC_000001.11:156136073:C:G	single nucleotide variant	missense variant	Likely pathogenic	Nov 11, 2015	criteria provided, single submitter							
NM_170707.4(LMNA):c.1115A>G (p.Glu372Gly)	LMNA	E291G, E260G, E372G	Charcot-Marie-Tooth disease type 2	VCV001467968	1	156105870	1	156136079	1467968	1462350	rs2102888292	NC_000001.11:156136078:A:G	single nucleotide variant	missense variant	Pathogenic	Apr 2, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.1116G>C (p.Glu372Asp)	LMNA	E372D, E260D, E291D	Charcot-Marie-Tooth disease type 2|Dilated cardiomyopathy 1A	VCV000559576	1	156105871	1	156136080	559576	550299	rs1553265736	NC_000001.11:156136079:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 27, 2020	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1117A>T (p.Ile373Phe)	LMNA	I373F, I292F, I261F	Dilated cardiomyopathy 1A	VCV000435770	1	156105872	1	156136081	435770	427650	rs1553265739	NC_000001.11:156136080:A:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 8, 2013	criteria provided, single submitter							
NM_170707.4(LMNA):c.1118T>G (p.Ile373Ser)	LMNA	I373S, I292S, I261S	Charcot-Marie-Tooth disease type 2	VCV000408993	1	156105873	1	156136082	408993	390832	rs1060502214	NC_000001.11:156136081:T:G	single nucleotide variant	missense variant	Likely pathogenic	Jun 19, 2017	criteria provided, single submitter							
NM_170707.4(LMNA):c.1119C>G (p.Ile373Met)	LMNA	I373M, I261M, I292M	Charcot-Marie-Tooth disease type 2	VCV000580670	1	156105874	1	156136083	580670	556616	rs1340894696	NC_000001.11:156136082:C:G	single nucleotide variant	missense variant	Pathogenic	Feb 25, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.1124C>G (p.Ala375Gly)	LMNA	A276G, A167G, A189G, A263G, A375G, A294G	Charcot-Marie-Tooth disease type 2	VCV002733998	1	156105879	1	156136088	2733998	2898331		NC_000001.11:156136087:C:G	single nucleotide variant	missense variant	Pathogenic	Oct 22, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.1126T>C (p.Tyr376His)	LMNA	Y376H, Y295H, Y264H	not provided	VCV000429219	1	156105881	1	156136090	429219	421178	rs1131691263	NC_000001.11:156136089:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 3, 2017	criteria provided, single submitter							
NM_170707.4(LMNA):c.1129C>T (p.Arg377Cys)	LMNA	R377C, R296C, R265C	not provided|Dilated cardiomyopathy 1A|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Congenital muscular dystrophy due to LMNA mutation|Dilated cardiomyopathy 1A|Cardiovascular phenotype|Charcot-Marie-Tooth disease type 2|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease type 2B1	VCV000048031	1	156105884	1	156136093	48031	57195	rs397517889	NC_000001.11:156136092:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1130G>T (p.Arg377Leu)	LMNA	R377L, R265L, R296L	Charcot-Marie-Tooth disease type 2|Primary dilated cardiomyopathy|Cardiovascular phenotype|Congenital muscular dystrophy due to LMNA mutation	VCV000066778	1	156105885	1	156136094	66778	77675	rs61672878	NC_000001.11:156136093:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1130G>A (p.Arg377His)	LMNA	R377H, R265H, R296H	not provided|Sudden unexplained death|Muscular dystrophy|Dilated cardiomyopathy 1A|Cardiovascular phenotype|Congenital muscular dystrophy due to LMNA mutation|Restrictive dermopathy 2|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Mandibuloacral dysplasia with type A lipodystrophy|Familial partial lipodystrophy, Dunnigan type|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Charcot-Marie-Tooth disease type 2B1|Hutchinson-Gilford syndrome|Heart-hand syndrome, Slovenian type|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Dilated cardiomyopathy 1A|Charcot-Marie-Tooth disease type 2	VCV000014495	1	156105885	1	156136094	14495	29534	rs61672878	NC_000001.11:156136093:G:A	single nucleotide variant	missense variant	Pathogenic	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1138T>A (p.Leu380Met)	LMNA	L268M, L281M, L299M, L380M, L172M, L194M	Charcot-Marie-Tooth disease type 2	VCV002974892	1	156105893	1	156136102	2974892	3130091		NC_000001.11:156136101:T:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 13, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.1139T>C (p.Leu380Ser)	LMNA	L380S, L268S, L299S	Congenital muscular dystrophy due to LMNA mutation	VCV000014523	1	156105894	1	156136103	14523	29562	rs121912495	NC_000001.11:156136102:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 1, 2008	no assertion criteria provided							
NM_170707.4(LMNA):c.1147G>A (p.Glu383Lys)	LMNA	E271K, E302K, E383K	Congenital muscular dystrophy due to LMNA mutation|Charcot-Marie-Tooth disease type 2|not provided	VCV000949101	1	156105902	1	156136111	949101	921669	rs1651580090	NC_000001.11:156136110:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1149G>T (p.Glu383Asp)	LMNA	E302D, E271D, E383D	Charcot-Marie-Tooth disease type 2	VCV000941172	1	156105904	1	156136113	941172	930068	rs267607603	NC_000001.11:156136112:G:T	single nucleotide variant	missense variant	Likely pathogenic	Sep 23, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.1150G>A (p.Glu384Lys)	LMNA	E272K, E303K, E384K	Charcot-Marie-Tooth disease type 2	VCV001069324	1	156105905	1	156136114	1069324	1058434	rs2102888695	NC_000001.11:156136113:G:A	single nucleotide variant	missense variant	Pathogenic	Apr 4, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.1156A>G (p.Arg386Gly)	LMNA	R274G, R386G, R305G	Charcot-Marie-Tooth disease type 2	VCV000647241	1	156105911	1	156136120	647241	626920	rs1572363397	NC_000001.11:156136119:A:G	single nucleotide variant	missense variant	Pathogenic	May 17, 2021	criteria provided, single submitter							
NM_170707.4(LMNA):c.1157G>C (p.Arg386Thr)	LMNA	R386T, R274T, R305T	Cardiovascular phenotype	VCV000264271	1	156105912	1	156136121	264271	257932	rs267607545	NC_000001.11:156136120:G:C	single nucleotide variant	missense variant	Pathogenic	Feb 16, 2016	criteria provided, single submitter							
NM_170707.4(LMNA):c.1157G>A (p.Arg386Lys)	LMNA	R386K, R274K, R305K	Charcot-Marie-Tooth disease type 2|not provided|Emery-Dreifuss muscular dystrophy 2, autosomal dominant	VCV000066782	1	156105912	1	156136121	66782	77679	rs267607545	NC_000001.11:156136120:G:A	single nucleotide variant	missense variant	Pathogenic	Feb 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1163G>C (p.Arg388Pro)	LMNA	R388P, R276P, R307P	Muscular dystrophy	VCV000435771	1	156106010	1	156136219	435771	427652	rs267607576	NC_000001.11:156136218:G:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 8, 2013	criteria provided, single submitter							
NM_170707.4(LMNA):c.1325T>A (p.Val442Glu)	LMNA	V234E, V256E, V330E, V343E, V361E, V442E	LMNA-related disorder	VCV003348644	1	156106172	1	156136381	3348644	3507873		NC_000001.11:156136380:T:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 25, 2024	no assertion criteria provided							
NM_170707.4(LMNA):c.1336G>A (p.Asp446Asn)	LMNA	D334N, D347N, D260N, D238N, D365N, D446N	Charcot-Marie-Tooth disease type 2	VCV003633636	1	156106183	1	156136392	3633636	3770392		NC_000001.11:156136391:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 13, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.1337A>T (p.Asp446Val)	LMNA	D446V, D334V, D365V	Charcot-Marie-Tooth disease type 2	VCV000066805	1	156106184	1	156136393	66805	77702	rs58541611	NC_000001.11:156136392:A:T	single nucleotide variant	missense variant	Likely pathogenic	May 14, 2021	criteria provided, single submitter							
NM_170707.4(LMNA):c.1346G>A (p.Gly449Asp)	LMNA	G449D, G337D, G368D	Charcot-Marie-Tooth disease type 2	VCV000066806	1	156106193	1	156136402	66806	77703	rs267607637	NC_000001.11:156136401:G:A	single nucleotide variant	missense variant	Pathogenic	Apr 18, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.1357C>T (p.Arg453Trp)	LMNA	R453W, R341W, R372W	Congenital muscular dystrophy due to LMNA mutation|Dilated cardiomyopathy 1A|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|not provided|Cardiovascular phenotype|Abnormality of the musculature|Charcot-Marie-Tooth disease type 2|Muscular dystrophy	VCV000014478	1	156106204	1	156136413	14478	29517	rs58932704	NC_000001.11:156136412:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1358G>C (p.Arg453Pro)	LMNA	R453P, R341P, R372P	Charcot-Marie-Tooth disease type 2	VCV000066808	1	156106205	1	156136414	66808	77705	rs267607598	NC_000001.11:156136413:G:C	single nucleotide variant	missense variant	Pathogenic	Aug 28, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.1361T>C (p.Leu454Pro)	LMNA	L454P, L373P, L342P	Charcot-Marie-Tooth disease type 2	VCV000066809	1	156106208	1	156136417	66809	77706	rs267607638	NC_000001.11:156136416:T:C	single nucleotide variant	missense variant	Pathogenic	Feb 8, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.1364G>C (p.Arg455Pro)	LMNA	R455P, R374P, R343P	Charcot-Marie-Tooth disease type 2	VCV000066810	1	156106211	1	156136420	66810	77707	rs267607597	NC_000001.11:156136419:G:C	single nucleotide variant	missense variant	Pathogenic	Oct 24, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.1366A>G (p.Asn456Asp)	LMNA	N456D, N344D, N375D	not provided|Charcot-Marie-Tooth disease type 2	VCV000066811	1	156106213	1	156136422	66811	77708	rs267607599	NC_000001.11:156136421:A:G	single nucleotide variant	missense variant	Pathogenic	Jan 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1367A>C (p.Asn456Thr)	LMNA	N344T, N456T, N375T, N248T, N270T, N357T	Charcot-Marie-Tooth disease type 2	VCV002011460	1	156106214	1	156136423	2011460	2070689		NC_000001.11:156136422:A:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.1368C>G (p.Asn456Lys)	LMNA	N375K, N344K, N456K	Charcot-Marie-Tooth disease type 2	VCV000842074	1	156106215	1	156136424	842074	822807	rs61235244	NC_000001.11:156136423:C:G	single nucleotide variant	missense variant	Likely pathogenic	Aug 24, 2021	criteria provided, single submitter							
NM_170707.4(LMNA):c.1368C>A (p.Asn456Lys)	LMNA	N456K, N375K, N344K	not provided	VCV000066813	1	156106215	1	156136424	66813	77710	rs61235244	NC_000001.11:156136423:C:A	single nucleotide variant	missense variant	Pathogenic	Apr 4, 2017	criteria provided, single submitter							
NM_170707.4(LMNA):c.1385A>C (p.Gln462Pro)	LMNA	Q462P, Q350P, Q381P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	VCV000488542	1	156106716	1	156136925	488542	481410	rs1553265999	NC_000001.11:156136924:A:C	single nucleotide variant	missense variant	Likely pathogenic	Dec 7, 2017	criteria provided, single submitter							
NM_170707.4(LMNA):c.1394G>A (p.Gly465Asp)	LMNA	G465D, G353D, G384D	Familial partial lipodystrophy, Dunnigan type|Charcot-Marie-Tooth disease type 2	VCV000014493	1	156106725	1	156136934	14493	29532	rs61282106	NC_000001.11:156136933:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1396A>G (p.Asn466Asp)	LMNA	N354D, N385D, N466D	not provided	VCV001338284	1	156106727	1	156136936	1338284	1329292	rs2102893640	NC_000001.11:156136935:A:G	single nucleotide variant	missense variant	Likely pathogenic	Aug 29, 2017	criteria provided, single submitter							
NM_170707.4(LMNA):c.1399T>A (p.Trp467Arg)	LMNA	W355R, W386R, W467R	Charcot-Marie-Tooth disease type 2	VCV000962895	1	156106730	1	156136939	962895	941501	rs267607639	NC_000001.11:156136938:T:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 1, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.1399T>C (p.Trp467Arg)	LMNA	W467R, W355R, W386R	not provided	VCV000066821	1	156106730	1	156136939	66821	77718	rs267607639	NC_000001.11:156136938:T:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 15, 2021	criteria provided, single submitter							
NM_170707.4(LMNA):c.1411C>T (p.Arg471Cys)	LMNA	R471C, R390C, R359C	not provided|Charcot-Marie-Tooth disease type 2	VCV000014503	1	156106742	1	156136951	14503	29542	rs28928902	NC_000001.11:156136950:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1412G>A (p.Arg471His)	LMNA	R471H, R359H, R390H	not provided|Dilated cardiomyopathy 1A|Charcot-Marie-Tooth disease type 2|Primary dilated cardiomyopathy|Cardiovascular phenotype	VCV000036476	1	156106743	1	156136952	36476	45138	rs267607578	NC_000001.11:156136951:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1444C>G (p.Arg482Gly)	LMNA	R401G, R482G, R370G	Charcot-Marie-Tooth disease type 2	VCV000964333	1	156106775	1	156136984	964333	941502	rs57920071	NC_000001.11:156136983:C:G	single nucleotide variant	missense variant	Pathogenic	Dec 18, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp)	LMNA	R482W, R401W, R370W	not provided|Familial partial lipodystrophy|Familial partial lipodystrophy, Dunnigan type|Charcot-Marie-Tooth disease|Cardiovascular phenotype|Congenital muscular dystrophy due to LMNA mutation|Restrictive dermopathy 2|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Mandibuloacral dysplasia with type A lipodystrophy|Familial partial lipodystrophy, Dunnigan type|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Charcot-Marie-Tooth disease type 2B1|Hutchinson-Gilford syndrome|Heart-hand syndrome, Slovenian type|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Dilated cardiomyopathy 1A|Charcot-Marie-Tooth disease type 2	VCV000014489	1	156106775	1	156136984	14489	29528	rs57920071	NC_000001.11:156136983:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1458G>T (p.Lys486Asn)	LMNA	K486N, K374N, K405N	Familial partial lipodystrophy, Dunnigan type	VCV000066829	1	156106789	1	156136998	66829	77726	rs59981161	NC_000001.11:156136997:G:T	single nucleotide variant	missense variant	Pathogenic	Jan 29, 2015	criteria provided, single submitter							
NM_170707.4(LMNA):c.1494G>T (p.Trp498Cys)	LMNA	W498C, W386C, W417C	Primary familial dilated cardiomyopathy	VCV000066838	1	156106909	1	156137118	66838	77735	rs57730570	NC_000001.11:156137117:G:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 17, 2017	criteria provided, single submitter							
NM_170707.4(LMNA):c.1540T>C (p.Trp514Arg)	LMNA	W514R, W433R, W402R	not provided	VCV000246077	1	156106955	1	156137164	246077	244235	rs879254082	NC_000001.11:156137163:T:C	single nucleotide variant	missense variant	Pathogenic	Mar 2, 2016	criteria provided, single submitter							
NM_170707.4(LMNA):c.1558T>A (p.Trp520Arg)	LMNA	W439R, W520R, W408R	Charcot-Marie-Tooth disease type 2	VCV000943114	1	156106973	1	156137182	943114	930071	rs267607557	NC_000001.11:156137181:T:A	single nucleotide variant	missense variant	Pathogenic	Aug 2, 2019	criteria provided, single submitter							
NM_170707.4(LMNA):c.1558T>C (p.Trp520Arg)	LMNA	W520R, W408R, W439R	Charcot-Marie-Tooth disease type 2	VCV000476824	1	156106973	1	156137182	476824	447237	rs267607557	NC_000001.11:156137181:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 13, 2021	criteria provided, single submitter							
NM_170707.4(LMNA):c.1560G>C (p.Trp520Cys)	LMNA	W312C, W334C, W408C, W421C, W439C, W520C	Congenital muscular dystrophy	VCV003233370	1	156106975	1	156137184	3233370	3392497		NC_000001.11:156137183:G:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 14, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.1560G>T (p.Trp520Cys)	LMNA	W439C, W520C, W334C, W421C, W312C, W408C	Charcot-Marie-Tooth disease type 2	VCV002734000	1	156106975	1	156137184	2734000	2898333		NC_000001.11:156137183:G:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 6, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.1562G>T (p.Gly521Val)	LMNA	G521V, G409V, G440V	not provided	VCV000200945	1	156106977	1	156137186	200945	196482	rs794728596	NC_000001.11:156137185:G:T	single nucleotide variant	missense variant	Likely pathogenic	Sep 4, 2015	criteria provided, single submitter							
NM_170707.4(LMNA):c.1580G>C (p.Arg527Pro)	LMNA	R527P, R446P, R415P	Cardiovascular phenotype|Charcot-Marie-Tooth disease type 2|Primary dilated cardiomyopathy|Familial partial lipodystrophy, Dunnigan type	VCV000014481	1	156106995	1	156137204	14481	29520	rs57520892	NC_000001.11:156137203:G:C	single nucleotide variant	missense variant	Pathogenic	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1582A>C (p.Thr528Pro)	LMNA	T528P, T416P, T447P	not provided	VCV000500663	1	156106997	1	156137206	500663	492087	rs1187380696	NC_000001.11:156137205:A:C	single nucleotide variant	missense variant	Pathogenic	Mar 3, 2017	criteria provided, single submitter							
NM_170707.4(LMNA):c.1583C>G (p.Thr528Arg)	LMNA	T528R, T416R, T447R	Abnormality of the musculature|Familial partial lipodystrophy, Dunnigan type|Charcot-Marie-Tooth disease type 2|not provided	VCV000066850	1	156106998	1	156137207	66850	77747	rs57629361	NC_000001.11:156137206:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1583C>A (p.Thr528Lys)	LMNA	T528K, T416K, T447K	Hutchinson-Gilford syndrome|not provided|Charcot-Marie-Tooth disease type 2|Emery-Dreifuss muscular dystrophy 2, autosomal dominant	VCV000066849	1	156106998	1	156137207	66849	77746	rs57629361	NC_000001.11:156137206:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1585G>C (p.Ala529Pro)	LMNA	A417P, A448P, A430P, A529P, A321P, A343P	Charcot-Marie-Tooth disease type 2	VCV002065107	1	156107000	1	156137209	2065107	2121667		NC_000001.11:156137208:G:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_170707.4(LMNA):c.1585G>A (p.Ala529Thr)	LMNA	A529T, A417T, A448T	Mandibuloacral dysplasia with type A lipodystrophy	VCV000014522	1	156107000	1	156137209	14522	29561	rs121912494	NC_000001.11:156137208:G:A	single nucleotide variant	missense variant	Pathogenic	Nov 1, 2007	no assertion criteria provided							
NM_170707.4(LMNA):c.1587_1588delinsCT (p.Leu530Phe)	LMNA	L449F, L530F, L418F	Charcot-Marie-Tooth disease type 2	VCV000581796	1	156107002 - 156107003	1	156137211 - 156137212	581796	556967	rs1558133435	NC_000001.11:156137210:TC:CT	Indel	missense variant	Pathogenic	Oct 29, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.1588C>T (p.Leu530Phe)	LMNA	L530F, L418F, L449F	Muscular dystrophy|Charcot-Marie-Tooth disease type 2	VCV000435773	1	156107003	1	156137212	435773	427654	rs780302064	NC_000001.11:156137211:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 28, 2020	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1589T>C (p.Leu530Pro)	LMNA	L530P, L418P, L449P	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	VCV000014482	1	156107004	1	156137213	14482	29521	rs60934003	NC_000001.11:156137212:T:C	single nucleotide variant	missense variant	Pathogenic	Mar 1, 1999	no assertion criteria provided							
NM_170707.4(LMNA):c.1619T>C (p.Met540Thr)	LMNA	M540T, M459T, M428T	Hutchinson-Gilford syndrome	VCV000066858	1	156107455	1	156137664	66858	77755	rs267607547	NC_000001.11:156137663:T:C	single nucleotide variant	missense variant|intron variant	Pathogenic	Feb 8, 2013	criteria provided, single submitter							
NM_170707.4(LMNA):c.1620G>A (p.Met540Ile)	LMNA	M540I, M459I, M428I	Mandibuloacral dysplasia with type A lipodystrophy	VCV000100690	1	156107456	1	156137665	100690	106555	rs483352811	NC_000001.11:156137664:G:A	single nucleotide variant	missense variant|intron variant	Pathogenic	Apr 30, 2016	criteria provided, single submitter							
NM_170707.4(LMNA):c.1621C>A (p.Arg541Ser)	LMNA	R541S, R460S, R429S	Charcot-Marie-Tooth disease type 2|Primary dilated cardiomyopathy	VCV000066859	1	156107457	1	156137666	66859	77756	rs56984562	NC_000001.11:156137665:C:A	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	Oct 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1621C>T (p.Arg541Cys)	LMNA	R541C, R460C, R429C	Dilated cardiomyopathy 1A|Cardiovascular phenotype|Laminopathy|Charcot-Marie-Tooth disease type 2|Primary dilated cardiomyopathy|not provided	VCV000048046	1	156107457	1	156137666	48046	57210	rs56984562	NC_000001.11:156137665:C:T	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1621C>G (p.Arg541Gly)	LMNA	R541G, R460G, R429G	Dilated cardiomyopathy 1A	VCV000029775	1	156107457	1	156137666	29775	38730	rs56984562	NC_000001.11:156137665:C:G	single nucleotide variant	missense variant|intron variant	Pathogenic	Jan 1, 2011	no assertion criteria provided							
NM_170707.4(LMNA):c.1622G>C (p.Arg541Pro)	LMNA	R541P, R460P, R429P	not provided|Bethlem myopathy 1A	VCV000066861	1	156107458	1	156137667	66861	77758	rs61444459	NC_000001.11:156137666:G:C	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	Feb 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1622G>A (p.Arg541His)	LMNA	R541H, R429H, R460H	Hutchinson-Gilford syndrome|Cardiovascular phenotype|Dilated cardiomyopathy 1A|Congenital muscular dystrophy|LMNA-related disorder|not provided|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease type 2	VCV000066860	1	156107458	1	156137667	66860	77757	rs61444459	NC_000001.11:156137666:G:A	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_170707.4(LMNA):c.1626G>C (p.Lys542Asn)	LMNA	K542N, K430N, K461N	Mandibuloacral dysplasia with type A lipodystrophy	VCV000014509	1	156107462	1	156137671	14509	29548	rs56673169	NC_000001.11:156137670:G:C	single nucleotide variant	missense variant|intron variant	Pathogenic	Aug 1, 2004	no assertion criteria provided							
NM_170707.4(LMNA):c.1750C>A (p.Arg584Ser)	LMNA	R503S, R376S, R398S, R472S, R554S, R584S, R485S	Charcot-Marie-Tooth disease type 2	VCV002705789	1	156108330	1	156138539	2705789	2856926		NC_000001.11:156138538:C:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 6, 2024	criteria provided, single submitter							
NM_170707.4(LMNA):c.1822G>A (p.Gly608Ser)	LMNA	G608S, G578S, G496S	Hutchinson-Gilford syndrome	VCV000014501	1	156108402	1	156138611	14501	29540	rs61064130	NC_000001.11:156138610:G:A	single nucleotide variant	missense variant|intron variant	Pathogenic	May 15, 2003	no assertion criteria provided							
NM_004446.3(EPRS1):c.4444C>A (p.Pro1482Thr)	EPRS1	P1482T	Leukodystrophy, hypomyelinating, 15	VCV003069175	1	220142243	1	219968901	3069175	3228500		NC_000001.11:219968900:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2024	criteria provided, single submitter							
NM_004446.3(EPRS1):c.3478C>T (p.Pro1160Ser)	EPRS1	P1160S	Leukodystrophy, hypomyelinating, 15	VCV000523135	1	220154175	1	219980833	523135	513761	rs898824971	NC_000001.11:219980832:G:A	single nucleotide variant	missense variant	Pathogenic	May 3, 2018	no assertion criteria provided							
NM_004446.3(EPRS1):c.3377T>C (p.Met1126Thr)	EPRS1	M1126T	Leukodystrophy, hypomyelinating, 15	VCV000523137	1	220154796	1	219981454	523137	513763	rs1474000585	NC_000001.11:219981453:A:G	single nucleotide variant	missense variant	Pathogenic	May 3, 2018	no assertion criteria provided							
NM_004446.3(EPRS1):c.1459A>G (p.Met487Val)	EPRS1	M487V	Intellectual disability	VCV001703007	1	220191826	1	220018484	1703007	1695399		NC_000001.11:220018483:T:C	single nucleotide variant	missense variant	Pathogenic	Oct 26, 2021	criteria provided, single submitter							
NM_004446.3(EPRS1):c.635T>C (p.Ile212Thr)	EPRS1	I212T	Global developmental delay	VCV001703006	1	220198589	1	220025247	1703006	1695398		NC_000001.11:220025246:A:G	single nucleotide variant	missense variant	Pathogenic	Oct 26, 2021	criteria provided, single submitter							
NM_002107.7(H3-3A):c.25C>G (p.Arg9Gly)	H3-3A|LOC129932634	R9G	not specified|not provided	VCV003103884	1	226252077	1	226064376	3103884	3273526		NC_000001.11:226064375:C:G	single nucleotide variant	missense variant	Likely pathogenic	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_002107.7(H3-3A):c.52A>G (p.Arg18Gly)	H3-3A	R18G	not provided	VCV001339283	1	226252104	1	226064403	1339283	1330334	rs2102735576	NC_000001.11:226064402:A:G	single nucleotide variant	missense variant	Pathogenic	Jul 26, 2022	criteria provided, single submitter							
NM_002107.7(H3-3A):c.68C>T (p.Thr23Ile)	H3-3A	T23I	not provided	VCV003343880	1	226252120	1	226064419	3343880	3503112		NC_000001.11:226064418:C:T	single nucleotide variant	missense variant	Pathogenic	Feb 2, 2024	criteria provided, single submitter							
NM_002107.7(H3-3A):c.88G>A (p.Ala30Thr)	H3-3A	A30T	not provided	VCV000429971	1	226252140	1	226064439	429971	421213	rs1131691704	NC_000001.11:226064438:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 5, 2024	criteria provided, single submitter							
NM_002107.7(H3-3A):c.92C>T (p.Pro31Leu)	H3-3A	P31L	not provided	VCV001306572	1	226252144	1	226064443	1306572	1296515	rs1439403341	NC_000001.11:226064442:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 17, 2024	criteria provided, single submitter							
NM_002107.7(H3-3A):c.121C>T (p.Arg41Cys)	H3-3A	R41C	Bryant-Li-Bhoj neurodevelopmental syndrome 1|Intellectual disability|Brain imaging abnormality|Delayed speech and language development|Short stature|Global developmental delay	VCV001183977	1	226252173	1	226064472	1183977	1173679	rs2102735801	NC_000001.11:226064471:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 1, 2022	no assertion criteria provided							
NM_002107.7(H3-3A):c.137C>T (p.Thr46Ile)	H3-3A	T46I	Inborn genetic diseases	VCV000985335	1	226253365	1	226065664	985335	973179	rs1657901999	NC_000001.11:226065663:C:T	single nucleotide variant	missense variant	Likely pathogenic	Dec 7, 2018	criteria provided, single submitter							
NM_002107.7(H3-3A):c.166C>A (p.Gln56Lys)	H3-3A	Q56K	Intellectual disability|Brain imaging abnormality|Delayed speech and language development|Short stature|Global developmental delay	VCV001183978	1	226253394	1	226065693	1183978	1173680	rs2102736976	NC_000001.11:226065692:C:A	single nucleotide variant	missense variant	Likely pathogenic	Jul 15, 2021	no assertion criteria provided							
NM_002107.7(H3-3A):c.244G>C (p.Asp82His)	H3-3A	D82H	Inborn genetic diseases	VCV000985323	1	226253472	1	226065771	985323	973180	rs1657903750	NC_000001.11:226065770:G:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 7, 2018	criteria provided, single submitter							
NM_002107.7(H3-3A):c.250C>G (p.Arg84Gly)	H3-3A	R84G	Bryant-Li-Bhoj neurodevelopmental syndrome 1|Neurodevelopmental disorder	VCV000983132	1	226253478	1	226065777	983132	970678	rs1657904113	NC_000001.11:226065776:C:G	single nucleotide variant	missense variant	Likely pathogenic	Dec 10, 2019	criteria provided, single submitter							
NM_002107.7(H3-3A):c.326A>T (p.Asn109Ile)	H3-3A	N109I	not provided	VCV003573591	1	226259095	1	226071394	3573591	3732481		NC_000001.11:226071393:A:T	single nucleotide variant	missense variant	Pathogenic	Jul 14, 2024	criteria provided, single submitter							
NM_002107.7(H3-3A):c.326A>G (p.Asn109Ser)	H3-3A	N109S	Bryant-Li-Bhoj neurodevelopmental syndrome 1|not specified	VCV000985263	1	226259095	1	226071394	985263	973182	rs1658118461	NC_000001.11:226071393:A:G	single nucleotide variant	missense variant	Likely pathogenic	Apr 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_002107.7(H3-3A):c.335C>T (p.Ala112Val)	H3-3A	A112V	not provided	VCV001306413	1	226259104	1	226071403	1306413	1296356	rs2102742543	NC_000001.11:226071402:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 30, 2024	criteria provided, single submitter							
NM_002107.7(H3-3A):c.362T>C (p.Met121Thr)	H3-3A	M121T	Bryant-Li-Bhoj neurodevelopmental syndrome 1	VCV003376608	1	226259131	1	226071430	3376608	3535792		NC_000001.11:226071429:T:C	single nucleotide variant	missense variant	Pathogenic	Feb 2, 2022	criteria provided, single submitter							
NM_002107.7(H3-3A):c.363G>A (p.Met121Ile)	H3-3A	M121I	Bryant-Li-Bhoj neurodevelopmental syndrome 1|not provided	VCV001183980	1	226259132	1	226071431	1183980	1173682	rs2102742562	NC_000001.11:226071430:G:A	single nucleotide variant	missense variant	Pathogenic	Mar 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_002107.7(H3-3A):c.365C>G (p.Pro122Arg)	H3-3A	P122R	H3F3A-related disorder|Inborn genetic diseases	VCV000986093	1	226259134	1	226071433	986093	973184	rs1576203003	NC_000001.11:226071432:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 28, 2017	criteria provided, multiple submitters, no conflicts							
NM_002107.7(H3-3A):c.377A>G (p.Gln126Arg)	H3-3A	Q126R	Bryant-Li-Bhoj neurodevelopmental syndrome 1|not provided|H3F3A-related disorder|Inborn genetic diseases	VCV000520774	1	226259146	1	226071445	520774	511233	rs1276519904	NC_000001.11:226071444:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_002107.7(H3-3A):c.386G>A (p.Arg129His)	H3-3A	R129H	Bryant-Li-Bhoj neurodevelopmental syndrome 1|Intellectual disability|Brain imaging abnormality|Delayed speech and language development|Short stature|Global developmental delay	VCV001183981	1	226259155	1	226071454	1183981	1173683	rs1658121882	NC_000001.11:226071453:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 1, 2022	no assertion criteria provided							
NM_133259.4(LRPPRC):c.3809C>T (p.Ala1270Val)	LRPPRC	A1270V	not provided	VCV000214617	2	44126374	2	43899235	214617	210826	rs863224058	NC_000002.12:43899234:G:A	single nucleotide variant	missense variant	Likely pathogenic	Dec 24, 2018	criteria provided, single submitter							
NM_133259.4(LRPPRC):c.2882T>C (p.Leu961Pro)	LRPPRC	L961P	Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	VCV002500755	2	44152220	2	43925081	2500755	2523653		NC_000002.12:43925080:A:G	single nucleotide variant	missense variant	Likely pathogenic	Oct 10, 2024	criteria provided, single submitter							
NM_133259.4(LRPPRC):c.2423T>G (p.Leu808Trp)	LRPPRC	L808W	not provided	VCV000214613	2	44170907	2	43943768	214613	210833	rs863224057	NC_000002.12:43943767:A:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 14, 2014	criteria provided, single submitter							
NM_133259.4(LRPPRC):c.1177T>C (p.Tyr393His)	LRPPRC	Y393H	Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	VCV000800943	2	44201018	2	43973879	800943	788754	rs863224054	NC_000002.12:43973878:A:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 26, 2019	no assertion criteria provided							
NM_133259.4(LRPPRC):c.1061C>T (p.Ala354Val)	LRPPRC	A354V	not provided|Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	VCV000003110	2	44201383	2	43974244	3110	18149	rs119466000	NC_000002.12:43974243:G:A	single nucleotide variant	missense variant	Pathogenic	Mar 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_133259.4(LRPPRC):c.3G>A (p.Met1Ile)	LRPPRC	M1I	Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	VCV000557643	2	44223084	2	43995945	557643	542137	rs1553416989	NC_000002.12:43995944:C:T	single nucleotide variant	missense variant|initiator_codon_variant	Likely pathogenic	Apr 3, 2018	criteria provided, single submitter							
NM_133259.4(LRPPRC):c.2T>A (p.Met1Lys)	LRPPRC	M1K	Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	VCV000556852	2	44223085	2	43995946	556852	542024	rs1160846305	NC_000002.12:43995945:A:T	single nucleotide variant	missense variant|initiator_codon_variant	Likely pathogenic	Feb 21, 2018	criteria provided, single submitter							
NM_006429.4(CCT7):c.1574C>T (p.Ser525Leu)	CCT7	S438L, S525L, S481L, S321L	Myocardial infarction, susceptibility to, 1	VCV000065429	2	73479931	2	73252803	65429	76356	rs587777929	NC_000002.12:73252802:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Sep 15, 2013	no assertion criteria provided							
NM_002156.5(HSPD1):c.1381C>G (p.Gln461Glu)	HSPD1		Hereditary spastic paraplegia 13	VCV000561192	2	198353050	2	197488326	561192	552299		NC_000002.12:197488325:G:C	single nucleotide variant	missense variant	Pathogenic	Sep 13, 2018	no assertion criteria provided							
NM_002156.5(HSPD1):c.397A>G (p.Lys133Glu)	HSPD1	K133E	not provided	VCV000214550	2	198361894	2	197497170	214550	210723	rs863224042	NC_000002.12:197497169:T:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 22, 2014	criteria provided, single submitter							
NM_002156.5(HSPD1):c.329G>T (p.Gly110Val)	HSPD1	G110V	not provided	VCV000986925	2	198361962	2	197497238	986925	975019	rs2086169784	NC_000002.12:197497237:C:A	single nucleotide variant	missense variant	Likely pathogenic	Oct 23, 2020	criteria provided, single submitter							
NM_002156.5(HSPD1):c.292G>A (p.Val98Ile)	HSPD1	V98I	Hereditary spastic paraplegia 13	VCV000017557	2	198361999	2	197497275	17557	32596	rs66468541	NC_000002.12:197497274:C:T	single nucleotide variant	missense variant	Pathogenic		criteria provided, single submitter							
NM_002156.5(HSPD1):c.188T>C (p.Ile63Thr)	HSPD1	I63T	HSPD1-related disorder	VCV002630153	2	198362103	2	197497379	2630153	2798094		NC_000002.12:197497378:A:G	single nucleotide variant	missense variant	Likely pathogenic	Feb 22, 2023	criteria provided, single submitter							
NM_002156.5(HSPD1):c.185T>C (p.Val62Ala)	HSPD1	V62A	Hypomyelinating leukodystrophy 4	VCV003767209	2	198362106	2	197497382	3767209	3883371		NC_000002.12:197497381:A:G	single nucleotide variant	missense variant	Likely pathogenic	Feb 27, 2024	criteria provided, single submitter							
NM_002156.5(HSPD1):c.139T>G (p.Leu47Val)	HSPD1	L47V	Hypomyelinating leukodystrophy 4	VCV000816623	2	198363434	2	197498710	816623	804829	rs2086193735	NC_000002.12:197498709:A:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 2, 2020	no assertion criteria provided							
NM_002156.5(HSPD1):c.86A>G (p.Asp29Gly)	HSPD1	D29G	Leukodystrophy	VCV000017558	2	198363487	2	197498763	17558	32597	rs72466451	NC_000002.12:197498762:T:C	single nucleotide variant	missense variant	Pathogenic	Jan 13, 2025	criteria provided, single submitter							
NM_005051.3(QARS1):c.1543C>T (p.Arg515Trp)	QARS1	R515W, R504W	Intellectual disability, autosomal dominant 43|not provided|Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome	VCV000127118	3	49136848	3	49099415	127118	132626	rs587777334	NC_000003.12:49099414:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_005051.3(QARS1):c.533G>T (p.Gly178Val)	QARS1	G167V, G178V	not provided	VCV001311814	3	49139889	3	49102456	1311814	1302345	rs2107109028	NC_000003.12:49102455:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 2, 2022	criteria provided, single submitter							
NM_005051.3(QARS1):c.169T>C (p.Tyr57His)	QARS1	Y57H	not provided	VCV000127117	3	49141853	3	49104420	127117	132625	rs587777333	NC_000003.12:49104419:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jul 1, 2024	criteria provided, single submitter							
NM_005051.3(QARS1):c.134G>T (p.Gly45Val)	QARS1	G45V	not provided|Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome	VCV000127115	3	49141888	3	49104455	127115	132623	rs587777331	NC_000003.12:49104454:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_005051.3(QARS1):c.3G>A (p.Met1Ile)	QARS1	M1I	Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome	VCV002011161	3	49142164	3	49104731	2011161	2074235		NC_000003.12:49104730:C:T	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Pathogenic	Jun 26, 2022	criteria provided, single submitter							
NM_005051.3(QARS1):c.2T>C (p.Met1Thr)	QARS1	M1T	Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome	VCV000958755	3	49142165	3	49104732	958755	943608	rs2042518770	NC_000003.12:49104731:A:G	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Pathogenic	Oct 28, 2022	criteria provided, single submitter							
NM_001457.4(FLNB):c.482T>G (p.Phe161Cys)	FLNB	F161C	Connective tissue disorder	VCV000006398	3	58062962	3	58077235	6398	21437	rs80356506	NC_000003.12:58077234:T:G	single nucleotide variant	missense variant	Likely pathogenic	Jan 14, 2021	criteria provided, single submitter							
NM_001457.4(FLNB):c.500A>G (p.Asp167Gly)	FLNB	D167G	not provided	VCV001067019	3	58062980	3	58077253	1067019	1055380	rs2106946911	NC_000003.12:58077252:A:G	single nucleotide variant	missense variant	Likely pathogenic	May 22, 2020	criteria provided, single submitter							
NM_001457.4(FLNB):c.501C>G (p.Asp167Glu)	FLNB	D167E	not provided	VCV001457383	3	58062981	3	58077254	1457383	1393324	rs746892435	NC_000003.12:58077253:C:G	single nucleotide variant	missense variant	Pathogenic	Jul 14, 2021	criteria provided, single submitter							
NM_001457.4(FLNB):c.502G>T (p.Gly168Cys)	FLNB	G168C	not specified	VCV000812028	3	58062982	3	58077255	812028	799327	rs80356504	NC_000003.12:58077254:G:T	single nucleotide variant	missense variant	Likely pathogenic	May 8, 2019	criteria provided, single submitter							
NM_001457.4(FLNB):c.502G>A (p.Gly168Ser)	FLNB	G168S	not provided|Inborn genetic diseases|Larsen syndrome|See cases	VCV000038961	3	58062982	3	58077255	38961	47564	rs80356504	NC_000003.12:58077254:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_001457.4(FLNB):c.512T>G (p.Leu171Arg)	FLNB	L171R	Boomerang dysplasia	VCV000006403	3	58062992	3	58077265	6403	21442	rs80356494	NC_000003.12:58077264:T:G	single nucleotide variant	missense variant	Pathogenic	Jul 15, 2007	no assertion criteria provided							
NM_001457.4(FLNB):c.517G>A (p.Ala173Thr)	FLNB	A173T	Atelosteogenesis type I	VCV000126375	3	58062997	3	58077270	126375	131909	rs587777259	NC_000003.12:58077269:G:A	single nucleotide variant	missense variant	Pathogenic	Mar 1, 2014	no assertion criteria provided							
NM_001457.4(FLNB):c.518C>T (p.Ala173Val)	FLNB	A173V	not provided	VCV000006400	3	58062998	3	58077271	6400	21439	rs121908894	NC_000003.12:58077270:C:T	single nucleotide variant	missense variant	Pathogenic	Jul 29, 2023	criteria provided, single submitter							
NM_001457.4(FLNB):c.524T>C (p.Val175Ala)	FLNB	V175A	FLNB-related disorder	VCV003345956	3	58063004	3	58077277	3345956	3505625		NC_000003.12:58077276:T:C	single nucleotide variant	missense variant	Likely pathogenic	Aug 1, 2024	no assertion criteria provided							
NM_001457.4(FLNB):c.591T>A (p.Asn197Lys)	FLNB	N197K	Larsen syndrome	VCV001683439	3	58064493	3	58078766	1683439	1675337	rs1274950884	NC_000003.12:58078765:T:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 1, 2022	criteria provided, single submitter							
NM_001457.4(FLNB):c.604A>G (p.Met202Val)	FLNB	M202V	Atelosteogenesis type I|Atelosteogenesis type III	VCV000006401	3	58064506	3	58078779	6401	21440	rs121908895	NC_000003.12:58078778:A:G	single nucleotide variant	missense variant	Pathogenic	Apr 1, 2004	no assertion criteria provided							
NM_001457.4(FLNB):c.605T>C (p.Met202Thr)	FLNB	M202T	not provided	VCV001224317	3	58064507	3	58078780	1224317	1214285	rs2106952056	NC_000003.12:58078779:T:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 30, 2019	criteria provided, single submitter							
NM_001457.4(FLNB):c.613G>T (p.Ala205Ser)	FLNB	A205S	not provided	VCV001452279	3	58064515	3	58078788	1452279	1364000	rs2106952084	NC_000003.12:58078787:G:T	single nucleotide variant	missense variant	Pathogenic	Mar 25, 2021	criteria provided, single submitter							
NM_001457.4(FLNB):c.614C>T (p.Ala205Val)	FLNB	A205V	FLNB-related disorder	VCV003346475	3	58064516	3	58078789	3346475	3504825		NC_000003.12:58078788:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jul 18, 2024	no assertion criteria provided							
NM_001457.4(FLNB):c.622T>G (p.Trp208Gly)	FLNB	W208G	not provided	VCV002849851	3	58064524	3	58078797	2849851	3005806		NC_000003.12:58078796:T:G	single nucleotide variant	missense variant	Likely pathogenic	Apr 23, 2023	criteria provided, single submitter							
NM_001457.4(FLNB):c.644T>A (p.Ile215Asn)	FLNB	I215N	Atelosteogenesis type III	VCV000932049	3	58067360	3	58081633	932049	918851	rs2097209399	NC_000003.12:58081632:T:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 27, 2019	criteria provided, single submitter							
NM_001457.4(FLNB):c.679G>A (p.Glu227Lys)	FLNB	E227K	not provided	VCV000006405	3	58067395	3	58081668	6405	21444	rs80356508	NC_000003.12:58081667:G:A	single nucleotide variant	missense variant	Pathogenic	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_001457.4(FLNB):c.703T>C (p.Ser235Pro)	FLNB	S235P	Boomerang dysplasia	VCV000006404	3	58067419	3	58081692	6404	21443	rs121908896	NC_000003.12:58081691:T:C	single nucleotide variant	missense variant	Pathogenic	Jul 15, 2007	no assertion criteria provided							
NM_001457.4(FLNB):c.718G>A (p.Ala240Thr)	FLNB	A240T	not provided	VCV001483519	3	58067434	3	58081707	1483519	1380636	rs2106966046	NC_000003.12:58081706:G:A	single nucleotide variant	missense variant	Likely pathogenic	Mar 16, 2021	criteria provided, single submitter							
NM_001457.4(FLNB):c.1082G>A (p.Gly361Asp)	FLNB	G361D	not provided|Larsen syndrome	VCV000432006	3	58083639	3	58097912	432006	425576	rs794727854	NC_000003.12:58097911:G:A	single nucleotide variant	missense variant	Pathogenic	Aug 25, 2020	criteria provided, multiple submitters, no conflicts							
NM_001457.4(FLNB):c.1087G>C (p.Gly363Arg)	FLNB	G363R	not provided	VCV003635698	3	58083644	3	58097917	3635698	3767279		NC_000003.12:58097916:G:C	single nucleotide variant	missense variant	Pathogenic	Dec 10, 2024	criteria provided, single submitter							
NM_001457.4(FLNB):c.1739G>T (p.Gly580Val)	FLNB	G580V	Atelosteogenesis type III	VCV000915265	3	58090935	3	58105208	915265	903494	rs2097257677	NC_000003.12:58105207:G:T	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_001457.4(FLNB):c.2251G>C (p.Gly751Arg)	FLNB	G751R	not specified	VCV000006402	3	58095354	3	58109627	6402	21441	rs28937587	NC_000003.12:58109626:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 30, 2017	criteria provided, single submitter							
NM_001457.4(FLNB):c.2516T>A (p.Val839Asp)	FLNB|LOC129936935	V839D	not provided	VCV001503791	3	58097549	3	58111822	1503791	1424195	rs765267560	NC_000003.12:58111821:T:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 18, 2021	criteria provided, single submitter							
NM_001457.4(FLNB):c.2774G>A (p.Gly925Asp)	FLNB	G925D	Spondylocarpotarsal synostosis syndrome	VCV003236714	3	58104627	3	58118900	3236714	3395834		NC_000003.12:58118899:G:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 1, 2024	no assertion criteria provided							
NM_001457.4(FLNB):c.2806G>A (p.Val936Met)	FLNB	V936M	Larsen syndrome	VCV002882122	3	58104659	3	58118932	2882122	3042725		NC_000003.12:58118931:G:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 5, 2024	criteria provided, single submitter							
NM_001457.4(FLNB):c.4292T>G (p.Leu1431Arg)	FLNB	L1431R	not provided	VCV000021281	3	58116537	3	58130810	21281	34133	rs80356511	NC_000003.12:58130809:T:G	single nucleotide variant	missense variant	Likely pathogenic	Apr 20, 2020	criteria provided, single submitter							
NM_001457.4(FLNB):c.4550C>A (p.Ala1517Asp)	FLNB	A1517D, A1548D	Larsen syndrome	VCV001683442	3	58120378	3	58134651	1683442	1675340	rs372940610	NC_000003.12:58134650:C:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 1, 2022	criteria provided, single submitter							
NM_001457.4(FLNB):c.4570G>A (p.Gly1524Ser)	FLNB	G1524S, G1555S	Larsen syndrome	VCV001683438	3	58120398	3	58134671	1683438	1675336	rs2107220190	NC_000003.12:58134670:G:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 1, 2022	criteria provided, single submitter							
NM_001457.4(FLNB):c.4604G>A (p.Ser1535Asn)	FLNB	S1535N, S1566N	Larsen syndrome	VCV001705102	3	58120432	3	58134705	1705102	1699633		NC_000003.12:58134704:G:A	single nucleotide variant	missense variant	Likely pathogenic	Aug 15, 2022	criteria provided, single submitter							
NM_001457.4(FLNB):c.4640C>A (p.Ala1547Asp)	FLNB	A1547D, A1578D	not provided	VCV001224373	3	58120468	3	58134741	1224373	1214341	rs2107220476	NC_000003.12:58134740:C:A	single nucleotide variant	missense variant	Likely pathogenic	Nov 30, 2019	criteria provided, single submitter							
NM_001457.4(FLNB):c.4738T>G (p.Tyr1580Asp)	FLNB	Y1580D, Y1611D	not provided	VCV002053849	3	58121772	3	58136045	2053849	2115601		NC_000003.12:58136044:T:G	single nucleotide variant	missense variant	Pathogenic	Mar 12, 2022	criteria provided, single submitter							
NM_001457.4(FLNB):c.4756G>A (p.Gly1586Arg)	FLNB	G1586R, G1617R	Larsen syndrome	VCV000006399	3	58121790	3	58136063	6399	21438	rs80356513	NC_000003.12:58136062:G:A	single nucleotide variant	missense variant	Pathogenic	Apr 1, 2004	no assertion criteria provided							
NM_001457.4(FLNB):c.4769T>C (p.Ile1590Thr)	FLNB	I1590T, I1621T	not provided	VCV001006578	3	58121803	3	58136076	1006578	989770	rs2097315324	NC_000003.12:58136075:T:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 13, 2023	criteria provided, single submitter							
NM_001457.4(FLNB):c.4781A>C (p.Tyr1594Ser)	FLNB	Y1625S, Y1594S	not provided	VCV002734542	3	58121815	3	58136088	2734542	2894570		NC_000003.12:58136087:A:C	single nucleotide variant	missense variant	Pathogenic	Mar 20, 2023	criteria provided, single submitter							
NM_001457.4(FLNB):c.4807C>T (p.Pro1603Ser)	FLNB	P1603S, P1634S	Atelosteogenesis type I	VCV001685823	3	58121841	3	58136114	1685823	1677836	rs2107224894	NC_000003.12:58136113:C:T	single nucleotide variant	missense variant	Pathogenic	May 4, 2022	criteria provided, single submitter							
NM_001457.4(FLNB):c.4834G>C (p.Gly1612Arg)	FLNB	G1612R, G1643R	not provided	VCV002663010	3	58121868	3	58136141	2663010	2830460		NC_000003.12:58136140:G:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 10, 2023	criteria provided, single submitter							
NM_001457.4(FLNB):c.4834G>A (p.Gly1612Ser)	FLNB	G1643S, G1612S	not provided	VCV001490901	3	58121868	3	58136141	1490901	1512008	rs2107225016	NC_000003.12:58136140:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 11, 2023	criteria provided, single submitter							
NM_001457.4(FLNB):c.4928C>T (p.Ala1643Val)	FLNB	A1643V, A1674V	Larsen syndrome	VCV000694710	3	58124075	3	58138348	694710	682802	rs868820857	NC_000003.12:58138347:C:T	single nucleotide variant	missense variant	Pathogenic		criteria provided, single submitter							
NM_001457.4(FLNB):c.5071G>A (p.Gly1691Ser)	FLNB	G1691S, G1722S	Boomerang dysplasia|Atelosteogenesis type I|Atelosteogenesis type III|Larsen syndrome|Spondylocarpotarsal synostosis syndrome|Larsen syndrome|not provided	VCV000006406	3	58124218	3	58138491	6406	21445	rs80356503	NC_000003.12:58138490:G:A	single nucleotide variant	missense variant	Pathogenic	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_001457.4(FLNB):c.5072G>A (p.Gly1691Asp)	FLNB	G1691D, G1722D	Larsen syndrome|not provided|Abnormality of the skeletal system	VCV000522782	3	58124219	3	58138492	522782	513264	rs1553704446	NC_000003.12:58138491:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_001457.4(FLNB):c.5500G>A (p.Gly1834Arg)	FLNB	G1834R, G1810R, G1823R, G1865R	Larsen syndrome	VCV000021292	3	58131722	3	58145995	21292	34144	rs80356516	NC_000003.12:58145994:G:A	single nucleotide variant	missense variant	Pathogenic		no assertion criteria provided							
NM_001457.4(FLNB):c.6068T>C (p.Phe2023Ser)	FLNB	F1999S, F2023S, F2054S, F2012S	not provided	VCV002711306	3	58134556	3	58148829	2711306	2878758		NC_000003.12:58148828:T:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 23, 2024	criteria provided, single submitter							
NM_004637.6(RAB7A):c.385C>T (p.Leu129Phe)	RAB7A	L129F	Charcot-Marie-Tooth disease type 2B	VCV000007345	3	128525419	3	128806576	7345	22384	rs121909078	NC_000003.12:128806575:C:T	single nucleotide variant	missense variant	Pathogenic	Sep 6, 2021	criteria provided, single submitter							
NM_004637.6(RAB7A):c.471G>T (p.Lys157Asn)	RAB7A	K157N	Charcot-Marie-Tooth disease type 2B	VCV000846631	3	128526457	3	128807614	846631	827519	rs121909081	NC_000003.12:128807613:G:T	single nucleotide variant	missense variant	Pathogenic	Jan 20, 2019	criteria provided, single submitter							
NM_004637.6(RAB7A):c.482A>T (p.Asn161Ile)	RAB7A	N161I	Charcot-Marie-Tooth disease type 2B	VCV000637404	3	128526468	3	128807625	637404	625104	rs121909080	NC_000003.12:128807624:A:T	single nucleotide variant	missense variant	Pathogenic	Aug 29, 2020	criteria provided, single submitter							
NM_004637.6(RAB7A):c.484G>A (p.Val162Met)	RAB7A	V162M	Charcot-Marie-Tooth disease type 2B	VCV000007346	3	128526470	3	128807627	7346	22385	rs121909079	NC_000003.12:128807626:G:A	single nucleotide variant	missense variant	Pathogenic	Apr 25, 2024	criteria provided, single submitter							
NM_001388492.1(HTT):c.8150T>A (p.Phe2717Tyr)	HTT	F2719Y, F2717Y	Lopes-Maciel-Rodan syndrome	VCV000417745	4	3231654	4	3229927	417745	404646	rs1060505028	NC_000004.12:3229926:T:A	single nucleotide variant	missense variant	Pathogenic	Sep 9, 2024	no assertion criteria provided							
NM_031372.4(HNRNPDL):c.1132G>C (p.Asp378His)	HNRNPDL	D378H	HNRNPDL-related myopathy with protein aggregates and rimmed vacuoles|not provided|Autosomal dominant limb-girdle muscular dystrophy type 1G	VCV000144074	4	83347676	4	82426523	144074	153825	rs587777669	NC_000004.12:82426522:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_031372.4(HNRNPDL):c.115_116delinsTT (p.Ala39Phe)	HNRNPDL	A39F	not provided	VCV001701471	4	83350728 - 83350729	4	82429575 - 82429576	1701471	1693862	rs2110031828	NC_000004.12:82429574:GC:AA	Indel	missense variant|non-coding transcript variant	Likely pathogenic	Mar 1, 2021	criteria provided, single submitter							
NM_005573.4(LMNB1):c.97A>G (p.Lys33Glu)	LMNB1	K33E	Inborn genetic diseases|Microcephaly 26, primary, autosomal dominant	VCV000915455	5	126113297	5	126777605	915455	903683	rs1750497172	NC_000005.10:126777604:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_005573.4(LMNB1):c.124C>T (p.Arg42Trp)	LMNB1	R42W	Microcephaly 26, primary, autosomal dominant|not provided	VCV000915456	5	126113324	5	126777632	915456	903684	rs1245844735	NC_000005.10:126777631:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_005573.4(LMNB1):c.269G>C (p.Arg90Pro)	LMNB1	R90P	Microcephaly 26, primary, autosomal dominant	VCV000997433	5	126113469	5	126777777	997433	985145	rs1750506249	NC_000005.10:126777776:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jan 13, 2023	no assertion criteria provided							
NM_005573.4(LMNB1):c.455C>G (p.Ala152Gly)	LMNB1	A152G	Microcephaly 26, primary, autosomal dominant|Syndrome with microcephaly as major feature	VCV000915454	5	126140563	5	126804871	915454	903685	rs935132421	NC_000005.10:126804870:C:G	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant	Pathogenic	Feb 19, 2021	no assertion criteria provided							
NM_005573.4(LMNB1):c.1091T>C (p.Leu364Pro)	LMNB1	L364P, L154P	not provided	VCV000813713	5	126154765	5	126819073	813713	801808	rs1751797979	NC_000005.10:126819072:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Nov 2, 2023	criteria provided, single submitter							
NM_000176.3(NR3C1):c.2318T>C (p.Leu773Pro)	NR3C1	L773P, L458P, L443P, L676P, L684P, L688P, L438P, L747P, L774P	Glucocorticoid resistance	VCV000016155	5	142661470	5	143281905	16155	31194	rs104893912	NC_000005.10:143281904:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Sep 10, 2021	no assertion criteria provided							
NM_000176.3(NR3C1):c.2259A>T (p.Leu753Phe)	NR3C1	L753F, L664F, L418F, L668F, L727F, L423F, L438F, L754F, L656F	GLUCOCORTICOID RESISTANCE, CELLULAR	VCV000016149	5	142661529	5	143281964	16149	31188	rs121909726	NC_000005.10:143281963:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	May 1, 1993	no assertion criteria provided							
NM_000176.3(NR3C1):c.2241T>G (p.Ile747Met)	NR3C1	I747M, I412M, I432M, I417M, I650M, I662M, I658M, I721M, I748M	Glucocorticoid resistance	VCV000016152	5	142661547	5	143281982	16152	31191	rs104893910	NC_000005.10:143281981:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jun 1, 2002	no assertion criteria provided							
NM_000176.3(NR3C1):c.2209T>C (p.Phe737Leu)	NR3C1	F737L, F652L, F738L, F640L, F648L, F402L, F407L, F422L, F711L	Glucocorticoid resistance	VCV000016158	5	142661579	5	143282014	16158	31197	rs121909727	NC_000005.10:143282013:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Apr 1, 2006	no assertion criteria provided							
NM_000176.3(NR3C1):c.2186T>C (p.Val729Ala)	NR3C1	V730A, V399A, V644A, V703A, V414A, V632A, V640A, V394A, V729A	Glucocorticoid resistance	VCV003591801	5	142661602	5	143282037	3591801	3724965		NC_000005.10:143282036:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Apr 11, 2024	criteria provided, single submitter							
NM_000176.3(NR3C1):c.1922A>T (p.Asp641Val)	NR3C1	D641V, D306V, D326V, D544V, D552V, D615V, D642V, D311V, D556V	Glucocorticoid resistance	VCV000016147	5	142675126	5	143295561	16147	31186	rs104893908	NC_000005.10:143295560:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Feb 1, 1991	no assertion criteria provided							
NM_000176.3(NR3C1):c.1712T>C (p.Val571Ala)	NR3C1	V571A, V486A, V236A, V256A, V474A, V545A, V572A, V241A, V482A	GLUCOCORTICOID RESISTANCE, ATYPICAL	VCV000016153	5	142680085	5	143300520	16153	31192	rs104893911	NC_000005.10:143300519:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Apr 1, 2002	no assertion criteria provided							
NM_000176.3(NR3C1):c.1676T>A (p.Ile559Asn)	NR3C1	I559N, I229N, I244N, I462N, I470N, I533N, I560N, I224N, I474N	Glucocorticoid resistance	VCV000016151	5	142680121	5	143300556	16151	31190	rs104893909	NC_000005.10:143300555:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Nov 1, 2001	no assertion criteria provided							
NM_020117.11(LARS1):c.3064G>C (p.Glu1022Gln)	LARS1	E1022Q, E976Q, E968Q, E995Q	not provided	VCV000388497	5	145503577	5	146124014	388497	368378	rs1057523129	NC_000005.10:146124013:C:G	single nucleotide variant	missense variant	Likely pathogenic	Aug 4, 2016	criteria provided, single submitter							
NM_020117.11(LARS1):c.2816A>G (p.Tyr939Cys)	LARS1	Y939C, Y893C, Y912C, Y885C	not provided	VCV000418282	5	145508299	5	146128736	418282	406651	rs757195926	NC_000005.10:146128735:T:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 3, 2014	criteria provided, single submitter							
NM_020117.11(LARS1):c.2504A>G (p.Tyr835Cys)	LARS1	Y781C, Y789C, Y808C, Y835C	Infantile liver failure syndrome 1	VCV001048520	5	145509705	5	146130142	1048520	1036444	rs770802595	NC_000005.10:146130141:T:C	single nucleotide variant	missense variant	Pathogenic	Mar 25, 2021	criteria provided, single submitter							
NM_020117.11(LARS1):c.1306G>A (p.Gly436Ser)	LARS1	G436S, G409S, G382S, G390S	not provided	VCV000388496	5	145531544	5	146151981	388496	368389	rs1057523128	NC_000005.10:146151980:C:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 4, 2016	criteria provided, single submitter							
NM_020117.11(LARS1):c.1118A>G (p.Tyr373Cys)	LARS1	Y373C, Y346C, Y327C, Y319C	Infantile liver failure syndrome 1	VCV000065476	5	145533491	5	146153928	65476	76387	rs201861847	NC_000005.10:146153927:T:C	single nucleotide variant	missense variant	Pathogenic	Jul 1, 2012	no assertion criteria provided							
NM_020117.11(LARS1):c.743G>T (p.Cys248Phe)	LARS1	C194F, C202F, C221F, C248F	Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins	VCV003385080	5	145538998	5	146159435	3385080	3544223		NC_000005.10:146159434:C:A	single nucleotide variant	missense variant	Likely pathogenic	Oct 25, 2024	criteria provided, single submitter							
NM_020117.11(LARS1):c.554C>T (p.Pro185Leu)	LARS1	P131L, P139L, P158L, P185L	Infantile liver failure syndrome 1	VCV001699493	5	145543913	5	146164350	1699493	1691867	rs1363237554	NC_000005.10:146164349:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 24, 2022	criteria provided, single submitter							
NM_003900.5(SQSTM1):c.2T>A (p.Met1Lys)	SQSTM1	M1K	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	VCV000265780	5	179247938	5	179820938	265780	260470	rs886039780	NC_000005.10:179820937:T:A	single nucleotide variant	missense variant|initiator_codon_variant|intron variant	Pathogenic	Oct 10, 2016	no assertion criteria provided							
NM_003900.5(SQSTM1):c.1165G>C (p.Glu389Gln)	SQSTM1	E305Q, E389Q	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset	VCV001459183	5	179260782	5	179833782	1459183	1406310	rs1391182750	NC_000005.10:179833781:G:C	single nucleotide variant	missense variant	Pathogenic	Oct 7, 2024	criteria provided, single submitter							
NM_003900.5(SQSTM1):c.1210A>G (p.Met404Val)	SQSTM1	M320V, M404V	SQSTM1-related disorder|Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	VCV001071292	5	179263480	5	179836480	1071292	1060386	rs771966860	NC_000005.10:179836479:A:G	single nucleotide variant	missense variant	Pathogenic	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_003900.5(SQSTM1):c.1211T>C (p.Met404Thr)	SQSTM1	M320T, M404T	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset	VCV000855037	5	179263481	5	179836481	855037	830770	rs1247551175	NC_000005.10:179836480:T:C	single nucleotide variant	missense variant	Pathogenic	Feb 5, 2019	criteria provided, single submitter							
NM_003900.5(SQSTM1):c.1231G>A (p.Gly411Ser)	SQSTM1	G327S, G411S	Myopathy, distal, with rimmed vacuoles|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset	VCV001458052	5	179263501	5	179836501	1458052	1471618	rs143511494	NC_000005.10:179836500:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_003529.3(H3C1):c.400G>C (p.Glu134Gln)	H3C1	E134Q	Multiple myeloma	VCV000800339	6	26021117	6	26020889	800339	788692	rs764264135	NC_000006.12:26020888:G:C	single nucleotide variant	missense variant	Likely pathogenic	Aug 31, 2019	no assertion criteria provided							
NM_001320.7(CSNK2B):c.1A>G (p.Met1Val)	CSNK2B	M1V	not provided|Poirier-Bienvenu neurodevelopmental syndrome	VCV000932465	6	31634609	6	31666832	932465	920754	rs1801755635	NC_000006.12:31666831:A:G	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic/Likely pathogenic	May 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_001320.7(CSNK2B):c.2T>G (p.Met1Arg)	CSNK2B	M1R	not provided	VCV001254603	6	31634610	6	31666833	1254603	1244536	rs1562045237	NC_000006.12:31666832:T:G	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic	Jul 12, 2021	criteria provided, single submitter							
NM_001320.7(CSNK2B):c.2T>A (p.Met1Lys)	CSNK2B	M1K	not provided	VCV000562216	6	31634610	6	31666833	562216	553382	rs1562045237	NC_000006.12:31666832:T:A	single nucleotide variant	missense variant|initiator_codon_variant	Likely pathogenic	Jun 26, 2018	criteria provided, single submitter							
NM_001320.7(CSNK2B):c.3G>A (p.Met1Ile)	CSNK2B	M1I	Poirier-Bienvenu neurodevelopmental syndrome|not provided	VCV003341965	6	31634611	6	31666834	3341965	3501198		NC_000006.12:31666833:G:A	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic/Likely pathogenic	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_001320.7(CSNK2B):c.94G>T (p.Asp32Tyr)	CSNK2B	D32Y	Poirier-Bienvenu neurodevelopmental syndrome|not provided	VCV001685680	6	31635666	6	31667889	1685680	1677694	rs1554169984	NC_000006.12:31667888:G:T	single nucleotide variant	missense variant	Pathogenic	Jun 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_001320.7(CSNK2B):c.94G>A (p.Asp32Asn)	CSNK2B	D32N	Poirier-Bienvenu neurodevelopmental syndrome|not provided|CSNK2B-related disorder|Inborn genetic diseases	VCV000520596	6	31635666	6	31667889	520596	511653	rs1554169984	NC_000006.12:31667888:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_001320.7(CSNK2B):c.95A>C (p.Asp32Ala)	CSNK2B	D32A	Poirier-Bienvenu neurodevelopmental syndrome	VCV003024534	6	31635667	6	31667890	3024534	3184846		NC_000006.12:31667889:A:C	single nucleotide variant	missense variant	Pathogenic	Feb 7, 2024	criteria provided, single submitter							
NM_001320.7(CSNK2B):c.101T>G (p.Phe34Cys)	CSNK2B	F34C	not provided	VCV001275774	6	31635673	6	31667896	1275774	1265655	rs1374628000	NC_000006.12:31667895:T:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 15, 2021	criteria provided, single submitter							
NM_001320.7(CSNK2B):c.107T>C (p.Leu36Pro)	CSNK2B	L36P	Inborn genetic diseases|not provided	VCV001690342	6	31635679	6	31667902	1690342	1682733	rs2151185393	NC_000006.12:31667901:T:C	single nucleotide variant	missense variant	Pathogenic	Jun 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_001320.7(CSNK2B):c.116T>G (p.Leu39Arg)	CSNK2B	L39R	Poirier-Bienvenu neurodevelopmental syndrome	VCV001685289	6	31635688	6	31667911	1685289	1677310	rs2151185431	NC_000006.12:31667910:T:G	single nucleotide variant	missense variant	Likely pathogenic	May 4, 2022	criteria provided, single submitter							
NM_021221.3(LY6G5B):c.-3007T>C	CSNK2B|LY6G5B	L50P	Poirier-Bienvenu neurodevelopmental syndrome	VCV003061766	6	31635721	6	31667944	3061766	3221994		NC_000006.12:31667943:T:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 12, 2024	criteria provided, single submitter							
NM_001320.7(CSNK2B):c.229G>A (p.Glu77Lys)	CSNK2B	E77K	not provided	VCV001197434	6	31636369	6	31668592	1197434	1187056	rs1583608433	NC_000006.12:31668591:G:A	single nucleotide variant	missense variant	Pathogenic	May 31, 2023	criteria provided, single submitter							
NM_001320.7(CSNK2B):c.257G>C (p.Arg86Pro)	CSNK2B	R86P	not provided	VCV001803580	6	31636397	6	31668620	1803580	1860608		NC_000006.12:31668619:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 6, 2022	criteria provided, single submitter							
NM_001320.7(CSNK2B):c.291G>A (p.Met97Ile)	CSNK2B	M97I	Poirier-Bienvenu neurodevelopmental syndrome	VCV001685290	6	31636431	6	31668654	1685290	1677311	rs2151187334	NC_000006.12:31668653:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 4, 2022	criteria provided, single submitter							
NM_001320.7(CSNK2B):c.332G>T (p.Arg111Leu)	CSNK2B	R111L	not provided	VCV003391794	6	31636914	6	31669137	3391794	3550875		NC_000006.12:31669136:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 22, 2024	criteria provided, single submitter							
NM_001320.7(CSNK2B):c.332G>C (p.Arg111Pro)	CSNK2B	R111P	not provided|Poirier-Bienvenu neurodevelopmental syndrome	VCV001320202	6	31636914	6	31669137	1320202	1310447	rs2151188333	NC_000006.12:31669136:G:C	single nucleotide variant	missense variant	Pathogenic	Jun 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_001320.7(CSNK2B):c.368G>A (p.Gly123Asp)	CSNK2B	G123D	not provided	VCV002579310	6	31637096	6	31669319	2579310	2744348		NC_000006.12:31669318:G:A	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Sep 1, 2023	criteria provided, single submitter							
NM_001320.7(CSNK2B):c.409T>C (p.Cys137Arg)	CSNK2B	C134R, C137R	not provided	VCV003342385	6	31637137	6	31669360	3342385	3501617		NC_000006.12:31669359:T:C	single nucleotide variant	missense variant	Pathogenic	Feb 8, 2024	criteria provided, single submitter							
NM_001320.7(CSNK2B):c.410G>A (p.Cys137Tyr)	CSNK2B	C134Y, C137Y	Poirier-Bienvenu neurodevelopmental syndrome|Neurodevelopmental disorder	VCV001701862	6	31637138	6	31669361	1701862	1694250	rs2151188789	NC_000006.12:31669360:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_001320.7(CSNK2B):c.494A>G (p.His165Arg)	CSNK2B	H162R, H165R	See cases|Poirier-Bienvenu neurodevelopmental syndrome|not provided	VCV000996840	6	31637222	6	31669445	996840	984575	rs1802026476	NC_000006.12:31669444:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_001320.7(CSNK2B):c.560T>G (p.Leu187Arg)	CSNK2B	L184R, L187R	Poirier-Bienvenu neurodevelopmental syndrome	VCV001333706	6	31637615	6	31669838	1333706	1324476	rs1802055133	NC_000006.12:31669837:T:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_001320.7(CSNK2B):c.560T>C (p.Leu187Pro)	CSNK2B	L184P, L187P	Poirier-Bienvenu neurodevelopmental syndrome	VCV000982375	6	31637615	6	31669838	982375	970495	rs1802055133	NC_000006.12:31669837:T:C	single nucleotide variant	missense variant	Pathogenic	Jun 26, 2020	criteria provided, single submitter							
NM_001320.7(CSNK2B):c.569T>C (p.Phe190Ser)	CSNK2B	F187S, F190S	Poirier-Bienvenu neurodevelopmental syndrome	VCV001805910	6	31637624	6	31669847	1805910	1862920		NC_000006.12:31669846:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jul 17, 2023	criteria provided, single submitter							
NM_006303.4(AIMP2):c.74A>G (p.Tyr25Cys)	AIMP2	Y25C	Leukodystrophy, hypomyelinating, 17	VCV000982311	7	6049068	7	6009437	982311	970426	rs147658637	NC_000007.14:6009436:A:G	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Likely pathogenic		criteria provided, single submitter							
NM_006408.4(AGR2):c.428G>A (p.Gly143Glu)	AGR2	G143E	Respiratory infections, recurrent, and failure to thrive with or without diarrhea	VCV002443888	7	16834610	7	16794986	2443888	2417624		NC_000007.14:16794985:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 31, 2023	no assertion criteria provided							
NM_006408.4(AGR2):c.349C>T (p.His117Tyr)	AGR2	H117Y	Respiratory infections, recurrent, and failure to thrive with or without diarrhea	VCV002443886	7	16837300	7	16797676	2443886	2417622		NC_000007.14:16797675:G:A	single nucleotide variant	missense variant	Likely pathogenic	Mar 14, 2024	criteria provided, single submitter							
NM_006408.4(AGR2):c.211C>A (p.Pro71Thr)	AGR2	P71T	Respiratory infections, recurrent, and failure to thrive with or without diarrhea	VCV002443885	7	16840820	7	16801196	2443885	2417621		NC_000007.14:16801195:G:T	single nucleotide variant	missense variant	Likely pathogenic	Mar 25, 2024	criteria provided, single submitter							
NM_001540.5(HSPB1):c.116C>G (p.Pro39Arg)	HSPB1	P39R	Charcot-Marie-Tooth disease axonal type 2F	VCV002884503	7	75932145	7	76302828	2884503	3053514		NC_000007.14:76302827:C:G	single nucleotide variant	missense variant	Likely pathogenic	Mar 26, 2023	criteria provided, single submitter							
NM_001540.5(HSPB1):c.116C>T (p.Pro39Leu)	HSPB1	P39L	Charcot-Marie-Tooth disease axonal type 2F|Neuronopathy, distal hereditary motor, type 2B|HSPB1-related axonal neuropathies|not provided|Charcot-Marie-Tooth disease	VCV000533814	7	75932145	7	76302828	533814	522820	rs557327165	NC_000007.14:76302827:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.250G>A (p.Gly84Arg)	HSPB1	G84R	not provided|HSPB1-related disorder|Charcot-Marie-Tooth disease axonal type 2F	VCV000632006	7	75932279	7	76302962	632006	620269	rs770272088	NC_000007.14:76302961:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.250G>C (p.Gly84Arg)	HSPB1	G84R	Charcot-Marie-Tooth disease axonal type 2F|Neuronopathy, distal hereditary motor, type 2B|Inborn genetic diseases|Distal hereditary motor neuropathy type 2|Charcot-Marie-Tooth disease|not provided	VCV000220419	7	75932279	7	76302962	220419	221739	rs770272088	NC_000007.14:76302961:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.295C>A (p.Leu99Met)	HSPB1	L99M	Neuronopathy, distal hereditary motor, type 2B	VCV000007485	7	75932324	7	76303007	7485	22524	rs121909113	NC_000007.14:76303006:C:A	single nucleotide variant	missense variant	Pathogenic	Nov 18, 2008	no assertion criteria provided							
NM_001540.5(HSPB1):c.379C>T (p.Arg127Trp)	HSPB1	R127W	Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F|Inborn genetic diseases|not provided	VCV000007479	7	75933133	7	76303816	7479	22518	rs29001571	NC_000007.14:76303815:C:T	single nucleotide variant	missense variant	Pathogenic	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.380G>T (p.Arg127Leu)	HSPB1	R127L	Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease	VCV000157529	7	75933134	7	76303817	157529	167391	rs587781250	NC_000007.14:76303816:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 25, 2019	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.403T>G (p.Ser135Ala)	HSPB1	S135A	Charcot-Marie-Tooth disease axonal type 2F	VCV000565333	7	75933157	7	76303840	565333	562179	rs766728475	NC_000007.14:76303839:T:G	single nucleotide variant	missense variant	Likely pathogenic	Jul 18, 2022	criteria provided, single submitter							
NM_001540.5(HSPB1):c.404C>G (p.Ser135Cys)	HSPB1	S135C	Charcot-Marie-Tooth disease axonal type 2F|Neuronopathy, distal hereditary motor, type 2B	VCV000637060	7	75933158	7	76303841	637060	625148	rs28939680	NC_000007.14:76303840:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.404C>A (p.Ser135Tyr)	HSPB1	S135Y	not provided|Charcot-Marie-Tooth disease axonal type 2F	VCV000533813	7	75933158	7	76303841	533813	523269	rs28939680	NC_000007.14:76303840:C:A	single nucleotide variant	missense variant	Pathogenic	Oct 23, 2020	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.404C>T (p.Ser135Phe)	HSPB1	S135F	Charcot-Marie-Tooth disease axonal type 2F|not provided	VCV000007478	7	75933158	7	76303841	7478	22517	rs28939680	NC_000007.14:76303840:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.406C>T (p.Arg136Trp)	HSPB1	R136W	Charcot-Marie-Tooth disease axonal type 2F	VCV000007482	7	75933160	7	76303843	7482	22521	rs28939681	NC_000007.14:76303842:C:T	single nucleotide variant	missense variant	Pathogenic	Sep 6, 2023	criteria provided, single submitter							
NM_001540.5(HSPB1):c.407G>A (p.Arg136Gln)	HSPB1	R136Q	Charcot-Marie-Tooth disease axonal type 2F|not provided	VCV000810107	7	75933161	7	76303844	810107	796070	rs863225022	NC_000007.14:76303843:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.407G>T (p.Arg136Leu)	HSPB1	R136L	Charcot-Marie-Tooth disease axonal type 2F|Inborn genetic diseases|not provided|Charcot-Marie-Tooth disease	VCV000217230	7	75933161	7	76303844	217230	213813	rs863225022	NC_000007.14:76303843:G:T	single nucleotide variant	missense variant	Pathogenic	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.416C>T (p.Thr139Met)	HSPB1	T139M	Charcot-Marie-Tooth disease axonal type 2F|not provided	VCV000421350	7	75933170	7	76303853	421350	407260	rs1064795077	NC_000007.14:76303852:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.418C>G (p.Arg140Gly)	HSPB1	R140G	Charcot-Marie-Tooth disease axonal type 2F|Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F|Inborn genetic diseases|not provided|HSPB1-related axonal neuropathies|Charcot-Marie-Tooth disease	VCV000007484	7	75933172	7	76303855	7484	22523	rs121909112	NC_000007.14:76303854:C:G	single nucleotide variant	missense variant	Pathogenic	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.433C>T (p.Pro145Ser)	HSPB1	P145S	not provided	VCV002497721	7	75933305	7	76303988	2497721	2472804		NC_000007.14:76303987:C:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 8, 2023	no assertion criteria provided							
NM_001540.5(HSPB1):c.452C>T (p.Thr151Ile)	HSPB1	T151I	not provided|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease	VCV000007480	7	75933324	7	76304007	7480	22519	rs28937568	NC_000007.14:76304006:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.539C>T (p.Thr180Ile)	HSPB1	T180I	not provided|Charcot-Marie-Tooth disease axonal type 2F	VCV000447531	7	75933411	7	76304094	447531	441146	rs1422978230	NC_000007.14:76304093:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.544C>G (p.Pro182Ala)	HSPB1	P182A	Charcot-Marie-Tooth disease axonal type 2F	VCV000946496	7	75933416	7	76304099	946496	924907	rs104894020	NC_000007.14:76304098:C:G	single nucleotide variant	missense variant	Pathogenic	Jul 20, 2021	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.544C>T (p.Pro182Ser)	HSPB1	P182S	Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F	VCV000007483	7	75933416	7	76304099	7483	22522	rs104894020	NC_000007.14:76304098:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_001540.5(HSPB1):c.545C>T (p.Pro182Leu)	HSPB1	P182L	Charcot-Marie-Tooth disease axonal type 2F	VCV000007481	7	75933417	7	76304100	7481	22520	rs28937569	NC_000007.14:76304099:C:T	single nucleotide variant	missense variant	Pathogenic	Dec 2, 2024	criteria provided, single submitter							
NM_012479.4(YWHAG):c.683A>T (p.Asp228Val)	YWHAG	D228V	Developmental and epileptic encephalopathy, 56	VCV001027791	7	75958955	7	76329638	1027791	1016940	rs1803513587	NC_000007.14:76329637:T:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 28, 2019	criteria provided, single submitter							
NM_012479.4(YWHAG):c.682G>A (p.Asp228Asn)	YWHAG	D228N	not provided	VCV001312189	7	75958956	7	76329639	1312189	1302720	rs2115587401	NC_000007.14:76329638:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 2, 2022	criteria provided, single submitter							
NM_012479.4(YWHAG):c.619G>A (p.Glu207Lys)	YWHAG	E207K	not provided	VCV002747265	7	75959019	7	76329702	2747265	2908025		NC_000007.14:76329701:C:T	single nucleotide variant	missense variant	Likely pathogenic	Sep 10, 2023	criteria provided, single submitter							
NM_012479.4(YWHAG):c.542T>C (p.Val181Ala)	YWHAG	V181A	not provided	VCV002827317	7	75959096	7	76329779	2827317	2983269		NC_000007.14:76329778:A:G	single nucleotide variant	missense variant	Pathogenic	Feb 14, 2023	criteria provided, single submitter							
NM_012479.4(YWHAG):c.529C>T (p.Leu177Phe)	YWHAG	L177F	not provided	VCV002816056	7	75959109	7	76329792	2816056	2976726		NC_000007.14:76329791:G:A	single nucleotide variant	missense variant	Pathogenic	Jan 9, 2023	criteria provided, single submitter							
NM_012479.4(YWHAG):c.398A>G (p.Tyr133Cys)	YWHAG	Y133C	not provided	VCV001335673	7	75959240	7	76329923	1335673	1326644	rs1554616627	NC_000007.14:76329922:T:C	single nucleotide variant	missense variant	Pathogenic	Nov 1, 2021	criteria provided, single submitter							
NM_012479.4(YWHAG):c.394C>T (p.Arg132Cys)	YWHAG	R132C	not provided|Inborn genetic diseases|Developmental and epileptic encephalopathy, 56|YWHAG-related disorder	VCV000438804	7	75959244	7	76329927	438804	432435	rs1554616628	NC_000007.14:76329926:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_012479.4(YWHAG):c.387C>G (p.Asp129Glu)	YWHAG	D129E	not provided|Developmental and epileptic encephalopathy, 56	VCV000438806	7	75959251	7	76329934	438806	432437	rs1554616630	NC_000007.14:76329933:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_012479.4(YWHAG):c.170G>A (p.Arg57His)	YWHAG	R57H	Developmental and epileptic encephalopathy, 56|Inborn genetic diseases|not provided	VCV001338767	7	75959468	7	76330151	1338767	1329803	rs2115589045	NC_000007.14:76330150:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_012479.4(YWHAG):c.169C>T (p.Arg57Cys)	YWHAG	R57C	Intellectual disability|Microcephaly|Hypotonia|Severe global developmental delay|Seizure|Failure to thrive|Constipation|Spasticity|Developmental and epileptic encephalopathy, 56|Inborn genetic diseases|not provided	VCV000659092	7	75959469	7	76330152	659092	636344	rs1583981736	NC_000007.14:76330151:G:A	single nucleotide variant	missense variant	Pathogenic	Jan 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_012479.4(YWHAG):c.125G>A (p.Arg42Gln)	YWHAG	R42Q	not provided	VCV003657604	7	75959513	7	76330196	3657604	3779559		NC_000007.14:76330195:C:T	single nucleotide variant	missense variant	Pathogenic	Dec 18, 2024	criteria provided, single submitter							
NM_001458.5(FLNC):c.86C>A (p.Ala29Glu)	FLNC	A29E	Hypertrophic cardiomyopathy 26	VCV003068249	7	128470777	7	128830723	3068249	3227584		NC_000007.14:128830722:C:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 4, 2024	criteria provided, single submitter							
NM_001458.5(FLNC):c.368T>C (p.Val123Ala)	FLNC	V123A	Hypertrophic cardiomyopathy 26	VCV000253125	7	128475395	7	128835341	253125	247537	rs1562991002	NC_000007.14:128835340:T:C	single nucleotide variant	missense variant	Pathogenic	Jul 21, 2016	no assertion criteria provided							
NM_001458.5(FLNC):c.577G>A (p.Ala193Thr)	FLNC	A193T	Distal myopathy with posterior leg and anterior hand involvement|Myofibrillar myopathy 5|Dilated Cardiomyopathy, Dominant|Hypertrophic cardiomyopathy 26|not provided|Myofibrillar myopathy 5	VCV000029592	7	128475604	7	128835550	29592	38546	rs387906587	NC_000007.14:128835549:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_001458.5(FLNC):c.584T>G (p.Val195Gly)	FLNC	V195G	not provided	VCV000871195	7	128475611	7	128835557	871195	859580	rs1808061980	NC_000007.14:128835556:T:G	single nucleotide variant	missense variant	Likely pathogenic	Nov 1, 2023	criteria provided, single submitter							
NM_001458.5(FLNC):c.608G>A (p.Cys203Tyr)	FLNC	C203Y	Nemaline myopathy	VCV003233257	7	128477220	7	128837166	3233257	3392386		NC_000007.14:128837165:G:A	single nucleotide variant	missense variant	Likely pathogenic	Mar 1, 2024	criteria provided, single submitter							
NM_001458.5(FLNC):c.664A>G (p.Met222Val)	FLNC	M222V	Hypertrophic cardiomyopathy 26|Myofibrillar myopathy 5|Dilated Cardiomyopathy, Dominant|Distal myopathy with posterior leg and anterior hand involvement	VCV001446750	7	128477276	7	128837222	1446750	1410243	rs2128934074	NC_000007.14:128837221:A:G	single nucleotide variant	missense variant	Pathogenic	Jul 19, 2022	criteria provided, single submitter							
NM_001458.5(FLNC):c.665T>C (p.Met222Thr)	FLNC		Distal myopathy with posterior leg and anterior hand involvement	VCV001705740	7	128477277	7	128837223	1705740	1704062		NC_000007.14:128837222:T:C	single nucleotide variant	missense variant	Pathogenic	Sep 14, 2022	no assertion criteria provided							
NM_001458.5(FLNC):c.752T>C (p.Met251Thr)	FLNC	M251T	not provided	VCV000029591	7	128477504	7	128837450	29591	38545	rs387906586	NC_000007.14:128837449:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_001458.5(FLNC):c.3547_3548delinsCT (p.Ala1183Leu)	FLNC	A1183L	Hypertrophic cardiomyopathy 26	VCV000430733	7	128485066 - 128485067	7	128845012 - 128845013	430733	424271	rs1131692185	NC_000007.14:128845011:GC:CT	Indel	missense variant	Likely pathogenic	Jun 12, 2017	criteria provided, single submitter							
NM_001458.5(FLNC):c.3557C>T (p.Ala1186Val)	FLNC	A1186V	Hypertrophic cardiomyopathy 26|Distal myopathy with posterior leg and anterior hand involvement|Myofibrillar myopathy 5|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy 5|Hypertrophic cardiomyopathy 26|Distal myopathy with posterior leg and anterior hand involvement|Myofibrillar myopathy 5|Hypertrophic cardiomyopathy 26|not provided|Abnormality of the musculature|Inborn genetic diseases	VCV000427928	7	128485076	7	128845022	427928	419002	rs1114167361	NC_000007.14:128845021:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_001458.5(FLNC):c.4271G>T (p.Gly1424Val)	FLNC	G1424V	Hypertrophic cardiomyopathy 26|Myofibrillar myopathy 5|Distal myopathy with posterior leg and anterior hand involvement	VCV003382769	7	128486942	7	128846888	3382769	3541943		NC_000007.14:128846887:G:T	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_001458.5(FLNC):c.4615G>A (p.Ala1539Thr)	FLNC	A1539T	Myofibrillar myopathy 5|Dilated Cardiomyopathy, Dominant|Hypertrophic cardiomyopathy 26|Distal myopathy with posterior leg and anterior hand involvement	VCV000253123	7	128488649	7	128848595	253123	247535	rs1562999443	NC_000007.14:128848594:G:A	single nucleotide variant	missense variant	Pathogenic	Jul 31, 2021	criteria provided, single submitter							
NM_001458.5(FLNC):c.4637G>A (p.Gly1546Asp)	FLNC	G1546D	Myofibrillar myopathy 5|Distal myopathy with posterior leg and anterior hand involvement|Hypertrophic cardiomyopathy 26|Dilated Cardiomyopathy, Dominant	VCV001345536	7	128488671	7	128848617	1345536	1452404	rs1427917546	NC_000007.14:128848616:G:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 10, 2021	criteria provided, single submitter							
NM_001458.5(FLNC):c.4642G>C (p.Gly1548Arg)	FLNC	G1548R	Hypertrophic cardiomyopathy 26	VCV003362745	7	128488676	7	128848622	3362745	3521954		NC_000007.14:128848621:G:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 22, 2024	criteria provided, single submitter							
NM_001458.5(FLNC):c.4738G>A (p.Asp1580Asn)	FLNC	D1580N	Hypertrophic cardiomyopathy 26	VCV002683829	7	128488847	7	128848793	2683829	2844866		NC_000007.14:128848792:G:A	single nucleotide variant	missense variant	Likely pathogenic	Mar 19, 2023	no assertion criteria provided							
NM_001458.5(FLNC):c.4861A>T (p.Ile1621Phe)	FLNC	I1621F	Restrictive cardiomyopathy	VCV001027660	7	128488970	7	128848916	1027660	1015421	rs1808685364	NC_000007.14:128848915:A:T	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_001458.5(FLNC):c.5185C>T (p.Pro1729Ser)	FLNC	P1729S	Distal myopathy with posterior leg and anterior hand involvement	VCV003391421	7	128489618	7	128849564	3391421	3550503		NC_000007.14:128849563:C:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 15, 2024	no assertion criteria provided							
NM_001458.5(FLNC):c.5683G>C (p.Ala1895Pro)	FLNC|FLNC-AS1	A1862P, A1895P	Myofibrillar myopathy 5|Distal myopathy with posterior leg and anterior hand involvement|Hypertrophic cardiomyopathy 26|Dilated Cardiomyopathy, Dominant	VCV001364549	7	128491523	7	128851469	1364549	1409030	rs2128938435	NC_000007.14:128851468:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Likely pathogenic	May 17, 2023	criteria provided, single submitter							
NM_001458.5(FLNC):c.5810T>A (p.Ile1937Asn)	FLNC|FLNC-AS1	I1937N, I1904N	not provided|Myofibrillar myopathy 5|Distal myopathy with posterior leg and anterior hand involvement|Hypertrophic cardiomyopathy 26|Dilated Cardiomyopathy, Dominant	VCV000636849	7	128491650	7	128851596	636849	624344	rs1585166795	NC_000007.14:128851595:T:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_001458.5(FLNC):c.6889G>A (p.Val2297Met)	FLNC|FLNC-AS1	V2264M, V2297M	Cardiovascular phenotype|Restrictive cardiomyopathy|Hypertrophic cardiomyopathy 26|not provided|Myofibrillar myopathy 5|Hypertrophic cardiomyopathy 26|Dilated Cardiomyopathy, Dominant|Distal myopathy with posterior leg and anterior hand involvement	VCV000641618	7	128494628	7	128854574	641618	635757	rs1420394583	NC_000007.14:128854573:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_001458.5(FLNC):c.6892C>T (p.Pro2298Ser)	FLNC|FLNC-AS1	P2298S, P2265S	Restrictive cardiomyopathy	VCV000544829	7	128494631	7	128854577	544829	535269	rs1554401403	NC_000007.14:128854576:C:T	single nucleotide variant	missense variant	Likely pathogenic	May 23, 2018	criteria provided, single submitter							
NM_001458.5(FLNC):c.6943C>A (p.His2315Asn)	FLNC-AS1|FLNC	H2315N, H2282N	Hypertrophic cardiomyopathy 26	VCV000253124	7	128494682	7	128854628	253124	247536	rs1563003848	NC_000007.14:128854627:C:A	single nucleotide variant	missense variant	Pathogenic	Jul 21, 2016	no assertion criteria provided							
NM_001458.5(FLNC):c.6958G>A (p.Gly2320Arg)	FLNC-AS1|FLNC	G2320R, G2287R	Myofibrillar myopathy 5|Hypertrophic cardiomyopathy 26|Dilated Cardiomyopathy, Dominant|Distal myopathy with posterior leg and anterior hand involvement	VCV000472153	7	128494697	7	128854643	472153	456371	rs867808948	NC_000007.14:128854642:G:A	single nucleotide variant	missense variant	Likely pathogenic	Oct 9, 2024	criteria provided, single submitter							
NM_001458.5(FLNC):c.6982G>A (p.Val2328Met)	FLNC|FLNC-AS1	V2295M, V2328M	Hypertrophic cardiomyopathy 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy 5|Distal myopathy with posterior leg and anterior hand involvement	VCV001474818	7	128494721	7	128854667	1474818	1503904	rs2128939561	NC_000007.14:128854666:G:A	single nucleotide variant	missense variant	Pathogenic	Dec 6, 2023	criteria provided, single submitter							
NM_001458.5(FLNC):c.7559C>A (p.Thr2520Asn)	FLNC|FLNC-AS1	T2487N, T2520N	Distal myopathy with posterior leg and anterior hand involvement|Hypertrophic cardiomyopathy 26|Dilated Cardiomyopathy, Dominant|Myofibrillar myopathy 5	VCV001025130	7	128496973	7	128856919	1025130	1007237	rs1809086992	NC_000007.14:128856918:C:A	single nucleotide variant	missense variant	Likely pathogenic	Nov 28, 2020	criteria provided, single submitter							
NM_001458.5(FLNC):c.7687T>C (p.Tyr2563His)	FLNC-AS1|FLNC	Y2563H, Y2530H	not provided	VCV000636988	7	128497297	7	128857243	636988	624347	rs1470053697	NC_000007.14:128857242:T:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 15, 2019	criteria provided, single submitter							
NM_001458.5(FLNC):c.7688A>G (p.Tyr2563Cys)	FLNC|FLNC-AS1	Y2563C, Y2530C	Restrictive cardiomyopathy	VCV000549664	7	128497298	7	128857244	549664	540433	rs1563005534	NC_000007.14:128857243:A:G	single nucleotide variant	missense variant	Pathogenic	Apr 1, 2018	criteria provided, single submitter							
NM_001458.5(FLNC):c.7718T>G (p.Ile2573Ser)	FLNC|FLNC-AS1	I2540S, I2573S	Myofibrillar myopathy 5|Hypertrophic cardiomyopathy 26|Dilated Cardiomyopathy, Dominant|Distal myopathy with posterior leg and anterior hand involvement	VCV003755381	7	128497328	7	128857274	3755381	3876132		NC_000007.14:128857273:T:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 3, 2024	criteria provided, single submitter							
NM_145690.3(YWHAZ):c.379C>T (p.Arg127Cys)	YWHAZ	R127C	not provided	VCV003342334	8	101937183	8	100924955	3342334	3501566		NC_000008.11:100924954:G:A	single nucleotide variant	missense variant	Pathogenic	Mar 7, 2024	criteria provided, single submitter							
NM_002467.6(MYC):c.162G>C (p.Glu54Asp)	MYC	E54D, E53D	Burkitt lymphoma	VCV000012576	8	128750625	8	127738379	12576	27615	rs121918684	NC_000008.11:127738378:G:C	single nucleotide variant	missense variant	Pathogenic	Sep 1, 1993	no assertion criteria provided							
NM_002467.6(MYC):c.214C>T (p.Pro72Ser)	MYC	P72S, P71S	Burkitt lymphoma	VCV000012574	8	128750677	8	127738431	12574	27613	rs28933407	NC_000008.11:127738430:C:T	single nucleotide variant	missense variant	Pathogenic	Sep 1, 1993	no assertion criteria provided							
NM_002467.6(MYC):c.217A>G (p.Thr73Ala)	MYC	T72A, T73A	not provided|Acute myeloid leukemia	VCV002658815	8	128750680	8	127738434	2658815	2828509		NC_000008.11:127738433:A:G	single nucleotide variant	missense variant	Pathogenic	Jul 1, 2023	criteria provided, single submitter				Oncogenic	Jan 24, 2024	no assertion criteria provided	
NM_002467.6(MYC):c.302A>C (p.Asn101Thr)	MYC	N101T, N100T	Burkitt lymphoma	VCV000012575	8	128750765	8	127738519	12575	27614	rs121918683	NC_000008.11:127738518:A:C	single nucleotide variant	missense variant	Pathogenic	Sep 1, 1993	no assertion criteria provided							
NM_001130053.5(EEF1D):c.1099A>G (p.Met367Val)	EEF1D	M1V, M367V	Moyamoya angiopathy	VCV000982218	8	144669015	8	143586845	982218	970303	rs1826751784	NC_000008.11:143586844:T:C	single nucleotide variant	missense variant|initiator_codon_variant	Likely pathogenic		no assertion criteria provided							
NM_007126.5(VCP):c.2077C>T (p.Arg693Cys)	VCP	R693C, R648C	not provided	VCV000452025	9	35059144	9	35059147	452025	444477	rs1490390928	NC_000009.12:35059146:G:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 15, 2017	criteria provided, single submitter							
NM_007126.5(VCP):c.1874G>C (p.Arg625Pro)	VCP	R580P, R625P	Global developmental delay	VCV002444456	9	35059620	9	35059623	2444456	2418186		NC_000009.12:35059622:C:G	single nucleotide variant	missense variant	Pathogenic	Feb 26, 2023	criteria provided, single submitter							
NM_007126.5(VCP):c.1774G>A (p.Asp592Asn)	VCP	D592N, D547N	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	VCV000030153	9	35059720	9	35059723	30153	39109	rs387906790	NC_000009.12:35059722:C:T	single nucleotide variant	missense variant	Pathogenic	Dec 9, 2010	no assertion criteria provided							
NM_007126.5(VCP):c.1622C>A (p.Ser541Tyr)	VCP	S496Y, S541Y	Childhood Onset VCP-related Neurodevelopmental Disorder	VCV002582682	9	35060383	9	35060386	2582682	2750251		NC_000009.12:35060385:G:T	single nucleotide variant	missense variant	Likely pathogenic	Sep 1, 2023	criteria provided, single submitter							
NM_007126.5(VCP):c.1184A>G (p.Asp395Gly)	VCP	D395G, D350G	not provided	VCV000989440	9	35061584	9	35061587	989440	977365	rs1828721782	NC_000009.12:35061586:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 29, 2024	criteria provided, single submitter							
NM_007126.5(VCP):c.1084C>T (p.Arg362Cys)	VCP	R317C, R362C	Childhood Onset VCP-related Neurodevelopmental Disorder	VCV002582681	9	35061684	9	35061687	2582681	2750250		NC_000009.12:35061686:G:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 1, 2023	criteria provided, single submitter							
NM_007126.5(VCP):c.812G>A (p.Gly271Asp)	VCP	G226D, G271D	not provided	VCV002429745	9	35062347	9	35062350	2429745	2403247		NC_000009.12:35062349:C:T	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_007126.5(VCP):c.782A>C (p.Glu261Ala)	VCP	E216A, E261A	not provided	VCV003251039	9	35063004	9	35063007	3251039	3409838		NC_000009.12:35063006:T:G	single nucleotide variant	missense variant	Likely pathogenic	Jun 1, 2024	criteria provided, single submitter							
NM_007126.5(VCP):c.766C>G (p.Arg256Gly)	VCP	R211G, R256G	Childhood Onset VCP-related Neurodevelopmental Disorder|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|Charcot-Marie-Tooth disease type 2Y	VCV002582679	9	35063020	9	35063023	2582679	2750248		NC_000009.12:35063022:G:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_007126.5(VCP):c.753G>T (p.Lys251Asn)	VCP	K206N, K251N	Childhood Onset VCP-related Neurodevelopmental Disorder	VCV002582678	9	35063033	9	35063036	2582678	2750247		NC_000009.12:35063035:C:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 1, 2023	criteria provided, single submitter							
NM_007126.5(VCP):c.742G>A (p.Gly248Arg)	VCP	G203R, G248R	VCP-related disorder	VCV002584478	9	35063044	9	35063047	2584478	2752041		NC_000009.12:35063046:C:T	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_007126.5(VCP):c.695C>A (p.Ala232Glu)	VCP	A232E, A187E	not provided	VCV000008470	9	35064164	9	35064167	8470	23509	rs121909331	NC_000009.12:35064166:G:T	single nucleotide variant	missense variant	Pathogenic	Aug 1, 2020	criteria provided, single submitter							
NM_007126.5(VCP):c.648A>G (p.Ile216Met)	VCP	I171M, I216M	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	VCV000836876	9	35064211	9	35064214	836876	836087	rs1828783140	NC_000009.12:35064213:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 20, 2024	criteria provided, single submitter							
NM_007126.5(VCP):c.572G>C (p.Arg191Pro)	VCP	R146P, R191P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	VCV000873223	9	35065252	9	35065255	873223	861362	rs121909334	NC_000009.12:35065254:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_007126.5(VCP):c.572G>A (p.Arg191Gln)	VCP	R191Q, R146Q	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Charcot-Marie-Tooth disease type 2Y|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1	VCV000008473	9	35065252	9	35065255	8473	23512	rs121909334	NC_000009.12:35065254:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_007126.5(VCP):c.553G>A (p.Glu185Lys)	VCP	E185K, E140K	Inborn genetic diseases|Charcot-Marie-Tooth disease type 2Y|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	VCV000218305	9	35065271	9	35065274	218305	215001	rs864309501	NC_000009.12:35065273:C:T	single nucleotide variant	missense variant	Likely pathogenic	Nov 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_007126.5(VCP):c.476G>A (p.Arg159His)	VCP	R159H, R114H	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided	VCV000008474	9	35065348	9	35065351	8474	23513	rs121909335	NC_000009.12:35065350:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_007126.5(VCP):c.475C>A (p.Arg159Ser)	VCP	R159S, R114S	Amyotrophic lateral sclerosis type 6	VCV000989439	9	35065349	9	35065352	989439	977364	rs387906789	NC_000009.12:35065351:G:T	single nucleotide variant	missense variant	Pathogenic	Dec 23, 2020	no assertion criteria provided							
NM_007126.5(VCP):c.475C>T (p.Arg159Cys)	VCP	R159C, R114C	not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	VCV000280123	9	35065349	9	35065352	280123	264328	rs387906789	NC_000009.12:35065351:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_007126.5(VCP):c.475C>G (p.Arg159Gly)	VCP	R159G, R114G	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	VCV000030152	9	35065349	9	35065352	30152	39108	rs387906789	NC_000009.12:35065351:G:C	single nucleotide variant	missense variant	Pathogenic	Dec 9, 2010	no assertion criteria provided							
NM_007126.5(VCP):c.472A>G (p.Met158Val)	VCP	M158V, M113V	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	VCV001457378	9	35065352	9	35065355	1457378	1393319	rs1554668813	NC_000009.12:35065354:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 11, 2021	criteria provided, single submitter							
NM_007126.5(VCP):c.469G>A (p.Gly157Arg)	VCP	G112R, G157R	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	VCV001457379	9	35065355	9	35065358	1457379	1393320	rs1554668814	NC_000009.12:35065357:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 1, 2024	criteria provided, single submitter							
NM_007126.5(VCP):c.469G>C (p.Gly157Arg)	VCP	G112R, G157R	not provided	VCV000871718	9	35065355	9	35065358	871718	859757	rs1554668814	NC_000009.12:35065357:C:G	single nucleotide variant	missense variant	Pathogenic	Dec 1, 2019	criteria provided, single submitter							
NM_007126.5(VCP):c.466G>A (p.Gly156Ser)	VCP	G156S, G111S	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	VCV002136763	9	35065358	9	35065361	2136763	1877770		NC_000009.12:35065360:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_007126.5(VCP):c.464G>A (p.Arg155His)	VCP	R155H, R110H	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|Inborn genetic diseases|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|not provided	VCV000008468	9	35065360	9	35065363	8468	23507	rs121909329	NC_000009.12:35065362:C:T	single nucleotide variant	missense variant	Pathogenic	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_007126.5(VCP):c.463C>A (p.Arg155Ser)	VCP	R155S, R110S	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	VCV001457380	9	35065361	9	35065364	1457380	1393321	rs121909330	NC_000009.12:35065363:G:T	single nucleotide variant	missense variant	Pathogenic	Oct 15, 2024	criteria provided, single submitter							
NM_007126.5(VCP):c.463C>G (p.Arg155Gly)	VCP	R155G, R110G	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	VCV000217028	9	35065361	9	35065364	217028	213592	rs121909330	NC_000009.12:35065363:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_007126.5(VCP):c.463C>T (p.Arg155Cys)	VCP	R155C, R110C	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|not provided	VCV000008469	9	35065361	9	35065364	8469	23508	rs121909330	NC_000009.12:35065363:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_007126.5(VCP):c.410C>T (p.Pro137Leu)	VCP	P137L, P92L	Charcot-Marie-Tooth disease type 2Y	VCV003768936	9	35066707	9	35066710	3768936	3885091		NC_000009.12:35066709:G:A	single nucleotide variant	missense variant	Pathogenic	Feb 19, 2025	criteria provided, single submitter							
NM_007126.5(VCP):c.409C>T (p.Pro137Ser)	VCP	P137S, P92S	Alzheimer disease	VCV000599629	9	35066708	9	35066711	599629	590945	rs866101707	NC_000009.12:35066710:G:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 1, 2017	criteria provided, single submitter							
NM_007126.5(VCP):c.382G>A (p.Gly128Ser)	VCP	G83S, G128S	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	VCV002028838	9	35066735	9	35066738	2028838	2085473		NC_000009.12:35066737:C:T	single nucleotide variant	missense variant	Likely pathogenic	Sep 3, 2022	criteria provided, single submitter							
NM_007126.5(VCP):c.294T>A (p.Asp98Glu)	VCP	D53E, D98E	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1	VCV000976025	9	35067896	9	35067899	976025	964331	rs1828864269	NC_000009.12:35067898:A:T	single nucleotide variant	missense variant	Likely pathogenic	Mar 29, 2022	criteria provided, single submitter							
NM_007126.5(VCP):c.290G>A (p.Gly97Glu)	VCP	G97E, G52E	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	VCV000218306	9	35067900	9	35067903	218306	215002	rs864309502	NC_000009.12:35067902:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 22, 2022	criteria provided, single submitter							
NM_007126.5(VCP):c.286C>G (p.Leu96Val)	VCP	L51V, L96V	Progressive muscle weakness	VCV003767890	9	35067904	9	35067907	3767890	3884057		NC_000009.12:35067906:G:C	single nucleotide variant	missense variant	Likely pathogenic	Aug 13, 2024	criteria provided, single submitter							
NM_007126.5(VCP):c.284G>A (p.Arg95His)	VCP	R50H, R95H	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	VCV001513178	9	35067906	9	35067909	1513178	1472233	rs758169026	NC_000009.12:35067908:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jul 26, 2022	criteria provided, single submitter							
NM_007126.5(VCP):c.283C>A (p.Arg95Ser)	VCP	R50S, R95S	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	VCV002954479	9	35067907	9	35067910	2954479	3110799		NC_000009.12:35067909:G:T	single nucleotide variant	missense variant	Likely pathogenic	Dec 8, 2023	criteria provided, single submitter							
NM_007126.5(VCP):c.283C>G (p.Arg95Gly)	VCP	R95G, R50G	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	VCV000008471	9	35067907	9	35067910	8471	23510	rs121909332	NC_000009.12:35067909:G:C	single nucleotide variant	missense variant	Pathogenic	Mar 1, 2024	criteria provided, single submitter							
NM_007126.5(VCP):c.277C>T (p.Arg93Cys)	VCP	R93C, R48C	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|not provided	VCV000593071	9	35067913	9	35067916	593071	584135	rs1554669087	NC_000009.12:35067915:G:A	single nucleotide variant	missense variant	Pathogenic	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_007126.5(VCP):c.273C>A (p.Asn91Lys)	VCP	N46K, N91K	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	VCV001496153	9	35067917	9	35067920	1496153	1363068	rs1563980966	NC_000009.12:35067919:G:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 15, 2023	criteria provided, single submitter							
NM_007126.5(VCP):c.273C>G (p.Asn91Lys)	VCP	N46K, N91K	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	VCV001403085	9	35067917	9	35067920	1403085	1392697	rs1563980966	NC_000009.12:35067919:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 15, 2025	criteria provided, single submitter							
NM_007126.5(VCP):c.271A>T (p.Asn91Tyr)	VCP	N91Y, N46Y	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	VCV000217877	9	35067919	9	35067922	217877	214539	rs863225291	NC_000009.12:35067921:T:A	single nucleotide variant	missense variant	Pathogenic	Apr 11, 2022	criteria provided, single submitter							
NM_007126.5(VCP):c.266G>A (p.Arg89Gln)	VCP	R44Q, R89Q	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	VCV002051539	9	35067924	9	35067927	2051539	2108130		NC_000009.12:35067926:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 25, 2024	criteria provided, single submitter							
NM_007126.5(VCP):c.166A>G (p.Thr56Ala)	VCP	T11A, T56A	not provided	VCV002659168	9	35068024	9	35068027	2659168	2828862		NC_000009.12:35068026:T:C	single nucleotide variant	missense variant	Likely pathogenic	Oct 1, 2023	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.1282G>A (p.Glu428Lys)	HNRNPK	E404K, E428K	Au-Kline syndrome	VCV001077160	9	86585156	9	83970241	1077160	1065800	rs2133014993	NC_000009.12:83970240:C:T	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_031263.4(HNRNPK):c.1240C>T (p.Arg414Cys)	HNRNPK	R390C, R414C	Au-Kline syndrome	VCV001685880	9	86585198	9	83970283	1685880	1677893	rs1348162749	NC_000009.12:83970282:G:A	single nucleotide variant	missense variant	Pathogenic	May 4, 2022	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.1214A>C (p.Lys405Thr)	HNRNPK	K381T, K405T	Au-Kline syndrome	VCV003573011	9	86585224	9	83970309	3573011	3731902		NC_000009.12:83970308:T:G	single nucleotide variant	missense variant	Likely pathogenic	Oct 30, 2024	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.1123G>T (p.Gly375Trp)	HNRNPK	G351W, G375W	Au-Kline syndrome	VCV000689628	9	86585720	9	83970805	689628	677304	rs1588412390	NC_000009.12:83970804:C:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 25, 2019	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.1109A>G (p.Asp370Gly)	HNRNPK	D346G, D370G	Au-Kline syndrome	VCV001685346	9	86585734	9	83970819	1685346	1677366	rs2133020093	NC_000009.12:83970818:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 4, 2022	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.989G>A (p.Gly330Glu)	HNRNPK	G306E, G330E	not provided	VCV001690319	9	86586606	9	83971691	1690319	1682710	rs2133028167	NC_000009.12:83971690:C:T	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_031263.4(HNRNPK):c.673T>C (p.Tyr225His)	HNRNPK|HNRNPK-AS1	Y201H, Y225H	not provided|Au-Kline syndrome	VCV000818201	9	86587077	9	83972162	818201	806407	rs1588417800	NC_000009.12:83972161:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_031263.4(HNRNPK):c.575T>G (p.Val192Gly)	HNRNPK|HNRNPK-AS1	V168G, V192G	Au-Kline syndrome	VCV002412686	9	86587829	9	83972914	2412686	2401416		NC_000009.12:83972913:A:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 25, 2023	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.569A>C (p.Asp190Ala)	HNRNPK|HNRNPK-AS1	D190A, D166A	not provided	VCV000452722	9	86587835	9	83972920	452722	444521	rs1554699378	NC_000009.12:83972919:T:G	single nucleotide variant	missense variant	Likely pathogenic	Oct 18, 2017	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.566C>T (p.Thr189Ile)	HNRNPK|HNRNPK-AS1	T165I, T189I	HNRNPK-related disorder	VCV002637294	9	86587838	9	83972923	2637294	2799972		NC_000009.12:83972922:G:A	single nucleotide variant	missense variant	Likely pathogenic	Oct 21, 2022	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.464T>C (p.Leu155Pro)	HNRNPK-AS1|HNRNPK	L155P, L131P	not provided	VCV000625163	9	86588253	9	83973338	625163	613506	rs1564063967	NC_000009.12:83973337:A:G	single nucleotide variant	missense variant	Pathogenic	Oct 23, 2020	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.462T>G (p.Ser154Arg)	HNRNPK|HNRNPK-AS1	S130R, S154R	Au-Kline syndrome	VCV003255000	9	86588255	9	83973340	3255000	3413774		NC_000009.12:83973339:A:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 20, 2024	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.452T>A (p.Ile151Asn)	HNRNPK|HNRNPK-AS1	I127N, I151N	Generalized hypotonia	VCV001172625	9	86588265	9	83973350	1172625	1161820	rs2133039624	NC_000009.12:83973349:A:T	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_031263.4(HNRNPK):c.446T>C (p.Leu149Pro)	HNRNPK|HNRNPK-AS1	L125P, L149P	Au-Kline syndrome	VCV003254999	9	86588271	9	83973356	3254999	3413773		NC_000009.12:83973355:A:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 20, 2024	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.257G>A (p.Arg86His)	HNRNPK|HNRNPK-AS1	R86H	Au-Kline syndrome	VCV000212776	9	86590377	9	83975462	212776	209408	rs863223403	NC_000009.12:83975461:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 31, 2018	criteria provided, multiple submitters, no conflicts							
NM_031263.4(HNRNPK):c.248G>A (p.Gly83Asp)	HNRNPK|HNRNPK-AS1	G83D	not provided|Inborn genetic diseases	VCV000421187	9	86590386	9	83975471	421187	407716	rs1064794967	NC_000009.12:83975470:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jul 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_031263.4(HNRNPK):c.203T>G (p.Leu68Arg)	HNRNPK	L68R	Au-Kline syndrome	VCV000804254	9	86591920	9	83977005	804254	792606	rs1588432187	NC_000009.12:83977004:A:C	single nucleotide variant	missense variant	Likely pathogenic	Jul 12, 2019	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.140_143delinsATCA (p.Ile47_Leu48delinsAsnGln)	HNRNPK		Au-Kline syndrome	VCV000666583	9	86592617 - 86592620	9	83977702 - 83977705	666583	654134	rs1588434457	NC_000009.12:83977701:AGAA:TGAT	Indel	missense variant	Likely pathogenic	Aug 21, 2018	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.137G>T (p.Arg46Leu)	HNRNPK	R46L	not provided	VCV002663562	9	86592623	9	83977708	2663562	2831009		NC_000009.12:83977707:C:A	single nucleotide variant	missense variant	Pathogenic	May 9, 2023	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.136C>T (p.Arg46Cys)	HNRNPK	R46C	Au-Kline syndrome	VCV003766482	9	86592624	9	83977709	3766482	3882647		NC_000009.12:83977708:G:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 29, 2024	criteria provided, single submitter							
NM_031263.4(HNRNPK):c.65G>A (p.Arg22His)	HNRNPK	R22H	Inborn genetic diseases	VCV000520659	9	86592695	9	83977780	520659	511842	rs1397068742	NC_000009.12:83977779:C:T	single nucleotide variant	missense variant	Likely pathogenic	Mar 19, 2015	criteria provided, single submitter							
NM_002161.6(IARS1):c.3521T>A (p.Ile1174Asn)	IARS1	I1174N, I1142N, I1154N, I1129N, I1160N, I1181N, I1195N, I1146N, I1149N, I1133N	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	VCV000253318	9	94985660	9	92223378	253318	247766	rs886037873	NC_000009.12:92223377:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 20, 2019	no assertion criteria provided							
NM_002161.6(IARS1):c.2974A>G (p.Asn992Asp)	IARS1	N992D, N960D, N999D, N951D, N1013D, N964D, N967D	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	VCV000253322	9	95005524	9	92243242	253322	247770	rs886037877	NC_000009.12:92243241:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 20, 2019	no assertion criteria provided							
NM_002161.6(IARS1):c.2215C>T (p.Arg739Cys)	IARS1	R739C, R746C, R698C, R711C, R760C	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	VCV000559510	9	95015658	9	92253376	559510	550233	rs747311061	NC_000009.12:92253375:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 20, 2019	no assertion criteria provided							
NM_002161.6(IARS1):c.1667T>C (p.Phe556Ser)	IARS1	F556S, F515S, F563S, F577S	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	VCV000559509	9	95027244	9	92264962	559509	550232	rs1554728327	NC_000009.12:92264961:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 20, 2019	no assertion criteria provided							
NM_002161.6(IARS1):c.1310C>T (p.Pro437Leu)	IARS1	P437L, P444L, P396L, P458L	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	VCV000253319	9	95030577	9	92268295	253319	247767	rs886037874	NC_000009.12:92268294:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 20, 2019	no assertion criteria provided							
NM_002161.6(IARS1):c.1109T>G (p.Val370Gly)	IARS1	V370G, V377G, V391G, V329G	Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy	VCV000253321	9	95033819	9	92271537	253321	247769	rs886037876	NC_000009.12:92271536:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 20, 2019	no assertion criteria provided							
NM_003380.5(VIM):c.451G>A (p.Glu151Lys)	VIM|VIM-AS1	E151K	Cataract 30	VCV000012199	10	17271872	10	17229873	12199	27238	rs121917775	NC_000010.11:17229872:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Pathogenic	Mar 15, 2009	no assertion criteria provided							
NM_003380.5(VIM):c.1160T>C (p.Leu387Pro)	VIM	L387P	syndrome with premature-aging	VCV000692107	10	17277319	10	17235320	692107	679851	rs1588736025	NC_000010.11:17235319:T:C	single nucleotide variant	missense variant	Likely pathogenic	Oct 3, 2019	no assertion criteria provided							
NM_005343.4(HRAS):c.468C>G (p.Phe156Leu)	LRRC56|HRAS	F156L, F77L	not provided	VCV001198752	11	532738	11	532738	1198752	1187757	rs770648642	NC_000011.10:532737:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic	Apr 23, 2021	criteria provided, single submitter							
NM_005343.4(HRAS):c.466T>C (p.Phe156Leu)	HRAS|LRRC56	F156L, F77L	Costello syndrome	VCV001327492	11	532740	11	532740	1327492	1318065	rs2133982557	NC_000011.10:532739:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic	Dec 8, 2021	criteria provided, single submitter							
NM_005343.4(HRAS):c.437C>T (p.Ala146Val)	HRAS|LRRC56	A146V, P40S	Costello syndrome	VCV000012611	11	533466	11	533466	12611	27650	rs121917759	NC_000011.10:533465:G:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 29, 2018	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.436G>A (p.Ala146Thr)	HRAS|LRRC56	A146T	Costello syndrome	VCV000012607	11	533467	11	533467	12607	27646	rs104894231	NC_000011.10:533466:C:T	single nucleotide variant	missense variant|synonymous variant	Pathogenic	Mar 1, 2007	no assertion criteria provided							
NM_005343.4(HRAS):c.350A>G (p.Lys117Arg)	HRAS|LRRC56	K117R, S11G	Costello syndrome	VCV000012605	11	533553	11	533553	12605	27644	rs104894227	NC_000011.10:533552:T:C	single nucleotide variant	missense variant	Pathogenic	Apr 3, 2017	reviewed by expert panel							
NM_005343.4(HRAS):c.266C>G (p.Ser89Cys)	HRAS|LRRC56	S89C	not provided	VCV000040438	11	533790	11	533790	40438	48908	rs755322824	NC_000011.10:533789:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 4, 2014	criteria provided, single submitter							
NM_005343.4(HRAS):c.187G>A (p.Glu63Lys)	HRAS|LRRC56	E63K	not provided|Costello syndrome	VCV000012608	11	533869	11	533869	12608	27647	rs121917756	NC_000011.10:533868:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Sep 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.183G>T (p.Gln61His)	LRRC56|HRAS	Q61H	Noonan syndrome 3	VCV000376318	11	533873	11	533873	376318	363197	rs121913496	NC_000011.10:533872:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	May 22, 2017	criteria provided, single submitter							
NM_005343.4(HRAS):c.182A>G (p.Gln61Arg)	HRAS|LRRC56	Q61R	not provided|Noonan syndrome and Noonan-related syndrome|Costello syndrome|Epidermal nevus|Thyroid cancer, nonmedullary, 2|Large congenital melanocytic nevus|Linear nevus sebaceous syndrome|Malignant tumor of urinary bladder	VCV000160364	11	533874	11	533874	160364	170209	rs121913233	NC_000011.10:533873:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.181C>A (p.Gln61Lys)	HRAS|LRRC56	Q61K	not provided|Noonan syndrome 3|Epidermal nevus	VCV000012601	11	533875	11	533875	12601	27640	rs28933406	NC_000011.10:533874:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.179G>T (p.Gly60Val)	HRAS|LRRC56	G60V	Costello syndrome|not provided|Costello syndrome|Thyroid cancer, nonmedullary, 2|Large congenital melanocytic nevus|Linear nevus sebaceous syndrome|Malignant tumor of urinary bladder|Epidermal nevus	VCV000391700	11	533877	11	533877	391700	374144	rs730880460	NC_000011.10:533876:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.179G>A (p.Gly60Asp)	HRAS|LRRC56	G60D	not provided|Costello syndrome	VCV000040436	11	533877	11	533877	40436	48906	rs730880460	NC_000011.10:533876:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.178G>A (p.Gly60Ser)	HRAS|LRRC56	G60S	Costello syndrome	VCV000660897	11	533878	11	533878	660897	640156	rs1589792804	NC_000011.10:533877:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_005343.4(HRAS):c.176C>G (p.Ala59Gly)	HRAS|LRRC56	A59G	RASopathy	VCV001810343	11	533880	11	533880	1810343	1867353		NC_000011.10:533879:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jan 5, 2023	criteria provided, single submitter							
NM_005343.4(HRAS):c.175_176delinsCT (p.Ala59Leu)	HRAS|LRRC56	A59L	Costello syndrome	VCV000179260	11	533880 - 533881	11	533880 - 533881	179260	174803	rs727504747	NC_000011.10:533879:GC:AG	Indel	missense variant|5 prime UTR variant	Likely pathogenic	Aug 14, 2014	criteria provided, single submitter							
NM_005343.4(HRAS):c.175G>A (p.Ala59Thr)	LRRC56|HRAS	A59T	RASopathy	VCV000040435	11	533881	11	533881	40435	48905	rs727503093	NC_000011.10:533880:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Sep 17, 2024	reviewed by expert panel							
NM_005343.4(HRAS):c.173C>T (p.Thr58Ile)	HRAS|LRRC56	T58I	Costello syndrome	VCV000012610	11	533883	11	533883	12610	27649	rs121917758	NC_000011.10:533882:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Apr 3, 2017	reviewed by expert panel							
NM_005343.4(HRAS):c.64C>A (p.Gln22Lys)	HRAS|LRRC56	Q22K	not provided|Costello syndrome	VCV000012609	11	534259	11	534259	12609	27648	rs121917757	NC_000011.10:534258:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Dec 6, 2018	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.38G>T (p.Gly13Val)	HRAS|LRRC56	G13V	Costello syndrome|Large congenital melanocytic nevus|not provided	VCV000180848	11	534285	11	534285	180848	179419	rs104894226	NC_000011.10:534284:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.38G>A (p.Gly13Asp)	HRAS|LRRC56	G13D	not provided|HRAS-related disorder|RASopathy|Noonan syndrome and Noonan-related syndrome|Epidermal nevus|Malignant tumor of urinary bladder|Thyroid cancer, nonmedullary, 2|Large congenital melanocytic nevus|Costello syndrome|Linear nevus sebaceous syndrome|Non-immune hydrops fetalis|Costello syndrome	VCV000012604	11	534285	11	534285	12604	27643	rs104894226	NC_000011.10:534284:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Oct 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.37G>A (p.Gly13Ser)	HRAS|LRRC56	G13S	Costello syndrome	VCV000376323	11	534286	11	534286	376323	363202	rs104894228	NC_000011.10:534285:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	May 18, 2022	criteria provided, single submitter							
NM_005343.4(HRAS):c.37G>C (p.Gly13Arg)	HRAS|LRRC56	G13R	Epidermolytic nevus|Noonan syndrome and Noonan-related syndrome|Costello syndrome|Non-immune hydrops fetalis	VCV000035554	11	534286	11	534286	35554	44227	rs104894228	NC_000011.10:534285:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Oct 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.37G>T (p.Gly13Cys)	HRAS|LRRC56	G13C	Noonan syndrome	VCV000012606	11	534286	11	534286	12606	27645	rs104894228	NC_000011.10:534285:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Apr 3, 2017	reviewed by expert panel							
NM_005343.4(HRAS):c.35_36delinsTT (p.Gly12Val)	HRAS|LRRC56	G12V	not provided|Costello syndrome	VCV001209208	11	534287 - 534288	11	534287 - 534288	1209208	613672	rs727503094	NC_000011.10:534286:GC:AA	Indel	missense variant|5 prime UTR variant	Pathogenic	Jun 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.35_36delinsTA (p.Gly12Val)	HRAS|LRRC56	G12V	not provided	VCV000279921	11	534287 - 534288	11	534287 - 534288	279921	264557	rs727503094	NC_000011.10:534286:GC:TA	Indel	missense variant|5 prime UTR variant	Pathogenic	Apr 26, 2016	criteria provided, single submitter							
NM_005343.4(HRAS):c.35_36delinsAT (p.Gly12Asp)	LRRC56|HRAS	G12D	not provided	VCV000180854	11	534287 - 534288	11	534287 - 534288	180854	179420	rs727503094	NC_000011.10:534286:GC:AT	Indel	missense variant|5 prime UTR variant	Pathogenic	Aug 20, 2021	criteria provided, single submitter							
NM_005343.4(HRAS):c.35_36delinsAA (p.Gly12Glu)	HRAS|LRRC56	G12E	not provided|Costello syndrome	VCV000163690	11	534287 - 534288	11	534287 - 534288	163690	174805	rs727503094	NC_000011.10:534286:GC:TT	Indel	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	May 31, 2017	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.35_36delinsCT (p.Gly12Ala)	HRAS|LRRC56	G12A	not provided	VCV000040430	11	534287 - 534288	11	534287 - 534288	40430	48900	rs727503094	NC_000011.10:534286:GC:AG	Indel	missense variant|5 prime UTR variant	Pathogenic	Apr 28, 2017	criteria provided, single submitter							
NM_005343.4(HRAS):c.35G>A (p.Gly12Asp)	HRAS|LRRC56	G12D	Noonan syndrome and Noonan-related syndrome|RASopathy|Non-immune hydrops fetalis|not provided|Costello syndrome	VCV000012612	11	534288	11	534288	12612	27651	rs104894230	NC_000011.10:534287:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jul 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.35G>C (p.Gly12Ala)	HRAS|LRRC56	G12A	Linear nevus sebaceous syndrome|Thyroid cancer, nonmedullary, 2|Costello syndrome|Large congenital melanocytic nevus|Epidermal nevus|Malignant tumor of urinary bladder|Inborn genetic diseases|not provided|Noonan syndrome and Noonan-related syndrome|Costello syndrome	VCV000012603	11	534288	11	534288	12603	27642	rs104894230	NC_000011.10:534287:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.35G>T (p.Gly12Val)	HRAS|LRRC56	G12V	not provided|Costello syndrome|HRAS-related disorder|Cardiovascular phenotype	VCV000012600	11	534288	11	534288	12600	27639	rs104894230	NC_000011.10:534287:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Aug 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.34G>C (p.Gly12Arg)	HRAS|LRRC56	G12R	Costello syndrome	VCV000375961	11	534289	11	534289	375961	362840	rs104894229	NC_000011.10:534288:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Apr 25, 2022	criteria provided, single submitter							
NM_005343.4(HRAS):c.34G>T (p.Gly12Cys)	HRAS|LRRC56	G12C	Epidermal nevus|Malignant tumor of urinary bladder|Thyroid cancer, nonmedullary, 2|Large congenital melanocytic nevus|Costello syndrome|Linear nevus sebaceous syndrome|not provided|Costello syndrome	VCV000012613	11	534289	11	534289	12613	27652	rs104894229	NC_000011.10:534288:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jul 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_005343.4(HRAS):c.34G>A (p.Gly12Ser)	HRAS|LRRC56	G12S	Costello syndrome	VCV000012602	11	534289	11	534289	12602	27641	rs104894229	NC_000011.10:534288:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Apr 3, 2017	reviewed by expert panel							
NM_005566.4(LDHA):c.244G>A (p.Asp82Asn)	LDHA	D111N, D82N, V82M	Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency	VCV002137026	11	18421095	11	18399548	2137026	1878028		NC_000011.10:18399547:G:A	single nucleotide variant	missense variant	Likely pathogenic	Mar 12, 2022	criteria provided, single submitter							
NM_004551.3(NDUFS3):c.2T>G (p.Met1Arg)	NDUFS3	M1R	not provided	VCV000214805	11	47600645	11	47579093	214805	211535	rs863224106	NC_000011.10:47579092:T:G	single nucleotide variant	missense variant|initiator_codon_variant	Likely pathogenic	Jul 18, 2019	criteria provided, single submitter							
NM_004551.3(NDUFS3):c.3G>C (p.Met1Ile)	NDUFS3	M1I	Inborn genetic diseases	VCV002228564	11	47600646	11	47579094	2228564	2219306		NC_000011.10:47579093:G:C	single nucleotide variant	missense variant|initiator_codon_variant	Likely pathogenic	Dec 31, 2020	criteria provided, single submitter							
NM_004551.3(NDUFS3):c.434C>T (p.Thr145Ile)	NDUFS3	T145I	Mitochondrial complex 1 deficiency, nuclear type 8|Neurodevelopmental delay	VCV000006019	11	47603692	11	47582140	6019	21058	rs28939714	NC_000011.10:47582139:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 23, 2019	criteria provided, multiple submitters, no conflicts							
NM_004551.3(NDUFS3):c.595C>T (p.Arg199Trp)	NDUFS3	R199W	Mitochondrial complex 1 deficiency, nuclear type 8|not provided	VCV000006020	11	47603988	11	47582436	6020	21059	rs104894270	NC_000011.10:47582435:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_198334.3(GANAB):c.2516C>T (p.Thr839Ile)	GANAB	T598I, T725I, T742I, T747I, T839I, T861I	Polycystic kidney disease 3 with or without polycystic liver disease	VCV001711179	11	62393915	11	62626443	1711179	1709591		NC_000011.10:62626442:G:A	single nucleotide variant	missense variant	Pathogenic	Dec 24, 2021	no assertion criteria provided							
NM_198334.3(GANAB):c.2449C>T (p.Arg817Trp)	GANAB	R839W, R703W, R725W, R817W, R576W, R720W	Polycystic kidney disease 3 with or without polycystic liver disease|not provided	VCV000253132	11	62394105	11	62626633	253132	247544	rs879255643	NC_000011.10:62626632:G:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_198334.3(GANAB):c.1940A>G (p.Asp647Gly)	GANAB	D669G, D647G, D406G, D550G, D533G, D555G	Autosomal dominant polycystic liver disease	VCV000590354	11	62396481	11	62629009	590354	581286	rs1565092566	NC_000011.10:62629008:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2018	no assertion criteria provided							
NM_198334.3(GANAB):c.1786C>T (p.Arg596Cys)	GANAB	R618C, R596C, R355C, R482C, R499C, R504C	Autosomal dominant polycystic liver disease	VCV000590353	11	62397108	11	62629636	590353	581289	rs1565093675	NC_000011.10:62629635:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2018	no assertion criteria provided							
NM_198334.3(GANAB):c.1769G>C (p.Arg590Pro)	GANAB	R612P, R349P, R590P, R476P, R498P, R493P	Autosomal dominant polycystic liver disease	VCV000590349	11	62397125	11	62629653	590349	581290	rs1465649718	NC_000011.10:62629652:C:G	single nucleotide variant	missense variant	Pathogenic	Jan 1, 2018	no assertion criteria provided							
NM_198334.3(GANAB):c.1429T>C (p.Tyr477His)	GANAB	Y236H, Y363H, Y380H, Y385H, Y477H, Y499H	Polycystic kidney disease 3 with or without polycystic liver disease	VCV001803160	11	62397935	11	62630463	1803160	1860189		NC_000011.10:62630462:A:G	single nucleotide variant	missense variant	Likely pathogenic	Aug 11, 2021	criteria provided, single submitter							
NM_198334.3(GANAB):c.1148C>G (p.Thr383Arg)	GANAB	T405R, T269R, T142R, T286R, T383R, T291R	POLYCYSTIC KIDNEY DISEASE 3 WITHOUT POLYCYSTIC LIVER DISEASE	VCV000253130	11	62398504	11	62631032	253130	247542	rs879255642	NC_000011.10:62631031:G:C	single nucleotide variant	missense variant	Pathogenic	Feb 22, 2018	no assertion criteria provided							
NM_198334.3(GANAB):c.38G>A (p.Arg13Gln)	GANAB	R13Q	Autosomal dominant polycystic liver disease	VCV000590357	11	62414034	11	62646562	590357	581293	rs1565116806	NC_000011.10:62646561:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jan 1, 2018	no assertion criteria provided							
NM_033360.4(KRAS):c.*22C>G	KRAS	F156L	RASopathy|not provided|KRAS-related disorder	VCV000012595	12	25362828	12	25209894	12595	27634	rs104894362	NC_000012.12:25209893:G:C	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic	Mar 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004985.5(KRAS):c.467T>C (p.Phe156Ser)	KRAS	F156S	RASopathy	VCV002716407	12	25362829	12	25209895	2716407	2879953		NC_000012.12:25209894:A:G	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic	Aug 30, 2024	criteria provided, single submitter							
NM_004985.5(KRAS):c.466T>A (p.Phe156Ile)	KRAS	F156I	Noonan syndrome|Cardio-facio-cutaneous syndrome|Noonan syndrome 3|not provided	VCV000163758	12	25362830	12	25209896	163758	175711	rs397517042	NC_000012.12:25209895:A:T	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic	Jan 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_004985.5(KRAS):c.466T>G (p.Phe156Val)	KRAS	F156V	Noonan syndrome|not provided	VCV000045127	12	25362830	12	25209896	45127	54294	rs397517042	NC_000012.12:25209895:A:C	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic/Likely pathogenic	Aug 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_004985.5(KRAS):c.461A>G (p.Asp154Gly)	KRAS	D154G	Hereditary breast ovarian cancer syndrome	VCV000981803	12	25362835	12	25209901	981803	969947	rs2141481712	NC_000012.12:25209900:T:C	single nucleotide variant	3 prime UTR variant|missense variant	Likely pathogenic	Aug 1, 2020	criteria provided, single submitter							
NM_004985.5(KRAS):c.458A>G (p.Asp153Gly)	KRAS	D153G	Noonan syndrome|not provided|RASopathy	VCV000040465	12	25362838	12	25209904	40465	48935	rs104894360	NC_000012.12:25209903:T:C	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic/Likely pathogenic	Oct 1, 2020	criteria provided, multiple submitters, no conflicts							
NM_004985.5(KRAS):c.458A>T (p.Asp153Val)	KRAS	D153V	Noonan syndrome	VCV000012587	12	25362838	12	25209904	12587	27626	rs104894360	NC_000012.12:25209903:T:A	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic	Nov 15, 2018	reviewed by expert panel							
NM_033360.4(KRAS):c.*11G>A	KRAS	D153N	not provided	VCV000561755	12	25362839	12	25209905	561755	552688	rs1565878932	NC_000012.12:25209904:C:T	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic	Mar 16, 2018	criteria provided, single submitter							
NM_033360.4(KRAS):c.*9T>G	KRAS	V152G	Noonan syndrome 3	VCV000012591	12	25362841	12	25209907	12591	27630	rs104894367	NC_000012.12:25209906:A:C	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic	Jul 1, 2006	no assertion criteria provided							
NM_004985.5(KRAS):c.454G>T (p.Val152Phe)	KRAS	V152F	Noonan syndrome	VCV000045126	12	25362842	12	25209908	45126	54293	rs397517041	NC_000012.12:25209907:C:A	single nucleotide variant	3 prime UTR variant|missense variant	Likely pathogenic	May 3, 2011	criteria provided, single submitter							
NM_033360.4(KRAS):c.458A>C (p.Glu153Ala)	KRAS	E153A	Noonan syndrome	VCV000981551	12	25368487	12	25215553	981551	969698	rs1592798693	NC_000012.12:25215552:T:G	single nucleotide variant	missense variant|intron variant	Likely pathogenic		no assertion criteria provided							
NM_004985.5(KRAS):c.451-5642A>T	KRAS	E153V	KRAS-related disorder|Noonan syndrome 3	VCV000637030	12	25368487	12	25215553	637030	624857	rs1592798693	NC_000012.12:25215552:T:A	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	Jan 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004985.5(KRAS):c.441G>T (p.Lys147Asn)	KRAS	K147N	RASopathy	VCV002752227	12	25378557	12	25225623	2752227	2915995		NC_000012.12:25225622:C:A	single nucleotide variant	missense variant	Likely pathogenic	Jan 9, 2024	criteria provided, single submitter							
NM_004985.5(KRAS):c.440A>T (p.Lys147Met)	KRAS	K147M	Noonan syndrome 3	VCV001803998	12	25378558	12	25225624	1803998	1861023		NC_000012.12:25225623:T:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 12, 2021	criteria provided, single submitter							
NM_033360.4(KRAS):c.440A>G (p.Lys147Arg)	KRAS	K147R	Noonan syndrome 3	VCV000431103	12	25378558	12	25225624	431103	424626	rs1135401776	NC_000012.12:25225623:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 1, 2017	criteria provided, single submitter							
NM_033360.4(KRAS):c.439A>G (p.Lys147Glu)	KRAS	K147E	not provided	VCV000031941	12	25378559	12	25225625	31941	40606	rs387907206	NC_000012.12:25225624:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_033360.4(KRAS):c.436G>C (p.Ala146Pro)	KRAS	A146P	RASopathy|Autoimmune lymphoproliferative syndrome type 4	VCV000375963	12	25378562	12	25225628	375963	362842	rs121913527	NC_000012.12:25225627:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_033360.4(KRAS):c.355G>A (p.Asp119Asn)	KRAS	D119N	Autoimmune lymphoproliferative syndrome type 4|Acute myeloid leukemia|Cardiofaciocutaneous syndrome 2|Noonan syndrome 3|not provided|KRAS-related RASopathy	VCV000040460	12	25378643	12	25225709	40460	48930	rs730880471	NC_000012.12:25225708:C:T	single nucleotide variant	missense variant	Likely pathogenic	Sep 23, 2020	criteria provided, multiple submitters, no conflicts							
NM_033360.4(KRAS):c.351A>C (p.Lys117Asn)	KRAS	K117N	not provided	VCV000375965	12	25378647	12	25225713	375965	362844	rs770248150	NC_000012.12:25225712:T:G	single nucleotide variant	missense variant	Pathogenic	May 1, 2020	criteria provided, single submitter							
NM_004985.5(KRAS):c.350A>C (p.Lys117Thr)	KRAS	K117T	Cardiovascular phenotype	VCV003224559	12	25378648	12	25225714	3224559	3386922		NC_000012.12:25225713:T:G	single nucleotide variant	missense variant	Likely pathogenic	Apr 3, 2017	criteria provided, single submitter							
NM_033360.4(KRAS):c.347A>G (p.Asn116Ser)	KRAS	N116S	not provided	VCV000156338	12	25378651	12	25225717	156338	166118	rs202247812	NC_000012.12:25225716:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 24, 2024	criteria provided, single submitter							
NM_004985.5(KRAS):c.346A>C (p.Asn116His)	KRAS	N116H	not provided	VCV001219824	12	25378652	12	25225718	1219824	1209802	rs2141506264	NC_000012.12:25225717:T:G	single nucleotide variant	missense variant	Pathogenic	Apr 19, 2024	criteria provided, single submitter							
NM_004985.5(KRAS):c.290G>A (p.Arg97Lys)	KRAS	R97K	Non-small cell lung carcinoma	VCV000163761	12	25380168	12	25227234	163761	175713	rs727503106	NC_000012.12:25227233:C:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 28, 2014	no assertion criteria provided							
NM_004985.5(KRAS):c.221C>T (p.Thr74Ile)	KRAS	T74I	Noonan syndrome	VCV000981550	12	25380237	12	25227303	981550	969697	rs1951405479	NC_000012.12:25227302:G:A	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_004985.5(KRAS):c.214A>C (p.Met72Leu)	KRAS	M72L	RASopathy	VCV001016209	12	25380244	12	25227310	1016209	1010371	rs727504662	NC_000012.12:25227309:T:G	single nucleotide variant	missense variant	Likely pathogenic	Jun 19, 2022	criteria provided, single submitter							
NM_004985.5(KRAS):c.214A>T (p.Met72Leu)	KRAS	M72L	RASopathy|Noonan syndrome	VCV000179141	12	25380244	12	25227310	179141	175714	rs727504662	NC_000012.12:25227309:T:A	single nucleotide variant	missense variant	Pathogenic	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004985.5(KRAS):c.211T>G (p.Tyr71Asp)	KRAS	Y71D	Cardio-facio-cutaneous syndrome|not provided	VCV000228267	12	25380247	12	25227313	228267	230308	rs387907205	NC_000012.12:25227312:A:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_033360.4(KRAS):c.211T>C (p.Tyr71His)	KRAS	Y71H	Cardiofaciocutaneous syndrome 2	VCV000031940	12	25380247	12	25227313	31940	40605	rs387907205	NC_000012.12:25227312:A:G	single nucleotide variant	missense variant	Pathogenic	Jan 15, 2013	no assertion criteria provided							
NM_004985.5(KRAS):c.202A>T (p.Arg68Trp)	KRAS	R68W	Noonan syndrome 3	VCV003238829	12	25380256	12	25227322	3238829	3396748		NC_000012.12:25227321:T:A	single nucleotide variant	missense variant	Likely pathogenic	Dec 25, 2023	criteria provided, single submitter							
NM_004985.5(KRAS):c.202A>G (p.Arg68Gly)	KRAS	R68G	RASopathy	VCV002828010	12	25380256	12	25227322	2828010	2989948		NC_000012.12:25227321:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 13, 2023	criteria provided, single submitter							
NM_033360.4(KRAS):c.194G>T (p.Ser65Ile)	KRAS	S65I	RASopathy	VCV000438796	12	25380264	12	25227330	438796	432423	rs1555194026	NC_000012.12:25227329:C:A	single nucleotide variant	missense variant	Likely pathogenic	May 18, 2020	reviewed by expert panel							
NM_033360.4(KRAS):c.189G>C (p.Glu63Asp)	KRAS	E63D	Noonan syndrome 3|not provided	VCV000636802	12	25380269	12	25227335	636802	624731	rs1592808357	NC_000012.12:25227334:C:G	single nucleotide variant	missense variant	Likely pathogenic	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004985.5(KRAS):c.183A>T (p.Gln61His)	KRAS	Q61H	Non-small cell lung carcinoma|Cerebral arteriovenous malformation	VCV000045117	12	25380275	12	25227341	45117	54284	rs17851045	NC_000012.12:25227340:T:A	single nucleotide variant	missense variant	Pathogenic	Dec 7, 2007	no assertion criteria provided							
NM_004985.5(KRAS):c.182A>T (p.Gln61Leu)	KRAS	Q61L	Non-small cell lung carcinoma|Neoplasm	VCV000045116	12	25380276	12	25227342	45116	54283	rs121913240	NC_000012.12:25227341:T:A	single nucleotide variant	missense variant	Pathogenic	Nov 2, 2011	criteria provided, single submitter				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_004985.5(KRAS):c.181C>A (p.Gln61Lys)	KRAS	Q61K	Non-small cell lung carcinoma	VCV000177777	12	25380277	12	25227343	177777	175715	rs121913238	NC_000012.12:25227342:G:T	single nucleotide variant	missense variant	Pathogenic	Aug 28, 2014	criteria provided, single submitter							
NM_004985.5(KRAS):c.179G>T (p.Gly60Val)	KRAS	G60V	RASopathy|not provided	VCV000163766	12	25380279	12	25227345	163766	175855	rs727503108	NC_000012.12:25227344:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_033360.4(KRAS):c.178G>A (p.Gly60Ser)	KRAS	G60S	Cardiofaciocutaneous syndrome 2|RASopathy|not provided|Noonan syndrome 3	VCV000012597	12	25380280	12	25227346	12597	27636	rs104894359	NC_000012.12:25227345:C:T	single nucleotide variant	missense variant	Pathogenic	Mar 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004985.5(KRAS):c.178G>C (p.Gly60Arg)	KRAS	G60R	Cardio-facio-cutaneous syndrome	VCV000012586	12	25380280	12	25227346	12586	27625	rs104894359	NC_000012.12:25227345:C:G	single nucleotide variant	missense variant	Pathogenic	Apr 3, 2017	reviewed by expert panel							
NM_004985.5(KRAS):c.175_176delinsTT (p.Ala59Leu)	KRAS	A59L	Cardiofaciocutaneous syndrome 2	VCV002431456	12	25380282 - 25380283	12	25227348 - 25227349	2431456	2404960		NC_000012.12:25227347:GC:AA	Indel	missense variant	Likely pathogenic	Apr 22, 2022	criteria provided, single submitter							
NM_033360.4(KRAS):c.175G>T (p.Ala59Ser)	KRAS	A59S	not provided	VCV000222075	12	25380283	12	25227349	222075	223773	rs121913528	NC_000012.12:25227348:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 1, 2018	criteria provided, multiple submitters, no conflicts							
NM_033360.4(KRAS):c.175G>A (p.Ala59Thr)	KRAS	A59T	Bladder cancer, transitional cell, somatic	VCV000012581	12	25380283	12	25227349	12581	27620	rs121913528	NC_000012.12:25227348:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 1, 1992	no assertion criteria provided							
NM_004985.5(KRAS):c.173C>T (p.Thr58Ile)	KRAS	T58I	Noonan syndrome	VCV000012588	12	25380285	12	25227351	12588	27627	rs104894364	NC_000012.12:25227350:G:A	single nucleotide variant	missense variant	Pathogenic	Apr 3, 2017	reviewed by expert panel							
NM_004985.5(KRAS):c.148A>C (p.Thr50Pro)	KRAS	T50P	not provided	VCV002575733	12	25380310	12	25227376	2575733	2740629		NC_000012.12:25227375:T:G	single nucleotide variant	missense variant	Likely pathogenic	Feb 7, 2023	criteria provided, single submitter							
NM_004985.5(KRAS):c.108A>G (p.Ile36Met)	KRAS	I36M	Cardiofaciocutaneous syndrome 1|Noonan syndrome|Cardio-facio-cutaneous syndrome|RASopathy|not provided|Cardiovascular phenotype	VCV000163768	12	25398211	12	25245277	163768	175716	rs727503109	NC_000012.12:25245276:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004985.5(KRAS):c.101C>A (p.Pro34Gln)	KRAS	P34Q	KRAS-related disorder	VCV002630513	12	25398218	12	25245284	2630513	2798453		NC_000012.12:25245283:G:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 28, 2023	criteria provided, single submitter							
NM_004985.5(KRAS):c.101C>T (p.Pro34Leu)	KRAS	P34L	Noonan syndrome	VCV000040454	12	25398218	12	25245284	40454	48924	rs104894366	NC_000012.12:25245283:G:A	single nucleotide variant	missense variant	Pathogenic	Sep 17, 2024	reviewed by expert panel							
NM_004985.5(KRAS):c.101C>G (p.Pro34Arg)	KRAS	P34R	Acute myeloid leukemia|Autoimmune lymphoproliferative syndrome type 4|Cardiofaciocutaneous syndrome 2|Noonan syndrome 3|RASopathy|not provided|Noonan syndrome|Cardio-facio-cutaneous syndrome	VCV000012590	12	25398218	12	25245284	12590	27629	rs104894366	NC_000012.12:25245283:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_033360.4(KRAS):c.68T>G (p.Leu23Arg)	KRAS	L23R	not provided|Neoplasm	VCV000180860	12	25398251	12	25245317	180860	179462	rs730880472	NC_000012.12:25245316:A:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 15, 2014	criteria provided, single submitter				Uncertain significance	Mar 4, 2025	criteria provided, single submitter	
NM_033360.4(KRAS):c.65A>T (p.Gln22Leu)	KRAS	Q22L	not provided	VCV000040453	12	25398254	12	25245320	40453	48923	rs727503110	NC_000012.12:25245319:T:A	single nucleotide variant	missense variant	Likely pathogenic	Mar 8, 2024	criteria provided, single submitter							
NM_004985.5(KRAS):c.65A>G (p.Gln22Arg)	KRAS	Q22R	Noonan syndrome	VCV000040452	12	25398254	12	25245320	40452	48922	rs727503110	NC_000012.12:25245319:T:C	single nucleotide variant	missense variant	Pathogenic	Apr 3, 2017	reviewed by expert panel							
NM_033360.4(KRAS):c.64C>A (p.Gln22Lys)	KRAS	Q22K	RASopathy|Linear nevus sebaceous syndrome|Neoplasm	VCV000376325	12	25398255	12	25245321	376325	363204	rs121913236	NC_000012.12:25245320:G:T	single nucleotide variant	missense variant	Likely pathogenic	Nov 27, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_033360.4(KRAS):c.64C>G (p.Gln22Glu)	KRAS	Q22E	RASopathy	VCV000040451	12	25398255	12	25245321	40451	48921	rs121913236	NC_000012.12:25245320:G:C	single nucleotide variant	missense variant	Pathogenic	Jun 17, 2021	criteria provided, single submitter							
NM_033360.4(KRAS):c.57G>T (p.Leu19Phe)	KRAS	L19F	not provided|Neoplasm	VCV000376034	12	25398262	12	25245328	376034	362913	rs121913538	NC_000012.12:25245327:C:A	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_004985.5(KRAS):c.57G>C (p.Leu19Phe)	KRAS	L19F	RASopathy	VCV000217822	12	25398262	12	25245328	217822	214479	rs121913538	NC_000012.12:25245327:C:G	single nucleotide variant	missense variant	Pathogenic	Jan 18, 2023	criteria provided, single submitter							
NM_004985.5(KRAS):c.53C>T (p.Ala18Val)	KRAS	A18V	Noonan syndrome 3	VCV001695421	12	25398266	12	25245332	1695421	1687832	rs2135806030	NC_000012.12:25245331:G:A	single nucleotide variant	missense variant	Pathogenic		criteria provided, single submitter							
NM_033360.4(KRAS):c.44G>T (p.Gly15Val)	KRAS	G15V	not provided	VCV000452631	12	25398275	12	25245341	452631	444971	rs1555195579	NC_000012.12:25245340:C:A	single nucleotide variant	missense variant	Likely pathogenic	Oct 10, 2017	criteria provided, single submitter							
NM_004985.5(KRAS):c.40G>A (p.Val14Ile)	KRAS	V14I	Noonan syndrome	VCV000012589	12	25398279	12	25245345	12589	27628	rs104894365	NC_000012.12:25245344:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 3, 2017	reviewed by expert panel							
NM_004985.5(KRAS):c.38G>T (p.Gly13Val)	KRAS	G13V	Non-small cell lung carcinoma	VCV000045124	12	25398281	12	25245347	45124	54291	rs112445441	NC_000012.12:25245346:C:A	single nucleotide variant	missense variant	Pathogenic	Oct 13, 2011	criteria provided, single submitter							
NM_004985.5(KRAS):c.38G>A (p.Gly13Asp)	KRAS	G13D	Noonan syndrome and Noonan-related syndrome|RASopathy|not provided|Inborn genetic diseases|Nevus sebaceous|Familial pancreatic carcinoma|Non-small cell lung carcinoma|Neoplasm	VCV000012580	12	25398281	12	25245347	12580	27619	rs112445441	NC_000012.12:25245346:C:T	single nucleotide variant	missense variant	Pathogenic	Dec 18, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_004985.5(KRAS):c.36_37delinsGC (p.Gly13Arg)	KRAS	G13R	not provided	VCV001691382	12	25398282 - 25398283	12	25245348 - 25245349	1691382	1683861	rs2135806200	NC_000012.12:25245347:CA:GC	Indel	missense variant	Pathogenic	Dec 21, 2020	criteria provided, single submitter							
NM_004985.5(KRAS):c.37G>T (p.Gly13Cys)	KRAS	G13C	KRAS-related disorder|Non-small cell lung carcinoma|Autoimmune lymphoproliferative syndrome type 4|not provided	VCV000045123	12	25398282	12	25245348	45123	54290	rs121913535	NC_000012.12:25245347:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_004985.5(KRAS):c.37G>C (p.Gly13Arg)	KRAS	G13R	Non-small cell lung carcinoma	VCV000012593	12	25398282	12	25245348	12593	27632	rs121913535	NC_000012.12:25245347:C:G	single nucleotide variant	missense variant	Pathogenic	Apr 15, 2011	criteria provided, single submitter							
NM_004985.5(KRAS):c.35G>C (p.Gly12Ala)	KRAS	G12A	Linear nevus sebaceous syndrome|Toriello-Lacassie-Droste syndrome|Cerebral arteriovenous malformation|Malignant tumor of urinary bladder|Autoimmune lymphoproliferative syndrome type 4|Gastric cancer|Familial cancer of breast|Lung cancer|Acute myeloid leukemia|Cardiofaciocutaneous syndrome 2|Familial pancreatic carcinoma|Noonan syndrome 3|KRAS-related disorder|Neoplasm	VCV000045122	12	25398284	12	25245350	45122	54289	rs121913529	NC_000012.12:25245349:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 12, 2022	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_004985.5(KRAS):c.35G>T (p.Gly12Val)	KRAS	G12V	RASopathy|not provided|Linear nevus sebaceous syndrome|Non-small cell lung carcinoma|Juvenile myelomonocytic leukemia|Neoplasm	VCV000012583	12	25398284	12	25245350	12583	27622	rs121913529	NC_000012.12:25245349:C:A	single nucleotide variant	missense variant	Pathogenic	Oct 13, 2023	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_004985.5(KRAS):c.35G>A (p.Gly12Asp)	KRAS	G12D	Congenital Pulmonary Airway Malformations|Lung cancer|Acute myeloid leukemia|Toriello-Lacassie-Droste syndrome|Malignant tumor of urinary bladder|Gastric cancer|Autoimmune lymphoproliferative syndrome type 4|Familial pancreatic carcinoma|Cardiofaciocutaneous syndrome 2|Cerebral arteriovenous malformation|Familial cancer of breast|Linear nevus sebaceous syndrome|Noonan syndrome 3|RASopathy|not provided|Cardiovascular phenotype|Cerebral arteriovenous malformation|Linear nevus sebaceous syndrome|Neoplasm	VCV000012582	12	25398284	12	25245350	12582	27621	rs121913529	NC_000012.12:25245349:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 7, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_004985.5(KRAS):c.33_34delinsCT (p.Gly12Cys)	KRAS	G12C	not provided	VCV001701193	12	25398285 - 25398286	12	25245351 - 25245352	1701193	1693585	rs2135806256	NC_000012.12:25245350:CA:AG	Indel	missense variant	Pathogenic	Nov 1, 2018	criteria provided, single submitter							
NM_004985.5(KRAS):c.34G>A (p.Gly12Ser)	KRAS	G12S	not provided|Vascular malformation|RASopathy|Non-small cell lung carcinoma|Cardiofaciocutaneous syndrome 2|Neoplasm	VCV000012584	12	25398285	12	25245351	12584	27623	rs121913530	NC_000012.12:25245350:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 13, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_004985.5(KRAS):c.34G>C (p.Gly12Arg)	KRAS	G12R	RASopathy|not provided|Neoplasm	VCV000012579	12	25398285	12	25245351	12579	27618	rs121913530	NC_000012.12:25245350:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 4, 2022	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_004985.5(KRAS):c.34G>T (p.Gly12Cys)	KRAS	G12C	RASopathy|Neoplasm	VCV000012578	12	25398285	12	25245351	12578	27617	rs121913530	NC_000012.12:25245350:C:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 23, 2023	criteria provided, single submitter				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_004985.5(KRAS):c.20T>A (p.Val7Glu)	KRAS	V7E	RASopathy	VCV002503842	12	25398299	12	25245365	2503842	2668752		NC_000012.12:25245364:A:T	single nucleotide variant	missense variant	Likely pathogenic	Apr 3, 2023	criteria provided, single submitter							
NM_033360.4(KRAS):c.15A>C (p.Lys5Asn)	KRAS	K5N	not provided	VCV000372705	12	25398304	12	25245370	372705	360085	rs104894361	NC_000012.12:25245369:T:G	single nucleotide variant	missense variant	Pathogenic	Nov 13, 2015	criteria provided, single submitter							
NM_033360.4(KRAS):c.15A>T (p.Lys5Asn)	KRAS	K5N	Noonan syndrome	VCV000012594	12	25398304	12	25245370	12594	27633	rs104894361	NC_000012.12:25245369:T:A	single nucleotide variant	missense variant	Pathogenic	Apr 3, 2017	reviewed by expert panel							
NM_004985.5(KRAS):c.13A>C (p.Lys5Gln)	KRAS	K5Q	RASopathy	VCV002010214	12	25398306	12	25245372	2010214	2066878		NC_000012.12:25245371:T:G	single nucleotide variant	missense variant	Likely pathogenic	Jun 24, 2022	criteria provided, single submitter							
NM_004985.5(KRAS):c.13A>G (p.Lys5Glu)	KRAS	K5E	Noonan syndrome|KRAS-related disorder|RASopathy|not provided|Noonan syndrome 3	VCV000012596	12	25398306	12	25245372	12596	27635	rs193929331	NC_000012.12:25245371:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.587T>G (p.Leu196Trp)	DYNC1H1	L196W	Charcot-Marie-Tooth disease axonal type 2O	VCV000666296	14	102446124	14	101979787	666296	653886	rs1595597572	NC_000014.9:101979786:T:G	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2015	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.596A>C (p.Asn199Thr)	DYNC1H1	N199T	Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures	VCV002442259	14	102446133	14	101979796	2442259	2415968		NC_000014.9:101979795:A:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 24, 2023	no assertion criteria provided							
NM_001376.5(DYNC1H1):c.751C>A (p.Arg251Ser)	DYNC1H1	R251S	Charcot-Marie-Tooth disease axonal type 2O|not provided	VCV001315552	14	102446288	14	101979951	1315552	1305812	rs879253979	NC_000014.9:101979950:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.752G>A (p.Arg251His)	DYNC1H1	R251H	Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures|Charcot-Marie-Tooth disease axonal type 2O|Inborn genetic diseases|Charcot-Marie-Tooth disease|not provided|Peripheral neuropathy	VCV000197195	14	102446289	14	101979952	197195	194356	rs794727634	NC_000014.9:101979951:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.791G>C (p.Arg264Pro)	DYNC1H1	R264P	not provided|Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures	VCV001685305	14	102446717	14	101980380	1685305	1677326	rs713993043	NC_000014.9:101980379:G:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.791G>A (p.Arg264Gln)	DYNC1H1	R264Q	DYNC1H1-related neurological disorders|Charcot-Marie-Tooth disease axonal type 2O|Neurodevelopmental delay|not provided	VCV000210883	14	102446717	14	101980380	210883	208054	rs713993043	NC_000014.9:101980379:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.791G>T (p.Arg264Leu)	DYNC1H1	R264L	Spinal muscular atrophy	VCV000162033	14	102446717	14	101980380	162033	171752	rs713993043	NC_000014.9:101980379:G:T	single nucleotide variant	missense variant	Pathogenic	Jun 21, 2013	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.874C>T (p.Arg292Trp)	DYNC1H1	R292W	Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2O|Intellectual disability, autosomal dominant 13	VCV000800542	14	102446800	14	101980463	800542	789143	rs2047850664	NC_000014.9:101980462:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.915A>T (p.Lys305Asn)	DYNC1H1	K305N	Lissencephaly	VCV000996566	14	102446841	14	101980504	996566	984391	rs1566996726	NC_000014.9:101980503:A:T	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_001376.5(DYNC1H1):c.917A>G (p.His306Arg)	DYNC1H1	H306R	not provided|Charcot-Marie-Tooth disease axonal type 2O	VCV000030029	14	102446843	14	101980506	30029	38984	rs387906738	NC_000014.9:101980505:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.925C>T (p.Arg309Cys)	DYNC1H1	R309C	Charcot-Marie-Tooth disease axonal type 2O	VCV003613691	14	102446851	14	101980514	3613691	3738624		NC_000014.9:101980513:C:T	single nucleotide variant	missense variant	Likely pathogenic	Sep 30, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.926G>A (p.Arg309His)	DYNC1H1	R309H	not provided|Charcot-Marie-Tooth disease axonal type 2O	VCV000209107	14	102446852	14	101980515	209107	205703	rs797045177	NC_000014.9:101980514:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.944G>A (p.Ser315Asn)	DYNC1H1	S315N	Charcot-Marie-Tooth disease axonal type 2O	VCV000803047	14	102446870	14	101980533	803047	791379	rs1595597963	NC_000014.9:101980532:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 28, 2019	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1012G>C (p.Asp338His)	DYNC1H1	D338H	not provided	VCV000871283	14	102449406	14	101983069	871283	860076	rs1555408131	NC_000014.9:101983068:G:C	single nucleotide variant	missense variant	Pathogenic	Sep 1, 2018	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1013A>G (p.Asp338Gly)	DYNC1H1	D338G	not provided	VCV000452895	14	102449407	14	101983070	452895	445166	rs879254267	NC_000014.9:101983069:A:G	single nucleotide variant	missense variant	Likely pathogenic	Oct 23, 2017	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1013A>T (p.Asp338Val)	DYNC1H1	D338V	not provided	VCV000246457	14	102449407	14	101983070	246457	244860	rs879254267	NC_000014.9:101983069:A:T	single nucleotide variant	missense variant	Likely pathogenic	Mar 6, 2016	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1195A>G (p.Arg399Gly)	DYNC1H1	R399G	Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures	VCV000637515	14	102449589	14	101983252	637515	625287	rs1595599240	NC_000014.9:101983251:A:G	single nucleotide variant	missense variant	Likely pathogenic	Aug 13, 2019	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1339A>G (p.Lys447Glu)	DYNC1H1	K447E	DYNC1H1-related disorder	VCV003765665	14	102449824	14	101983487	3765665	3881830		NC_000014.9:101983486:A:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 24, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1351C>T (p.Arg451Cys)	DYNC1H1	R451C	not provided	VCV000916092	14	102449836	14	101983499	916092	904307	rs2047891781	NC_000014.9:101983498:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 19, 2019	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1396A>G (p.Met466Val)	DYNC1H1	M466V	Charcot-Marie-Tooth disease axonal type 2O	VCV001520504	14	102449881	14	101983544	1520504	1355863	rs2141272574	NC_000014.9:101983543:A:G	single nucleotide variant	missense variant	Pathogenic	Nov 1, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1407T>G (p.Phe469Leu)	DYNC1H1	F469L	Charcot-Marie-Tooth disease axonal type 2O	VCV002709788	14	102449892	14	101983555	2709788	2874686		NC_000014.9:101983554:T:G	single nucleotide variant	missense variant	Likely pathogenic	Apr 5, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1678G>A (p.Val560Met)	DYNC1H1	V560M	Charcot-Marie-Tooth disease axonal type 2O	VCV000844512	14	102452240	14	101985903	844512	841021	rs2047931446	NC_000014.9:101985902:G:A	single nucleotide variant	missense variant	Pathogenic	Jun 6, 2020	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1702C>A (p.Leu568Ile)	DYNC1H1	L568I	not provided	VCV000390610	14	102452264	14	101985927	390610	372881	rs1057523839	NC_000014.9:101985926:C:A	single nucleotide variant	missense variant	Likely pathogenic	Nov 8, 2016	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1706G>C (p.Arg569Pro)	DYNC1H1	R569P	Intellectual disability, autosomal dominant 13|Lissencephaly	VCV000209108	14	102452268	14	101985931	209108	205704	rs797045178	NC_000014.9:101985930:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 19, 2015	no assertion criteria provided							
NM_001376.5(DYNC1H1):c.1738G>A (p.Glu580Lys)	DYNC1H1	E580K	Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures	VCV000208862	14	102452300	14	101985963	208862	205474	rs863223361	NC_000014.9:101985962:G:A	single nucleotide variant	missense variant	Likely pathogenic	Oct 22, 2021	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1739A>C (p.Glu580Ala)	DYNC1H1	E580A	Charcot-Marie-Tooth disease axonal type 2O|Charcot-Marie-Tooth disease axonal type 2O|Intellectual disability, autosomal dominant 13|Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures	VCV001075692	14	102452301	14	101985964	1075692	1063045	rs2141274671	NC_000014.9:101985963:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.1741A>T (p.Met581Leu)	DYNC1H1	M581L	not provided	VCV000623856	14	102452303	14	101985966	623856	612976	rs1566999047	NC_000014.9:101985965:A:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 1, 2020	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1777G>T (p.Val593Phe)	DYNC1H1	V593F	Charcot-Marie-Tooth disease axonal type 2O	VCV000943318	14	102452339	14	101986002	943318	936494	rs2047932647	NC_000014.9:101986001:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 10, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1792C>T (p.Arg598Cys)	DYNC1H1	R598C	Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures|Charcot-Marie-Tooth disease axonal type 2O|Inborn genetic diseases|Hereditary motor and sensory neuropathy|not provided|Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures|Charcot-Marie-Tooth disease axonal type 2O|Intellectual disability, autosomal dominant 13	VCV000139652	14	102452354	14	101986017	139652	143271	rs587780564	NC_000014.9:101986016:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.1793G>C (p.Arg598Pro)	DYNC1H1	R598P	Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures	VCV002506366	14	102452355	14	101986018	2506366	2671321		NC_000014.9:101986017:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 15, 2023	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1793G>A (p.Arg598His)	DYNC1H1	R598H	not provided	VCV000430529	14	102452355	14	101986018	430529	421966	rs879254085	NC_000014.9:101986017:G:A	single nucleotide variant	missense variant	Likely pathogenic	Oct 18, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1793G>T (p.Arg598Leu)	DYNC1H1	R598L	Charcot-Marie-Tooth disease axonal type 2O|not provided	VCV000246081	14	102452355	14	101986018	246081	244863	rs879254085	NC_000014.9:101986017:G:T	single nucleotide variant	missense variant	Pathogenic	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.1795G>C (p.Gly599Arg)	DYNC1H1	G599R	not provided	VCV000916058	14	102452357	14	101986020	916058	904308	rs2047932793	NC_000014.9:101986019:G:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 11, 2020	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1802T>A (p.Ile601Asn)	DYNC1H1	I601N	Motor delay|Global developmental delay|Hypotonia|Polymicrogyria	VCV000373929	14	102452364	14	101986027	373929	360955	rs1057518776	NC_000014.9:101986026:T:A	single nucleotide variant	missense variant	Likely pathogenic	Jul 5, 2016	no assertion criteria provided							
NM_001376.5(DYNC1H1):c.1808A>T (p.Glu603Val)	DYNC1H1	E603V	Spinal muscular atrophy with lower extremity predominance	VCV000637517	14	102452370	14	101986033	637517	625289	rs1595600898	NC_000014.9:101986032:A:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 8, 2021	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1825A>G (p.Ile609Val)	DYNC1H1	I609V	Charcot-Marie-Tooth disease axonal type 2O	VCV002194803	14	102452387	14	101986050	2194803	1932646		NC_000014.9:101986049:A:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 19, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1834G>A (p.Val612Met)	DYNC1H1	V612M	not provided|Charcot-Marie-Tooth disease axonal type 2O	VCV000637518	14	102452396	14	101986059	637518	625290	rs1555408333	NC_000014.9:101986058:G:A	single nucleotide variant	missense variant	Pathogenic	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.1867T>C (p.Phe623Leu)	DYNC1H1	F623L	Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures	VCV001526100	14	102452429	14	101986092	1526100	1517504	rs2141274749	NC_000014.9:101986091:T:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 22, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1869C>G (p.Phe623Leu)	DYNC1H1	F623L	not provided	VCV000373146	14	102452431	14	101986094	373146	360072	rs1057518250	NC_000014.9:101986093:C:G	single nucleotide variant	missense variant	Likely pathogenic	Dec 1, 2016	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.1998A>T (p.Glu666Asp)	DYNC1H1	E666D	not provided	VCV000807172	14	102452560	14	101986223	807172	796967	rs1595600991	NC_000014.9:101986222:A:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2020	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.2003T>A (p.Val668Asp)	DYNC1H1	V668D	Lissencephaly	VCV000996568	14	102452565	14	101986228	996568	984392	rs2047935205	NC_000014.9:101986227:T:A	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_001376.5(DYNC1H1):c.2321T>C (p.Leu774Pro)	DYNC1H1	L774P	Lissencephaly	VCV000996569	14	102452883	14	101986546	996569	984393	rs2047938879	NC_000014.9:101986545:T:C	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_001376.5(DYNC1H1):c.2327C>T (p.Pro776Leu)	DYNC1H1	P776L	Charcot-Marie-Tooth disease axonal type 2O|Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures|not provided|Charcot-Marie-Tooth disease axonal type 2O|Intellectual disability, autosomal dominant 13|Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures	VCV000372934	14	102452889	14	101986552	372934	360017	rs1057518083	NC_000014.9:101986551:C:T	single nucleotide variant	missense variant	Pathogenic	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.2644C>A (p.Gln882Lys)	DYNC1H1	Q882K	Intellectual disability, autosomal dominant 13|Intellectual disability	VCV000977612	14	102453895	14	101987558	977612	965741	rs2047950288	NC_000014.9:101987557:C:A	single nucleotide variant	missense variant	Likely pathogenic	Aug 3, 2020	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.2821G>C (p.Asp941His)	DYNC1H1	D941H	not provided	VCV001336525	14	102455142	14	101988805	1336525	1327536	rs2141276690	NC_000014.9:101988804:G:C	single nucleotide variant	missense variant	Likely pathogenic	Apr 13, 2018	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.2900A>G (p.Gln967Arg)	DYNC1H1|LOC130056502	Q967R	Intellectual disability, autosomal dominant 13|Intellectual disability	VCV000981304	14	102457895	14	101991558	981304	969380	rs2047998539	NC_000014.9:101991557:A:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 10, 2020	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.2906T>C (p.Ile969Thr)	DYNC1H1|LOC130056502	I969T	not provided	VCV001200540	14	102457901	14	101991564	1200540	1191546	rs2141278577	NC_000014.9:101991563:T:C	single nucleotide variant	missense variant	Pathogenic	Feb 25, 2021	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.3174G>C (p.Gln1058His)	DYNC1H1	Q1058H	DYNC1H1-related disorder	VCV002631523	14	102461027	14	101994690	2631523	2801057		NC_000014.9:101994689:G:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 6, 2023	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.3185A>G (p.Asp1062Gly)	DYNC1H1	D1062G	Charcot-Marie-Tooth disease axonal type 2O	VCV003256726	14	102461038	14	101994701	3256726	3415482		NC_000014.9:101994700:A:G	single nucleotide variant	missense variant	Likely pathogenic	Jun 1, 2022	no assertion criteria provided							
NM_001376.5(DYNC1H1):c.3185A>C (p.Asp1062Ala)	DYNC1H1	D1062A	Charcot-Marie-Tooth disease axonal type 2O	VCV002027827	14	102461038	14	101994701	2027827	2078038		NC_000014.9:101994700:A:C	single nucleotide variant	missense variant	Pathogenic	Aug 30, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.3269G>A (p.Arg1090Lys)	DYNC1H1	R1090K	Charcot-Marie-Tooth disease axonal type 2O	VCV002000607	14	102461122	14	101994785	2000607	2061111		NC_000014.9:101994784:G:A	single nucleotide variant	missense variant	Pathogenic	Dec 3, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.3278T>C (p.Phe1093Ser)	DYNC1H1	F1093S	Inborn genetic diseases|not provided	VCV000449962	14	102461131	14	101994794	449962	445168	rs1555408829	NC_000014.9:101994793:T:C	single nucleotide variant	missense variant	Pathogenic	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.3280G>T (p.Asp1094Tyr)	DYNC1H1	D1094Y	not provided	VCV001012657	14	102461133	14	101994796	1012657	1000855	rs2048039273	NC_000014.9:101994795:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2021	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.3281A>G (p.Asp1094Gly)	DYNC1H1	D1094G	Intellectual disability, autosomal dominant 13	VCV003366944	14	102461134	14	101994797	3366944	3526145		NC_000014.9:101994796:A:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 23, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.3347T>C (p.Val1116Ala)	DYNC1H1	V1116A	Lower limb muscle weakness	VCV000813292	14	102461336	14	101994999	813292	801539	rs1595605449	NC_000014.9:101994998:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 14, 2019	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.3370C>T (p.His1124Tyr)	DYNC1H1	H1124Y	not provided	VCV000246228	14	102461359	14	101995022	246228	244865	rs879254164	NC_000014.9:101995021:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 8, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.3372T>A (p.His1124Gln)	DYNC1H1	H1124Q	Charcot-Marie-Tooth disease axonal type 2O	VCV001723125	14	102461361	14	101995024	1723125	1780627		NC_000014.9:101995023:T:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 6, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.3395G>A (p.Gly1132Glu)	DYNC1H1	G1132E	not provided|Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures	VCV001685755	14	102461384	14	101995047	1685755	1677769	rs2141280974	NC_000014.9:101995046:G:A	single nucleotide variant	missense variant	Pathogenic	Oct 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.3603G>T (p.Arg1201Ser)	DYNC1H1	R1201S	not provided	VCV000180211	14	102463410	14	101997073	180211	178391	rs727505393	NC_000014.9:101997072:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 8, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.3781T>G (p.Trp1261Gly)	DYNC1H1	W1261G	Intellectual disability, autosomal dominant 13	VCV000975382	14	102463588	14	101997251	975382	963773	rs879253961	NC_000014.9:101997250:T:G	single nucleotide variant	missense variant	Pathogenic	Jan 1, 2019	no assertion criteria provided							
NM_001376.5(DYNC1H1):c.3911T>C (p.Leu1304Pro)	DYNC1H1	L1304P	DYNC1H1-related disorder	VCV002506265	14	102466432	14	102000095	2506265	2671221		NC_000014.9:102000094:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 8, 2023	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.3980A>C (p.Gln1327Pro)	DYNC1H1	Q1327P	not provided	VCV000421896	14	102466642	14	102000305	421896	409057	rs763711252	NC_000014.9:102000304:A:C	single nucleotide variant	missense variant	Likely pathogenic	Aug 10, 2016	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.4042G>A (p.Glu1348Lys)	DYNC1H1	E1348K	Intellectual disability, autosomal dominant 13	VCV000496684	14	102466704	14	102000367	496684	488159	rs1047509819	NC_000014.9:102000366:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jan 11, 2017	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.4067C>T (p.Pro1356Leu)	DYNC1H1	P1356L	Intellectual disability, autosomal dominant 13	VCV002585408	14	102466729	14	102000392	2585408	2752969		NC_000014.9:102000391:C:T	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.4234C>T (p.His1412Tyr)	DYNC1H1	H1412Y	Intellectual disability	VCV000813291	14	102467530	14	102001193	813291	801538	rs1595609005	NC_000014.9:102001192:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 31, 2020	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.4235A>G (p.His1412Arg)	DYNC1H1	H1412R	not provided	VCV000422277	14	102467531	14	102001194	422277	409058	rs1064795677	NC_000014.9:102001193:A:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 29, 2016	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.4366G>A (p.Glu1456Lys)	DYNC1H1	E1456K	Inborn genetic diseases	VCV002406240	14	102467662	14	102001325	2406240	2395859		NC_000014.9:102001324:G:A	single nucleotide variant	missense variant	Likely pathogenic	Oct 20, 2021	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.4462C>T (p.Arg1488Cys)	DYNC1H1	R1488C	Charcot-Marie-Tooth disease axonal type 2O	VCV003256727	14	102467938	14	102001601	3256727	3415483		NC_000014.9:102001600:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 1, 2022	no assertion criteria provided							
NM_001376.5(DYNC1H1):c.4501A>T (p.Ile1501Phe)	DYNC1H1	I1501F	not provided	VCV001336986	14	102467977	14	102001640	1336986	1327996	rs368821864	NC_000014.9:102001639:A:T	single nucleotide variant	missense variant	Likely pathogenic	Mar 29, 2019	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.4520T>C (p.Met1507Thr)	DYNC1H1	M1507T	not provided	VCV003342696	14	102467996	14	102001659	3342696	3501928		NC_000014.9:102001658:T:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 8, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.4532C>T (p.Pro1511Leu)	DYNC1H1	P1511L	Progressive muscle weakness|Charcot-Marie-Tooth disease axonal type 2O	VCV000472535	14	102468008	14	102001671	472535	463431	rs1327664377	NC_000014.9:102001670:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.4699C>T (p.Arg1567Trp)	DYNC1H1	R1567W	Charcot-Marie-Tooth disease axonal type 2O	VCV001513471	14	102469030	14	102002693	1513471	1472526	rs377013246	NC_000014.9:102002692:C:T	single nucleotide variant	missense variant	Likely pathogenic	May 22, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.4700G>T (p.Arg1567Leu)	DYNC1H1	R1567L	Intellectual disability, autosomal dominant 13	VCV000216921	14	102469031	14	102002694	216921	213627	rs797044901	NC_000014.9:102002693:G:T	single nucleotide variant	missense variant	Likely pathogenic	Apr 16, 2013	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.4700G>A (p.Arg1567Gln)	DYNC1H1	R1567Q	Intellectual disability, autosomal dominant 13|Charcot-Marie-Tooth disease axonal type 2O|Inborn genetic diseases|not provided|Intellectual disability	VCV000208709	14	102469031	14	102002694	208709	205280	rs797044901	NC_000014.9:102002693:G:A	single nucleotide variant	missense variant	Pathogenic	Jun 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.4741A>G (p.Lys1581Glu)	DYNC1H1	K1581E	not provided	VCV000246128	14	102469160	14	102002823	246128	244870	rs879254112	NC_000014.9:102002822:A:G	single nucleotide variant	missense variant	Likely pathogenic	Jun 6, 2018	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.4867C>T (p.Arg1623Trp)	DYNC1H1	R1623W	not provided	VCV002579938	14	102469286	14	102002949	2579938	2747448		NC_000014.9:102002948:C:T	single nucleotide variant	missense variant	Pathogenic	Mar 3, 2023	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.4868G>A (p.Arg1623Gln)	DYNC1H1	R1623Q	Charcot-Marie-Tooth disease axonal type 2O|not provided|Intellectual disability, autosomal dominant 13	VCV000424046	14	102469287	14	102002950	424046	409059	rs1064796765	NC_000014.9:102002949:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.5035C>T (p.Arg1679Trp)	DYNC1H1	R1679W	Charcot-Marie-Tooth disease axonal type 2O	VCV001053168	14	102471006	14	102004669	1053168	1048395	rs1351401023	NC_000014.9:102004668:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 30, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.5645C>A (p.Thr1882Asn)	DYNC1H1	T1882N	Inborn genetic diseases	VCV003086436	14	102472436	14	102006099	3086436	3241396		NC_000014.9:102006098:C:A	single nucleotide variant	missense variant	Likely pathogenic	Jan 29, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.5705G>T (p.Gly1902Val)	DYNC1H1	G1902V	not provided	VCV001212893	14	102472496	14	102006159	1212893	1202887	rs1370693832	NC_000014.9:102006158:G:T	single nucleotide variant	missense variant	Pathogenic	Jan 23, 2025	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.5884C>A (p.Arg1962Ser)	DYNC1H1	R1962S	not provided	VCV003387953	14	102474581	14	102008244	3387953	3547081		NC_000014.9:102008243:C:A	single nucleotide variant	missense variant	Likely pathogenic	Oct 1, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.5884C>T (p.Arg1962Cys)	DYNC1H1	R1962C	DYNC1H1-related neurodevelopmental disorders|Charcot-Marie-Tooth disease axonal type 2O|not provided	VCV000245597	14	102474581	14	102008244	245597	244873	rs879253881	NC_000014.9:102008243:C:T	single nucleotide variant	missense variant	Pathogenic	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.5885G>A (p.Arg1962His)	DYNC1H1	R1962H	not provided|Charcot-Marie-Tooth disease axonal type 2O|Inborn genetic diseases|Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures|Charcot-Marie-Tooth disease axonal type 2O|Intellectual disability, autosomal dominant 13	VCV000373213	14	102474582	14	102008245	373213	360026	rs1057518287	NC_000014.9:102008244:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jan 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.5902C>T (p.Leu1968Phe)	DYNC1H1	L1968F	Intellectual disability, autosomal dominant 13	VCV002500271	14	102474599	14	102008262	2500271	2523169		NC_000014.9:102008261:C:T	single nucleotide variant	missense variant	Likely pathogenic	Oct 17, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.6058C>T (p.Pro2020Ser)	DYNC1H1	P2020S	not provided	VCV002506791	14	102476260	14	102009923	2506791	2671763		NC_000014.9:102009922:C:T	single nucleotide variant	missense variant	Pathogenic	Jun 21, 2023	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.6074G>A (p.Arg2025Gln)	DYNC1H1	R2025Q	Abnormal cerebral morphology	VCV001701046	14	102476276	14	102009939	1701046	1693439	rs2152577516	NC_000014.9:102009938:G:A	single nucleotide variant	missense variant	Pathogenic		no assertion criteria provided							
NM_001376.5(DYNC1H1):c.6122T>C (p.Met2041Thr)	DYNC1H1	M2041T	Intellectual disability, autosomal dominant 13	VCV000434987	14	102476324	14	102009987	434987	429525	rs1555409836	NC_000014.9:102009986:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 21, 2019	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.6148G>C (p.Ala2050Pro)	DYNC1H1	A2050P	Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures|Intellectual disability, autosomal dominant 13|Charcot-Marie-Tooth disease axonal type 2O	VCV002582561	14	102476350	14	102010013	2582561	2750131		NC_000014.9:102010012:G:C	single nucleotide variant	missense variant	Likely pathogenic	Apr 25, 2023	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.6260A>G (p.Asp2087Gly)	DYNC1H1	D2087G	not provided	VCV000453045	14	102476651	14	102010314	453045	445170	rs1555409850	NC_000014.9:102010313:A:G	single nucleotide variant	missense variant	Likely pathogenic	Oct 30, 2017	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.6268C>T (p.Leu2090Phe)	DYNC1H1	L2090F	Inborn genetic diseases	VCV002321718	14	102476659	14	102010322	2321718	2314506		NC_000014.9:102010321:C:T	single nucleotide variant	missense variant	Likely pathogenic	Dec 9, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.6271C>T (p.Arg2091Trp)	DYNC1H1	R2091W	not provided	VCV000451292	14	102476662	14	102010325	451292	445171	rs866242352	NC_000014.9:102010324:C:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 14, 2017	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.6272G>A (p.Arg2091Gln)	DYNC1H1	R2091Q	not provided	VCV002429633	14	102476663	14	102010326	2429633	2403131		NC_000014.9:102010325:G:A	single nucleotide variant	missense variant	Pathogenic	Feb 7, 2023	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.6490G>A (p.Val2164Met)	DYNC1H1	V2164M	not provided	VCV000560252	14	102477161	14	102010824	560252	551313	rs1567010427	NC_000014.9:102010823:G:A	single nucleotide variant	missense variant	Likely pathogenic	Aug 1, 2017	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.6870C>A (p.Ser2290Arg)	DYNC1H1	S2290R	Intellectual disability, autosomal dominant 13	VCV002442374	14	102478663	14	102012326	2442374	2416087		NC_000014.9:102012325:C:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 21, 2021	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.6872T>G (p.Val2291Gly)	DYNC1H1	V2291G	Intellectual disability, autosomal dominant 13	VCV001708257	14	102478665	14	102012328	1708257	1706556		NC_000014.9:102012327:T:G	single nucleotide variant	missense variant	Likely pathogenic	Oct 4, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.6880G>A (p.Glu2294Lys)	DYNC1H1	E2294K	not provided	VCV001319231	14	102478673	14	102012336	1319231	1309484	rs2152579365	NC_000014.9:102012335:G:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.6943T>G (p.Leu2315Val)	DYNC1H1	L2315V	Intellectual disability, autosomal dominant 13	VCV002572651	14	102478736	14	102012399	2572651	2737595		NC_000014.9:102012398:T:G	single nucleotide variant	missense variant	Likely pathogenic	Jun 29, 2023	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.6989G>A (p.Gly2330Glu)	DYNC1H1	G2330E	not provided|Inborn genetic diseases	VCV000521709	14	102478782	14	102012445	521709	512069	rs1555410010	NC_000014.9:102012444:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.6994C>T (p.Arg2332Cys)	DYNC1H1	R2332C	Global developmental delay|Delayed speech and language development|Seizure|Delayed gross motor development|Microcephaly|Inborn genetic diseases|Intellectual disability, autosomal dominant 13|Charcot-Marie-Tooth disease axonal type 2O	VCV000374190	14	102478787	14	102012450	374190	360957	rs1057518961	NC_000014.9:102012449:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.6995G>T (p.Arg2332Leu)	DYNC1H1	R2332L	Charcot-Marie-Tooth disease axonal type 2O	VCV003636156	14	102478788	14	102012451	3636156	3764076		NC_000014.9:102012450:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jul 20, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.6995G>A (p.Arg2332His)	DYNC1H1	R2332H	not provided|Intellectual disability	VCV000981302	14	102478788	14	102012451	981302	969382	rs1236304133	NC_000014.9:102012450:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jul 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.7064C>T (p.Thr2355Ile)	DYNC1H1	T2355I	not provided	VCV000452710	14	102481491	14	102015154	452710	445172	rs1555410129	NC_000014.9:102015153:C:T	single nucleotide variant	missense variant	Likely pathogenic	Oct 10, 2017	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.7793G>T (p.Gly2598Val)	DYNC1H1	G2598V	not provided	VCV000245840	14	102483281	14	102016944	245840	244879	rs879253971	NC_000014.9:102016943:G:T	single nucleotide variant	missense variant	Likely pathogenic	Apr 3, 2017	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.7994A>G (p.Glu2665Gly)	DYNC1H1	E2665G	Intellectual disability, autosomal dominant 13	VCV002500292	14	102483570	14	102017233	2500292	2523190		NC_000014.9:102017232:A:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 26, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.8234C>A (p.Thr2745Lys)	DYNC1H1	T2745K	Intellectual disability, autosomal dominant 13	VCV001700199	14	102484844	14	102018507	1700199	1692593	rs2152583773	NC_000014.9:102018506:C:A	single nucleotide variant	missense variant	Pathogenic		criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.8462T>G (p.Leu2821Arg)	DYNC1H1	L2821R	not provided	VCV003372794	14	102486348	14	102020011	3372794	3531984		NC_000014.9:102020010:T:G	single nucleotide variant	missense variant	Likely pathogenic	Apr 22, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.9055G>A (p.Gly3019Ser)	DYNC1H1|LOC126862060	G3019S	Intellectual disability, autosomal dominant 13	VCV001697224	14	102493962	14	102027625	1697224	1689619	rs2152589131	NC_000014.9:102027624:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 13, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.9684G>C (p.Glu3228Asp)	DYNC1H1	E3228D	not provided	VCV000432895	14	102496197	14	102029860	432895	426049	rs1555411143	NC_000014.9:102029859:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 28, 2017	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.9721A>G (p.Lys3241Glu)	DYNC1H1	K3241E	Charcot-Marie-Tooth disease axonal type 2O	VCV001720236	14	102496234	14	102029897	1720236	1779275		NC_000014.9:102029896:A:G	single nucleotide variant	missense variant	Likely pathogenic	Aug 23, 2023	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.9751G>A (p.Glu3251Lys)	DYNC1H1	E3251K	Intellectual disability, autosomal dominant 13	VCV001065624	14	102496264	14	102029927	1065624	1053975	rs2152590264	NC_000014.9:102029926:G:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 7, 2020	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.9790C>A (p.Leu3264Met)	DYNC1H1	L3264M	Charcot-Marie-Tooth disease axonal type 2O	VCV000803050	14	102496526	14	102030189	803050	791382	rs373682811	NC_000014.9:102030188:C:A	single nucleotide variant	missense variant	Likely pathogenic	May 28, 2019	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.9928A>G (p.Met3310Val)	DYNC1H1	M3310V	Charcot-Marie-Tooth disease axonal type 2O	VCV003636170	14	102498653	14	102032316	3636170	3764090		NC_000014.9:102032315:A:G	single nucleotide variant	missense variant	Pathogenic	May 17, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.9959C>T (p.Ala3320Val)	DYNC1H1	A3320V	Intellectual disability, autosomal dominant 13	VCV000434992	14	102498684	14	102032347	434992	429533	rs1555411305	NC_000014.9:102032346:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 28, 2016	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.10016G>A (p.Arg3339His)	DYNC1H1	R3339H	Intellectual disability, autosomal dominant 13|not provided|Charcot-Marie-Tooth disease axonal type 2O	VCV001298386	14	102498741	14	102032404	1298386	1288248	rs2152591288	NC_000014.9:102032403:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.10030C>T (p.Arg3344Trp)	DYNC1H1	R3344W	not provided|Charcot-Marie-Tooth disease axonal type 2O	VCV000996573	14	102498755	14	102032418	996573	984397	rs2048519381	NC_000014.9:102032417:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.10031G>A (p.Arg3344Gln)	DYNC1H1	R3344Q	Charcot-Marie-Tooth disease axonal type 2O|Intellectual disability, autosomal dominant 13|Intellectual disability	VCV000055855	14	102498756	14	102032419	55855	70509	rs397509412	NC_000014.9:102032418:G:A	single nucleotide variant	missense variant	Pathogenic	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.10033G>A (p.Glu3345Lys)	DYNC1H1	E3345K	Inborn genetic diseases	VCV000208747	14	102498758	14	102032421	208747	205282	rs797044928	NC_000014.9:102032420:G:A	single nucleotide variant	missense variant	Pathogenic	Jul 20, 2013	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.10051A>T (p.Ile3351Phe)	DYNC1H1	I3351F	Inborn genetic diseases	VCV000590003	14	102498776	14	102032439	590003	579880	rs1567018763	NC_000014.9:102032438:A:T	single nucleotide variant	missense variant	Likely pathogenic	Jul 5, 2017	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.10151G>A (p.Arg3384Gln)	DYNC1H1	R3384Q	not provided	VCV000055854	14	102499473	14	102033136	55854	70508	rs397509411	NC_000014.9:102033135:G:A	single nucleotide variant	missense variant	Pathogenic	Jul 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.10160T>C (p.Leu3387Pro)	DYNC1H1	L3387P	Charcot-Marie-Tooth disease axonal type 2O	VCV000572088	14	102499482	14	102033145	572088	572658	rs1567019064	NC_000014.9:102033144:T:C	single nucleotide variant	missense variant	Likely pathogenic	Oct 8, 2017	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.10172C>T (p.Pro3391Leu)	DYNC1H1	P3391L	Intellectual disability, autosomal dominant 13	VCV000438584	14	102499494	14	102033157	438584	432219	rs1555411378	NC_000014.9:102033156:C:T	single nucleotide variant	missense variant	Likely pathogenic	Sep 1, 2017	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.10213A>C (p.Met3405Leu)	DYNC1H1	M3405L	not provided	VCV000916417	14	102499621	14	102033284	916417	904584	rs2048531389	NC_000014.9:102033283:A:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 1, 2020	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.10280A>C (p.Gln3427Pro)	DYNC1H1	Q3427P	Intellectual disability, autosomal dominant 13	VCV000488494	14	102499688	14	102033351	488494	481362	rs1555411394	NC_000014.9:102033350:A:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 16, 2017	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.10348G>A (p.Glu3450Lys)	DYNC1H1	E3450K	not provided	VCV000453004	14	102499756	14	102033419	453004	445176	rs1555411399	NC_000014.9:102033418:G:A	single nucleotide variant	missense variant	Pathogenic	Apr 1, 2019	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.10415T>G (p.Val3472Gly)	DYNC1H1	V3472G	not provided	VCV003337062	14	102500314	14	102033977	3337062	3495724		NC_000014.9:102033976:T:G	single nucleotide variant	missense variant	Likely pathogenic	Mar 26, 2024	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.10420C>T (p.Arg3474Trp)	DYNC1H1	R3474W	Charcot-Marie-Tooth disease axonal type 2O|not provided|Spinal muscular atrophy with lower extremity predominance	VCV000246393	14	102500319	14	102033982	246393	244887	rs757725348	NC_000014.9:102033981:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.10436T>C (p.Leu3479Pro)	DYNC1H1	L3479P	DYNC1H1-related disorder	VCV002632640	14	102500335	14	102033998	2632640	2797080		NC_000014.9:102033997:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 6, 2023	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.10478G>T (p.Ser3493Ile)	DYNC1H1	S3493I	Neurodevelopmental delay	VCV001700162	14	102500377	14	102034040	1700162	1692557	rs2152592151	NC_000014.9:102034039:G:T	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.10573C>T (p.Arg3525Cys)	DYNC1H1	R3525C	not provided|Intellectual disability, autosomal dominant 13	VCV000224130	14	102500472	14	102034135	224130	225860	rs869312693	NC_000014.9:102034134:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 29, 2020	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.10574G>A (p.Arg3525His)	DYNC1H1	R3525H	not provided|Charcot-Marie-Tooth disease axonal type 2O	VCV001193236	14	102500473	14	102034136	1193236	1184848	rs2152592202	NC_000014.9:102034135:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.10973G>A (p.Gly3658Glu)	DYNC1H1	G3658E	Intellectual disability|not provided	VCV000813289	14	102504861	14	102038524	813289	801536	rs1595629181	NC_000014.9:102038523:G:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.11015C>T (p.Ser3672Leu)	DYNC1H1	S3672L	not provided|Charcot-Marie-Tooth disease axonal type 2O|Intellectual disability, autosomal dominant 13	VCV001359385	14	102504903	14	102038566	1359385	1370565	rs2152594747	NC_000014.9:102038565:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_001376.5(DYNC1H1):c.11083C>T (p.Arg3695Trp)	DYNC1H1	R3695W	Inborn genetic diseases	VCV001794141	14	102505062	14	102038725	1794141	1842421		NC_000014.9:102038724:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 13, 2018	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.11183G>C (p.Arg3728Pro)	DYNC1H1	R3728P	Intellectual disability, autosomal dominant 13	VCV000210861	14	102505162	14	102038825	210861	208078	rs797045529	NC_000014.9:102038824:G:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 18, 2014	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.11311G>A (p.Glu3771Lys)	DYNC1H1	E3771K	Lissencephaly	VCV000996576	14	102505442	14	102039105	996576	984400	rs2048611744	NC_000014.9:102039104:G:A	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_001376.5(DYNC1H1):c.11897C>G (p.Pro3966Arg)	DYNC1H1	P3966R	not provided	VCV000245966	14	102506966	14	102040629	245966	244891	rs879254021	NC_000014.9:102040628:C:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 24, 2015	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.12214G>A (p.Gly4072Ser)	DYNC1H1	G4072S	not provided	VCV001801985	14	102508461	14	102042124	1801985	1859176		NC_000014.9:102042123:G:A	single nucleotide variant	missense variant	Likely pathogenic	Dec 4, 2022	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.12214G>T (p.Gly4072Cys)	DYNC1H1	G4072C	Intellectual disability, autosomal dominant 13	VCV001320087	14	102508461	14	102042124	1320087	1310332	rs2152596521	NC_000014.9:102042123:G:T	single nucleotide variant	missense variant	Likely pathogenic	Oct 2, 2021	criteria provided, single submitter							
NM_001382430.1(AKT1):c.1303A>C (p.Thr435Pro)	AKT1	T435P	Cowden syndrome 6	VCV000040163	14	105237142	14	104770805	40163	48663	rs397514645	NC_000014.9:104770804:T:G	single nucleotide variant	missense variant	Pathogenic	Jan 10, 2013	no assertion criteria provided							
NM_001382430.1(AKT1):c.968A>G (p.Asp323Gly)	AKT1	D323G	Familial cancer of breast	VCV001685237	14	105239419	14	104773082	1685237	1677258	rs2140903030	NC_000014.9:104773081:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 4, 2022	criteria provided, single submitter							
NM_001382430.1(AKT1):c.73C>T (p.Arg25Cys)	AKT1	R25C	Cowden syndrome 6	VCV000040162	14	105246527	14	104780190	40162	48662	rs397514644	NC_000014.9:104780189:G:A	single nucleotide variant	missense variant	Pathogenic	Jan 10, 2013	no assertion criteria provided							
NM_001382430.1(AKT1):c.49_50delinsAG (p.Glu17Arg)	AKT1	E17R	Proteus syndrome	VCV000800567	14	105246550 - 105246551	14	104780213 - 104780214	800567	789168	rs1595251483	NC_000014.9:104780212:TC:CT	Indel	missense variant	Pathogenic	Dec 11, 2019	criteria provided, single submitter							
NM_001382430.1(AKT1):c.49G>A (p.Glu17Lys)	AKT1	E17K	Proteus syndrome|not provided|Cowden syndrome 6|Neoplasm	VCV000013983	14	105246551	14	104780214	13983	29022	rs121434592	NC_000014.9:104780213:C:T	single nucleotide variant	missense variant	Pathogenic	Oct 31, 2023	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_004663.5(RAB11A):c.335A>G (p.His112Arg)	RAB11A	H112R	Intellectual disability, mild|Precocious puberty in females|Delayed fine motor development|EEG abnormality|Coarse facial features|Primary microcephaly|Delayed speech and language development	VCV002430281	15	66170198	15	65877860	2430281	2403789		NC_000015.10:65877859:A:G	single nucleotide variant	missense variant	Likely pathogenic	Jan 27, 2023	criteria provided, single submitter							
NM_004663.5(RAB11A):c.461C>T (p.Ser154Leu)	RAB11A	S154L	not provided	VCV002582937	15	66172039	15	65879701	2582937	2750507		NC_000015.10:65879700:C:T	single nucleotide variant	missense variant|intron variant	Pathogenic/Likely pathogenic	Sep 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_001761.3(CCNF):c.1175G>C (p.Arg392Thr)	CCNF	R392T, R84T	Frontotemporal dementia and/or amyotrophic lateral sclerosis 5	VCV000992593	16	2498936	16	2448935	992593	980518	rs954539468	NC_000016.10:2448934:G:C	single nucleotide variant	missense variant	Pathogenic	Jan 6, 2021	no assertion criteria provided							
NM_001761.3(CCNF):c.1861A>G (p.Ser621Gly)	CCNF	S621G, S313G	not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 5	VCV000992591	16	2505541	16	2455540	992591	980516	rs778264897	NC_000016.10:2455539:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_001761.3(CCNF):c.1870G>A (p.Glu624Lys)	LOC105371050|CCNF	E624K, E316K	Frontotemporal dementia and/or amyotrophic lateral sclerosis 5	VCV000992594	16	2505550	16	2455549	992594	980519	rs771621178	NC_000016.10:2455548:G:A	single nucleotide variant	missense variant	Pathogenic	Jan 6, 2021	no assertion criteria provided							
NM_001243177.4(ALDOA):c.548A>G (p.Asp183Gly)	ALDOA|LOC112694756	D129G, D183G	HNSHA due to aldolase A deficiency	VCV000018177	16	30080145	16	30068824	18177	33216	rs121909533	NC_000016.10:30068823:A:G	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic	Dec 1, 1987	no assertion criteria provided							
NM_001243177.4(ALDOA):c.781G>A (p.Glu261Lys)	ALDOA|LOC112694756	E207K, E261K	HNSHA due to aldolase A deficiency	VCV000018178	16	30080705	16	30069384	18178	33217	rs121909534	NC_000016.10:30069383:G:A	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic	Apr 25, 1996	no assertion criteria provided							
NM_001243177.4(ALDOA):c.1001C>T (p.Ala334Val)	LOC112694756|ALDOA	A280V, A334V	HNSHA due to aldolase A deficiency	VCV001299556	16	30081190	16	30069869	1299556	1289611	rs2151019295	NC_000016.10:30069868:C:T	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic/Likely pathogenic	Oct 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_001243177.4(ALDOA):c.1178G>A (p.Cys393Tyr)	ALDOA|LOC112694756	C339Y, C393Y	HNSHA due to aldolase A deficiency	VCV001299547	16	30081454	16	30070133	1299547	1289602	rs2151019809	NC_000016.10:30070132:G:A	single nucleotide variant	3 prime UTR variant|missense variant	Likely pathogenic	Oct 1, 2021	criteria provided, single submitter							
NM_002945.5(RPA1):c.680T>C (p.Val227Ala)	RPA1	V227A, V214A	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 6	VCV001342932	17	1780598	17	1877304	1342932	1334578	rs570041689	NC_000017.11:1877303:T:C	single nucleotide variant	missense variant	Pathogenic	May 10, 2023	no assertion criteria provided							
NM_002945.5(RPA1):c.718G>A (p.Glu240Lys)	RPA1	E240K, E227K	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 6	VCV001342931	17	1782314	17	1879020	1342931	1334577	rs916648829	NC_000017.11:1879019:G:A	single nucleotide variant	missense variant	Pathogenic	May 10, 2023	no assertion criteria provided							
NM_005022.4(PFN1):c.353G>T (p.Gly118Val)	PFN1	G118V	not provided	VCV000037036	17	4849265	17	4945970	37036	45722	rs387907266	NC_000017.11:4945969:C:A	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic	Jun 9, 2024	criteria provided, single submitter							
NM_005022.4(PFN1):c.341T>G (p.Met114Arg)	PFN1	M114R	Lower limb muscle weakness	VCV000373953	17	4849277	17	4945982	373953	361020	rs387907265	NC_000017.11:4945981:A:C	single nucleotide variant	3 prime UTR variant|missense variant	Likely pathogenic	Apr 15, 2016	no assertion criteria provided							
NM_005022.4(PFN1):c.341T>C (p.Met114Thr)	PFN1	M114T	not provided	VCV000037035	17	4849277	17	4945982	37035	45721	rs387907265	NC_000017.11:4945981:A:G	single nucleotide variant	3 prime UTR variant|missense variant	Pathogenic	Nov 11, 2021	criteria provided, single submitter							
NM_005022.4(PFN1):c.211T>G (p.Cys71Gly)	PFN1	C71G	Amyotrophic lateral sclerosis type 18	VCV000037034	17	4850037	17	4946742	37034	45720	rs387907264	NC_000017.11:4946741:A:C	single nucleotide variant	missense variant	Pathogenic	Aug 23, 2012	no assertion criteria provided							
NM_000546.6(TP53):c.1040C>A (p.Ala347Asp)	TP53	A215D, A308D, A347D, A188D	Li-Fraumeni syndrome	VCV000043587	17	7573987	17	7670669	43587	52756	rs397516434	NC_000017.11:7670668:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.1031T>C (p.Leu344Pro)	TP53	L344P, L212P, L305P, L185P	Li-Fraumeni syndrome	VCV000012375	17	7573996	17	7670678	12375	27414	rs121912662	NC_000017.11:7670677:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.1025G>C (p.Arg342Pro)	TP53	R210P, R303P, R342P, R183P	Li-Fraumeni syndrome	VCV000215996	17	7574002	17	7670684	215996	213385	rs375338359	NC_000017.11:7670683:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic	Sep 6, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.1021_1022delinsAG (p.Phe341Ser)	TP53	F209S, F182S, F302S, F341S	Hereditary cancer-predisposing syndrome	VCV002450748	17	7574005 - 7574006	17	7670687 - 7670688	2450748	2423234		NC_000017.11:7670686:AA:CT	Indel	missense variant|3 prime UTR variant|non-coding transcript variant	Likely pathogenic	Dec 29, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.1010G>C (p.Arg337Pro)	TP53	R205P, R298P, R337P, R178P	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000177879	17	7574017	17	7670699	177879	176640	rs121912664	NC_000017.11:7670698:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	Jun 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.1010G>T (p.Arg337Leu)	TP53	R205L, R298L, R337L, R178L	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000142828	17	7574017	17	7670699	142828	152542	rs121912664	NC_000017.11:7670698:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	Feb 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.1010G>A (p.Arg337His)	TP53	R337H, R205H, R298H, R178H	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Colorectal cancer|Li-Fraumeni syndrome 1|Glioma susceptibility 1|Adrenocortical carcinoma, hereditary|Bone marrow failure syndrome 5|Hepatocellular carcinoma|Basal cell carcinoma, susceptibility to, 7|Carcinoma of pancreas|Choroid plexus papilloma|Nasopharyngeal carcinoma|Bone osteosarcoma|Familial cancer of breast|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|not provided|Breast neoplasm|Li-Fraumeni syndrome 1	VCV000012379	17	7574017	17	7670699	12379	27418	rs121912664	NC_000017.11:7670698:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic/Likely pathogenic	Dec 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.1009C>T (p.Arg337Cys)	TP53	R205C, R298C, R337C, R178C	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Neoplasm	VCV000142536	17	7574018	17	7670700	142536	152250	rs587782529	NC_000017.11:7670699:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic/Likely pathogenic	Aug 1, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.1000G>T (p.Gly334Trp)	TP53	G202W, G295W, G334W, G175W	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000428876	17	7574027	17	7670709	428876	420637	rs730882028	NC_000017.11:7670708:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	Jun 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.995T>A (p.Ile332Asn)	TP53	I173N, I200N, I293N, I332N	Hereditary cancer-predisposing syndrome	VCV001768732	17	7574032	17	7670714	1768732	1825732		NC_000017.11:7670713:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	Feb 4, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.977A>T (p.Glu326Val)	TP53	E167V, E194V, E287V, E326V	Acute myeloid leukemia	VCV002578514	17	7576869	17	7673551	2578514	2743448		NC_000017.11:7673550:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic		no assertion criteria provided							
NM_000546.6(TP53):c.887A>G (p.His296Arg)	TP53	H164R, H257R, H296R, H137R	not provided	VCV000100816	17	7577051	17	7673733	100816	106676	rs483352696	NC_000017.11:7673732:T:C	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_000546.6(TP53):c.857A>C (p.Glu286Ala)	TP53	E154A, E247A, E286A, E127A	Li-Fraumeni syndrome 1	VCV000376593	17	7577081	17	7673763	376593	363472	rs1057519985	NC_000017.11:7673762:T:G	single nucleotide variant	missense variant	Likely pathogenic	Feb 21, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.856G>A (p.Glu286Lys)	TP53	E154K, E247K, E286K, E127K	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000183752	17	7577082	17	7673764	183752	185345	rs786201059	NC_000017.11:7673763:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 15, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.854A>T (p.Glu285Val)	TP53	E285V, E153V, E246V, E126V	Li-Fraumeni syndrome|Neoplasm	VCV000012384	17	7577084	17	7673766	12384	27423	rs121912667	NC_000017.11:7673765:T:A	single nucleotide variant	missense variant	Pathogenic	Dec 21, 2018	criteria provided, single submitter				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.853G>A (p.Glu285Lys)	TP53	E153K, E246K, E285K, E126K	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000420133	17	7577085	17	7673767	420133	410258	rs112431538	NC_000017.11:7673766:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 16, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.845G>C (p.Arg282Pro)	TP53	R150P, R243P, R282P, R123P	Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Glioma susceptibility 1|Li-Fraumeni syndrome 1|Nasopharyngeal carcinoma|Basal cell carcinoma, susceptibility to, 7|Hepatocellular carcinoma|Colorectal cancer|Bone osteosarcoma|Carcinoma of pancreas|Choroid plexus papilloma|Bone marrow failure syndrome 5|Familial cancer of breast|Hereditary cancer-predisposing syndrome	VCV000376659	17	7577093	17	7673775	376659	363538	rs730882008	NC_000017.11:7673774:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.844C>G (p.Arg282Gly)	TP53	R150G, R243G, R282G, R123G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1	VCV000140821	17	7577094	17	7673776	140821	150535	rs28934574	NC_000017.11:7673775:G:C	single nucleotide variant	missense variant	Pathogenic	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.844C>T (p.Arg282Trp)	TP53	R282W, R150W, R243W, R123W	not provided|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Pleomorphic xanthoastrocytoma|Astrocytoma, anaplastic|Colorectal cancer|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Neoplasm	VCV000012364	17	7577094	17	7673776	12364	27403	rs28934574	NC_000017.11:7673775:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 3, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.843C>A (p.Asp281Glu)	TP53	D149E, D242E, D281E, D122E	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Neoplasm	VCV000406568	17	7577095	17	7673777	406568	403007	rs1057519984	NC_000017.11:7673776:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 12, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.842A>C (p.Asp281Ala)	TP53	D149A, D242A, D281A, D122A	Adrenocortical carcinoma, hereditary	VCV000376589	17	7577096	17	7673778	376589	363468	rs587781525	NC_000017.11:7673777:T:G	single nucleotide variant	missense variant	Likely pathogenic	Jun 18, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.842A>T (p.Asp281Val)	TP53	D149V, D242V, D281V, D122V	Glioma susceptibility 1|Bone osteosarcoma|Familial pancreatic carcinoma|Hepatocellular carcinoma|Adrenocortical carcinoma, hereditary|Colorectal cancer|Li-Fraumeni syndrome 1|Nasopharyngeal carcinoma|Choroid plexus papilloma|Familial cancer of breast|Basal cell carcinoma, susceptibility to, 7|Bone marrow failure syndrome 5|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome	VCV000182968	17	7577096	17	7673778	182968	180995	rs587781525	NC_000017.11:7673777:T:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.842A>G (p.Asp281Gly)	TP53	D149G, D242G, D281G, D122G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1	VCV000141141	17	7577096	17	7673778	141141	150855	rs587781525	NC_000017.11:7673777:T:C	single nucleotide variant	missense variant	Pathogenic	Jul 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.841G>C (p.Asp281His)	TP53	D149H, D242H, D281H, D122H	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376588	17	7577097	17	7673779	376588	363467	rs764146326	NC_000017.11:7673778:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.841G>A (p.Asp281Asn)	TP53	D149N, D242N, D281N, D122N	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000376586	17	7577097	17	7673779	376586	363465	rs764146326	NC_000017.11:7673778:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 30, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.841G>T (p.Asp281Tyr)	TP53	D149Y, D242Y, D281Y, D122Y	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000376585	17	7577097	17	7673779	376585	363464	rs764146326	NC_000017.11:7673778:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.840A>C (p.Arg280Ser)	TP53	R148S, R241S, R280S, R121S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000634747	17	7577098	17	7673780	634747	622585	rs1567547687	NC_000017.11:7673779:T:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.839G>C (p.Arg280Thr)	TP53	R280T, R148T, R241T, R121T	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000012368	17	7577099	17	7673781	12368	27407	rs121912660	NC_000017.11:7673780:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.833C>T (p.Pro278Leu)	TP53	P146L, P239L, P278L, P119L	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000232497	17	7577105	17	7673787	232497	236459	rs876659802	NC_000017.11:7673786:G:A	single nucleotide variant	missense variant	Pathogenic	Aug 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.832C>A (p.Pro278Thr)	TP53	P146T, P239T, P278T, P119T	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376643	17	7577106	17	7673788	376643	363522	rs17849781	NC_000017.11:7673787:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.832C>T (p.Pro278Ser)	TP53	P146S, P239S, P278S, P119S	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided	VCV000376642	17	7577106	17	7673788	376642	363521	rs17849781	NC_000017.11:7673787:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.827C>G (p.Ala276Gly)	TP53	A144G, A237G, A276G, A117G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000185319	17	7577111	17	7673793	185319	185349	rs786202082	NC_000017.11:7673792:G:C	single nucleotide variant	missense variant	Pathogenic	Jul 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.825T>G (p.Cys275Trp)	TP53	C143W, C236W, C275W, C116W	Hereditary cancer-predisposing syndrome	VCV000485044	17	7577113	17	7673795	485044	479287	rs1555525279	NC_000017.11:7673794:A:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 9, 2017	criteria provided, single submitter							
NM_000546.6(TP53):c.824G>T (p.Cys275Phe)	TP53	C143F, C236F, C275F, C116F	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000376582	17	7577114	17	7673796	376582	363461	rs863224451	NC_000017.11:7673795:C:A	single nucleotide variant	missense variant	Pathogenic	Jul 30, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.824G>A (p.Cys275Tyr)	TP53	C143Y, C236Y, C275Y, C116Y	not provided|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000215997	17	7577114	17	7673796	215997	213392	rs863224451	NC_000017.11:7673795:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 22, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.818G>T (p.Arg273Leu)	TP53	R141L, R234L, R273L, R114L	not provided|Li-Fraumeni syndrome 1|Nasopharyngeal carcinoma|Glioma susceptibility 1|Adrenocortical carcinoma, hereditary|Bone osteosarcoma|Familial cancer of breast|Basal cell carcinoma, susceptibility to, 7|Bone marrow failure syndrome 5|Hepatocellular carcinoma|Carcinoma of pancreas|Choroid plexus papilloma|Colorectal cancer|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000376655	17	7577120	17	7673802	376655	363534	rs28934576	NC_000017.11:7673801:C:A	single nucleotide variant	missense variant	Pathogenic	Sep 29, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.818G>C (p.Arg273Pro)	TP53	R141P, R234P, R273P, R114P	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000231060	17	7577120	17	7673802	231060	236461	rs28934576	NC_000017.11:7673801:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.818G>A (p.Arg273His)	TP53	R273H, R141H, R234H, R114H	Li-Fraumeni syndrome|Neoplasm	VCV000012366	17	7577120	17	7673802	12366	27405	rs28934576	NC_000017.11:7673801:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.817C>G (p.Arg273Gly)	TP53	R141G, R234G, R273G, R114G	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Familial cancer of breast|Glioma susceptibility 1|Colorectal cancer|Bone marrow failure syndrome 5|Bone osteosarcoma|Li-Fraumeni syndrome 1|Nasopharyngeal carcinoma|Carcinoma of pancreas|Choroid plexus papilloma|Basal cell carcinoma, susceptibility to, 7|Hepatocellular carcinoma|Neoplasm	VCV000634682	17	7577121	17	7673803	634682	622586	rs121913343	NC_000017.11:7673802:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 3, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.817C>A (p.Arg273Ser)	TP53	R141S, R234S, R273S, R114S	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000376656	17	7577121	17	7673803	376656	363535	rs121913343	NC_000017.11:7673802:G:T	single nucleotide variant	missense variant	Pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.817C>T (p.Arg273Cys)	TP53	R141C, R234C, R273C, R114C	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Neoplasm	VCV000043594	17	7577121	17	7673803	43594	52763	rs121913343	NC_000017.11:7673802:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 4, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.814G>C (p.Val272Leu)	TP53	V140L, V233L, V272L, V113L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000574679	17	7577124	17	7673806	574679	574631	rs121912657	NC_000017.11:7673805:C:G	single nucleotide variant	missense variant	Pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.814G>A (p.Val272Met)	TP53	V140M, V233M, V272M, V113M	Li-Fraumeni syndrome 1|Neoplasm	VCV000185814	17	7577124	17	7673806	185814	185350	rs121912657	NC_000017.11:7673805:C:T	single nucleotide variant	missense variant	Pathogenic	Mar 18, 2022	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.814G>T (p.Val272Leu)	TP53	V272L, V140L, V233L, V113L	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000012358	17	7577124	17	7673806	12358	27397	rs121912657	NC_000017.11:7673805:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.812A>T (p.Glu271Val)	TP53	E139V, E112V, E232V, E271V	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV003147994	17	7577126	17	7673808	3147994	3307242		NC_000017.11:7673807:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.809T>G (p.Phe270Cys)	TP53	F138C, F231C, F270C, F111C	not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000376597	17	7577129	17	7673811	376597	363476	rs1057519986	NC_000017.11:7673810:A:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.809T>C (p.Phe270Ser)	TP53	F138S, F231S, F270S, F111S	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided	VCV000376594	17	7577129	17	7673811	376594	363473	rs1057519986	NC_000017.11:7673810:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.808T>G (p.Phe270Val)	TP53	F138V, F231V, F270V, F111V	Hereditary cancer-predisposing syndrome	VCV000376598	17	7577130	17	7673812	376598	363477	rs1057519988	NC_000017.11:7673811:A:C	single nucleotide variant	missense variant	Pathogenic	Jun 7, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.806G>T (p.Ser269Ile)	TP53	S110I, S137I, S230I, S269I	Acute myeloid leukemia	VCV002575169	17	7577132	17	7673814	2575169	2740099		NC_000017.11:7673813:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic		no assertion criteria provided							
NM_000546.6(TP53):c.799C>G (p.Arg267Gly)	TP53	R228G, R267G, R108G, R135G	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary	VCV001761541	17	7577139	17	7673821	1761541	1813848		NC_000017.11:7673820:G:C	single nucleotide variant	missense variant	Pathogenic	Jul 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.799C>T (p.Arg267Trp)	TP53	R135W, R228W, R267W, R108W	Familial cancer of breast|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|not provided|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Carcinoma of colon|Li-Fraumeni syndrome 1|Basal cell carcinoma, susceptibility to, 7|Nasopharyngeal carcinoma|Bone osteosarcoma|Glioma susceptibility 1|Familial cancer of breast|Adrenocortical carcinoma, hereditary|Hepatocellular carcinoma|Carcinoma of pancreas|Choroid plexus papilloma	VCV000141764	17	7577139	17	7673821	141764	151478	rs55832599	NC_000017.11:7673820:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.797G>A (p.Gly266Glu)	TP53	G134E, G227E, G266E, G107E	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the head and neck|not provided|Li-Fraumeni syndrome 1|Neoplasm	VCV000161516	17	7577141	17	7673823	161516	171614	rs193920774	NC_000017.11:7673822:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 28, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.796G>A (p.Gly266Arg)	TP53	G134R, G266R, G227R, G107R	Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Neoplasm	VCV000458566	17	7577142	17	7673824	458566	469137	rs1057519990	NC_000017.11:7673823:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 25, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.796G>C (p.Gly266Arg)	TP53	G134R, G227R, G266R, G107R	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376605	17	7577142	17	7673824	376605	363484	rs1057519990	NC_000017.11:7673823:C:G	single nucleotide variant	missense variant	Pathogenic	Jun 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.794T>A (p.Leu265Gln)	TP53	L106Q, L226Q, L133Q, L265Q	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000953467	17	7577144	17	7673826	953467	950307	rs879253942	NC_000017.11:7673825:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.794T>C (p.Leu265Pro)	TP53	L133P, L226P, L265P, L106P	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000245777	17	7577144	17	7673826	245777	245069	rs879253942	NC_000017.11:7673825:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.776A>C (p.Asp259Ala)	TP53	D100A, D127A, D220A, D259A	Malignant lymphoma, large B-cell, diffuse	VCV002671888	17	7577505	17	7674187	2671888	2839415		NC_000017.11:7674186:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 4, 2023	no assertion criteria provided							
NM_000546.6(TP53):c.772G>A (p.Glu258Lys)	TP53	E258K, E126K, E219K, E99K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided	VCV000012348	17	7577509	17	7674191	12348	27387	rs121912652	NC_000017.11:7674190:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.761_762delinsAT (p.Ile254Asn)	TP53	I215N, I254N, I122N, I95N	Li-Fraumeni syndrome	VCV002817584	17	7577519 - 7577520	17	7674201 - 7674202	2817584	2977395		NC_000017.11:7674200:GA:AT	Indel	missense variant|non-coding transcript variant	Pathogenic	Nov 30, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.761T>C (p.Ile254Thr)	TP53	I215T, I122T, I254T, I95T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV001759844	17	7577520	17	7674202	1759844	1813445		NC_000017.11:7674201:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.761T>A (p.Ile254Asn)	TP53	I254N, I95N, I122N, I215N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000856299	17	7577520	17	7674202	856299	846265	rs1330865474	NC_000017.11:7674201:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.757A>G (p.Thr253Ala)	TP53	T214A, T253A, T94A, T121A	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000827132	17	7577524	17	7674206	827132	814470	rs1597364185	NC_000017.11:7674205:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.751A>T (p.Ile251Phe)	TP53	I251F, I92F, I119F, I212F	Li-Fraumeni syndrome	VCV001518844	17	7577530	17	7674212	1518844	1343038	rs730882007	NC_000017.11:7674211:T:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 8, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.751A>C (p.Ile251Leu)	TP53	I119L, I212L, I251L, I92L	Gastric cancer|Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome	VCV000182937	17	7577530	17	7674212	182937	180998	rs730882007	NC_000017.11:7674211:T:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.749C>T (p.Pro250Leu)	TP53	P118L, P211L, P250L, P91L	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000420136	17	7577532	17	7674214	420136	410263	rs1064794311	NC_000017.11:7674213:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 22, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.747G>T (p.Arg249Ser)	TP53	R249S, R117S, R210S, R90S	not provided|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000012352	17	7577534	17	7674216	12352	27391	rs28934571	NC_000017.11:7674215:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 14, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.746G>C (p.Arg249Thr)	TP53	R117T, R210T, R249T, R90T	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided	VCV000376015	17	7577535	17	7674217	376015	362894	rs587782329	NC_000017.11:7674216:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.743G>C (p.Arg248Pro)	TP53	R116P, R209P, R248P, R89P	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000237954	17	7577538	17	7674220	237954	242980	rs11540652	NC_000017.11:7674219:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.743G>T (p.Arg248Leu)	TP53	R116L, R209L, R248L, R89L	Li-Fraumeni syndrome	VCV000230253	17	7577538	17	7674220	230253	236469	rs11540652	NC_000017.11:7674219:C:A	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.743G>A (p.Arg248Gln)	TP53	R248Q, R116Q, R209Q, R89Q	Li-Fraumeni syndrome|Neoplasm	VCV000012356	17	7577538	17	7674220	12356	27395	rs11540652	NC_000017.11:7674219:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.741_742delinsTT (p.Arg248Trp)	TP53	R209W, R89W, R116W, R248W	Li-Fraumeni syndrome	VCV000437017	17	7577539 - 7577540	17	7674221 - 7674222	437017	430018	rs1555525498	NC_000017.11:7674220:GG:AA	Indel	missense variant	Likely pathogenic	Mar 31, 2017	criteria provided, single submitter							
NM_000546.6(TP53):c.742C>G (p.Arg248Gly)	TP53	R116G, R209G, R248G, R89G	Li-Fraumeni syndrome 1|Carcinoma of colon|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376652	17	7577539	17	7674221	376652	363531	rs121912651	NC_000017.11:7674220:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.742C>T (p.Arg248Trp)	TP53	R248W, R116W, R209W, R89W	Li-Fraumeni syndrome|Neoplasm	VCV000012347	17	7577539	17	7674221	12347	27386	rs121912651	NC_000017.11:7674220:G:A	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.738G>C (p.Met246Ile)	TP53	M87I, M207I, M246I, M114I	Hereditary cancer-predisposing syndrome	VCV001758655	17	7577543	17	7674225	1758655	1819366		NC_000017.11:7674224:C:G	single nucleotide variant	missense variant	Likely pathogenic	Dec 12, 2017	criteria provided, single submitter							
NM_000546.6(TP53):c.738G>A (p.Met246Ile)	TP53	M246I, M114I, M207I, M87I	Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000480961	17	7577543	17	7674225	480961	479328	rs1019340046	NC_000017.11:7674224:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 19, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.737T>A (p.Met246Lys)	TP53	M114K, M246K, M207K, M87K	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000480764	17	7577544	17	7674226	480764	479245	rs587780074	NC_000017.11:7674225:A:T	single nucleotide variant	missense variant	Likely pathogenic	Sep 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.736A>G (p.Met246Val)	TP53	M114V, M207V, M246V, M87V	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000100815	17	7577545	17	7674227	100815	106675	rs483352695	NC_000017.11:7674226:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.734_735delinsAT (p.Gly245Asp)	TP53	G206D, G113D, G245D, G86D	Li-Fraumeni syndrome	VCV000861760	17	7577546 - 7577547	17	7674228 - 7674229	861760	846267	rs2073251813	NC_000017.11:7674227:GC:AT	Indel	missense variant	Pathogenic	Apr 1, 2019	criteria provided, single submitter							
NM_000546.6(TP53):c.734G>T (p.Gly245Val)	TP53	G113V, G206V, G245V, G86V	Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000376603	17	7577547	17	7674229	376603	363482	rs121912656	NC_000017.11:7674228:C:A	single nucleotide variant	missense variant	Pathogenic	Nov 15, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.734G>A (p.Gly245Asp)	TP53	G245D, G113D, G206D, G86D	Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000012355	17	7577547	17	7674229	12355	27394	rs121912656	NC_000017.11:7674228:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.733G>A (p.Gly245Ser)	TP53	G245S, G113S, G206S, G86S	Li-Fraumeni syndrome	VCV000012365	17	7577548	17	7674230	12365	27404	rs28934575	NC_000017.11:7674229:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.733G>T (p.Gly245Cys)	TP53	G245C, G113C, G206C, G86C	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000012349	17	7577548	17	7674230	12349	27388	rs28934575	NC_000017.11:7674229:C:A	single nucleotide variant	missense variant	Pathogenic	Mar 14, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.731G>C (p.Gly244Ala)	TP53	G112A, G205A, G244A, G85A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000458560	17	7577550	17	7674232	458560	467518	rs985033810	NC_000017.11:7674231:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.731G>T (p.Gly244Val)	TP53	G112V, G205V, G244V, G85V	Li-Fraumeni syndrome 1	VCV000376601	17	7577550	17	7674232	376601	363480	rs985033810	NC_000017.11:7674231:C:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 16, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.731G>A (p.Gly244Asp)	TP53	G112D, G205D, G244D, G85D	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Neoplasm	VCV000372785	17	7577550	17	7674232	372785	360335	rs985033810	NC_000017.11:7674231:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 17, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.730G>A (p.Gly244Ser)	TP53	G112S, G205S, G244S, G85S	Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000376600	17	7577551	17	7674233	376600	363479	rs1057519989	NC_000017.11:7674232:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 15, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.726C>G (p.Cys242Trp)	TP53	C110W, C203W, C242W, C83W	Li-Fraumeni syndrome	VCV000376580	17	7577555	17	7674237	376580	363459	rs375874539	NC_000017.11:7674236:G:C	single nucleotide variant	missense variant	Pathogenic	Mar 9, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.725G>A (p.Cys242Tyr)	TP53	C242Y, C110Y, C203Y, C83Y	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Familial cancer of breast	VCV000012354	17	7577556	17	7674238	12354	27393	rs121912655	NC_000017.11:7674237:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.722C>A (p.Ser241Tyr)	TP53	S109Y, S202Y, S241Y, S82Y	not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm	VCV000376663	17	7577559	17	7674241	376663	363542	rs28934573	NC_000017.11:7674240:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 29, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.722C>G (p.Ser241Cys)	TP53	S109C, S202C, S241C, S82C	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome	VCV000177791	17	7577559	17	7674241	177791	176503	rs28934573	NC_000017.11:7674240:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.722C>T (p.Ser241Phe)	TP53	S241F, S109F, S202F, S82F	Li-Fraumeni syndrome 1|Colorectal cancer|Li-Fraumeni syndrome 1|Glioma susceptibility 1|Adrenocortical carcinoma, hereditary|Bone marrow failure syndrome 5|Hepatocellular carcinoma|Basal cell carcinoma, susceptibility to, 7|Carcinoma of pancreas|Choroid plexus papilloma|Nasopharyngeal carcinoma|Bone osteosarcoma|Familial cancer of breast|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Neoplasm	VCV000012359	17	7577559	17	7674241	12359	27398	rs28934573	NC_000017.11:7674240:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 18, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.721T>A (p.Ser241Thr)	TP53	S109T, S202T, S241T, S82T	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000959232	17	7577560	17	7674242	959232	950308	rs1057520002	NC_000017.11:7674241:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.721T>G (p.Ser241Ala)	TP53	S109A, S202A, S241A, S82A	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376665	17	7577560	17	7674242	376665	363544	rs1057520002	NC_000017.11:7674241:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.719G>A (p.Ser240Asn)	TP53	S108N, S201N, S240N, S81N	Acute myeloid leukemia	VCV002502882	17	7577562	17	7674244	2502882	2667997		NC_000017.11:7674243:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic		no assertion criteria provided							
NM_000546.6(TP53):c.718A>G (p.Ser240Gly)	TP53	S201G, S240G, S108G, S81G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck	VCV000584921	17	7577563	17	7674245	584921	576031	rs1567549584	NC_000017.11:7674244:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.716A>G (p.Asn239Ser)	TP53	N107S, N200S, N239S, N80S	not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000376637	17	7577565	17	7674247	376637	363516	rs1057519999	NC_000017.11:7674246:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.714T>G (p.Cys238Trp)	TP53	C106W, C199W, C238W, C79W	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000161515	17	7577567	17	7674249	161515	171615	rs193920789	NC_000017.11:7674248:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 28, 2020	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.713G>C (p.Cys238Ser)	TP53	C106S, C199S, C238S, C79S	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000376575	17	7577568	17	7674250	376575	363454	rs730882005	NC_000017.11:7674249:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.713G>T (p.Cys238Phe)	TP53	C106F, C199F, C238F, C79F	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000376574	17	7577568	17	7674250	376574	363453	rs730882005	NC_000017.11:7674249:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.713G>A (p.Cys238Tyr)	TP53	C106Y, C199Y, C238Y, C79Y	not provided|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Hereditary breast ovarian cancer syndrome|Neoplasm	VCV000182935	17	7577568	17	7674250	182935	181000	rs730882005	NC_000017.11:7674249:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 12, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.712T>G (p.Cys238Gly)	TP53	C106G, C199G, C238G, C79G	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376577	17	7577569	17	7674251	376577	363456	rs1057519981	NC_000017.11:7674250:A:C	single nucleotide variant	missense variant	Pathogenic	Mar 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.712T>C (p.Cys238Arg)	TP53	C106R, C199R, C238R, C79R	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376576	17	7577569	17	7674251	376576	363455	rs1057519981	NC_000017.11:7674250:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.711G>C (p.Met237Ile)	TP53	M105I, M198I, M237I, M78I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV001757269	17	7577570	17	7674252	1757269	1819274		NC_000017.11:7674251:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.711G>T (p.Met237Ile)	TP53	M105I, M198I, M237I, M78I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV000634770	17	7577570	17	7674252	634770	622595	rs587782664	NC_000017.11:7674251:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.711G>A (p.Met237Ile)	TP53	M105I, M198I, M237I, M78I	Li-Fraumeni syndrome 1|Neoplasm	VCV000142714	17	7577570	17	7674252	142714	152428	rs587782664	NC_000017.11:7674251:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 20, 2021	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.710T>A (p.Met237Lys)	TP53	M105K, M198K, M237K, M78K	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000376636	17	7577571	17	7674253	376636	363515	rs765848205	NC_000017.11:7674252:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.706T>C (p.Tyr236His)	TP53	Y104H, Y197H, Y236H, Y77H	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000216469	17	7577575	17	7674257	216469	213394	rs587782289	NC_000017.11:7674256:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.701A>G (p.Tyr234Cys)	TP53	Y102C, Y195C, Y234C, Y75C	not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm	VCV000127820	17	7577580	17	7674262	127820	133277	rs587780073	NC_000017.11:7674261:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 4, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.700T>A (p.Tyr234Asn)	TP53	Y102N, Y195N, Y234N, Y75N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376692	17	7577581	17	7674263	376692	363571	rs864622237	NC_000017.11:7674262:A:T	single nucleotide variant	missense variant	Pathogenic	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.700T>C (p.Tyr234His)	TP53	Y102H, Y195H, Y234H, Y75H	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Neoplasm	VCV000376691	17	7577581	17	7674263	376691	363570	rs864622237	NC_000017.11:7674262:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 30, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.700T>G (p.Tyr234Asp)	TP53	Y102D, Y195D, Y234D, Y75D	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000219759	17	7577581	17	7674263	219759	222738	rs864622237	NC_000017.11:7674262:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.695T>A (p.Ile232Asn)	TP53	I232N, I193N, I73N, I100N	Li-Fraumeni syndrome	VCV000850008	17	7577586	17	7674268	850008	846269	rs587781589	NC_000017.11:7674267:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 23, 2021	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.695T>G (p.Ile232Ser)	TP53	I100S, I193S, I232S, I73S	Hereditary cancer-predisposing syndrome	VCV000634756	17	7577586	17	7674268	634756	622596	rs587781589	NC_000017.11:7674267:A:C	single nucleotide variant	missense variant	Pathogenic	Mar 28, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.695T>C (p.Ile232Thr)	TP53	I100T, I193T, I232T, I73T	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000141224	17	7577586	17	7674268	141224	150938	rs587781589	NC_000017.11:7674267:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.659A>G (p.Tyr220Cys)	TP53	Y181C, Y220C, Y88C, Y61C	Li-Fraumeni syndrome|Neoplasm	VCV000127819	17	7578190	17	7674872	127819	133276	rs121912666	NC_000017.11:7674871:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.659A>C (p.Tyr220Ser)	TP53	Y220S, Y181S, Y88S, Y61S	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000012383	17	7578190	17	7674872	12383	27422	rs121912666	NC_000017.11:7674871:T:G	single nucleotide variant	missense variant	Pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.658T>C (p.Tyr220His)	TP53	Y181H, Y220H, Y88H, Y61H	Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376687	17	7578191	17	7674873	376687	363566	rs530941076	NC_000017.11:7674872:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.653T>A (p.Val218Glu)	TP53	V179E, V218E, V86E, V59E	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV001754112	17	7578196	17	7674878	1754112	1804667		NC_000017.11:7674877:A:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.646G>A (p.Val216Met)	TP53	V177M, V216M, V84M, V57M	not provided|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000182965	17	7578203	17	7674885	182965	181005	rs730882025	NC_000017.11:7674884:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 23, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.641A>G (p.His214Arg)	TP53	H175R, H214R, H82R, H55R	Li-Fraumeni syndrome|Neoplasm	VCV000376615	17	7578208	17	7674890	376615	363494	rs1057519992	NC_000017.11:7674889:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.637_639delinsTGG (p.Arg213Trp)	TP53	R174W, R54W, R81W, R213W	Hereditary cancer-predisposing syndrome	VCV003460335	17	7578210 - 7578212	17	7674892 - 7674894	3460335	3611146		NC_000017.11:7674891:TCG:CCA	Indel	missense variant	Likely pathogenic	Nov 19, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.638G>C (p.Arg213Pro)	TP53	R174P, R213P, R81P, R54P	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not specified|Li-Fraumeni syndrome 1|Neoplasm	VCV000231214	17	7578211	17	7674893	231214	236477	rs587778720	NC_000017.11:7674892:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 17, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.638G>A (p.Arg213Gln)	TP53	R174Q, R213Q, R81Q, R54Q	Breast and/or ovarian cancer|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000135359	17	7578211	17	7674893	135359	139098	rs587778720	NC_000017.11:7674892:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.614A>G (p.Tyr205Cys)	TP53	Y166C, Y205C, Y73C, Y46C	not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000376681	17	7578235	17	7674917	376681	363560	rs1057520007	NC_000017.11:7674916:T:C	single nucleotide variant	missense variant	Pathogenic	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.613T>G (p.Tyr205Asp)	TP53	Y166D, Y205D, Y73D, Y46D	not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000376686	17	7578236	17	7674918	376686	363565	rs1057520008	NC_000017.11:7674917:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.613T>C (p.Tyr205His)	TP53	Y166H, Y205H, Y73H, Y46H	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376685	17	7578236	17	7674918	376685	363564	rs1057520008	NC_000017.11:7674917:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.596G>T (p.Gly199Val)	TP53	G160V, G199V, G67V, G40V	not provided	VCV000451799	17	7578253	17	7674935	451799	445903	rs1555525857	NC_000017.11:7674934:C:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 20, 2018	criteria provided, single submitter							
NM_000546.6(TP53):c.587G>C (p.Arg196Pro)	TP53	R157P, R196P, R64P, R37P	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000231165	17	7578262	17	7674944	231165	236479	rs483352697	NC_000017.11:7674943:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 2, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.584T>C (p.Ile195Thr)	TP53	I156T, I195T, I63T, I36T	Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Neoplasm	VCV000216077	17	7578265	17	7674947	216077	213398	rs760043106	NC_000017.11:7674946:A:G	single nucleotide variant	missense variant	Pathogenic	Jan 10, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.580C>T (p.Leu194Phe)	TP53	L155F, L194F, L62F, L35F	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000127817	17	7578269	17	7674951	127817	133274	rs587780071	NC_000017.11:7674950:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 10, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.578A>C (p.His193Pro)	TP53	H154P, H193P, H61P, H34P	Li-Fraumeni syndrome	VCV000376612	17	7578271	17	7674953	376612	363491	rs786201838	NC_000017.11:7674952:T:G	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.578A>G (p.His193Arg)	TP53	H154R, H193R, H61R, H34R	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided|Adrenocortical carcinoma, hereditary|Squamous cell carcinoma of the head and neck	VCV000184979	17	7578271	17	7674953	184979	185367	rs786201838	NC_000017.11:7674952:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.577C>A (p.His193Asn)	TP53	H154N, H193N, H61N, H34N	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV003460301	17	7578272	17	7674954	3460301	363493	rs876658468	NC_000017.11:7674953:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.577C>T (p.His193Tyr)	TP53	H154Y, H193Y, H61Y, H34Y	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000230256	17	7578272	17	7674954	230256	236481	rs876658468	NC_000017.11:7674953:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.569C>T (p.Pro190Leu)	TP53	P151L, P190L, P58L, P31L	Li-Fraumeni syndrome 1	VCV000418517	17	7578280	17	7674962	418517	410268	rs876660825	NC_000017.11:7674961:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 27, 2022	reviewed by expert panel							
NM_000546.6(TP53):c.542G>C (p.Arg181Pro)	TP53	R181P, R22P, R142P, R49P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000825729	17	7578388	17	7675070	825729	814487	rs397514495	NC_000017.11:7675069:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.542G>A (p.Arg181His)	TP53	R142H, R181H, R49H, R22H	Adrenocortical carcinoma, hereditary|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the head and neck	VCV000142320	17	7578388	17	7675070	142320	152034	rs397514495	NC_000017.11:7675069:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.538G>A (p.Glu180Lys)	TP53	E141K, E180K, E48K, E21K	Li-Fraumeni syndrome	VCV000245711	17	7578392	17	7675074	245711	245073	rs879253911	NC_000017.11:7675073:C:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.537T>A (p.His179Gln)	TP53	H140Q, H47Q, H179Q, H20Q	Li-Fraumeni syndrome	VCV000406578	17	7578393	17	7675075	406578	402563	rs876660821	NC_000017.11:7675074:A:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.537T>G (p.His179Gln)	TP53	H140Q, H179Q, H47Q, H20Q	not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376607	17	7578393	17	7675075	376607	363486	rs876660821	NC_000017.11:7675074:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.535C>G (p.His179Asp)	TP53	H140D, H179D, H47D, H20D	Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376610	17	7578395	17	7675077	376610	363489	rs587780070	NC_000017.11:7675076:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.535C>T (p.His179Tyr)	TP53	H140Y, H179Y, H47Y, H20Y	Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Neoplasm	VCV000127815	17	7578395	17	7675077	127815	133272	rs587780070	NC_000017.11:7675076:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 22, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.534C>G (p.His178Gln)	TP53	H178Q, H46Q, H19Q, H139Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000947223	17	7578396	17	7675078	947223	928554	rs1555526001	NC_000017.11:7675077:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.534C>A (p.His178Gln)	TP53	H46Q, H139Q, H178Q, H19Q	Li-Fraumeni syndrome|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000575702	17	7578396	17	7675078	575702	569777	rs1555526001	NC_000017.11:7675077:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.532C>G (p.His178Asp)	TP53	H178D, H46D, H139D, H19D	Li-Fraumeni syndrome	VCV000482223	17	7578398	17	7675080	482223	480057	rs1064795203	NC_000017.11:7675079:G:C	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.530C>G (p.Pro177Arg)	TP53	P177R, P45R, P138R, P18R	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000458547	17	7578400	17	7675082	458547	468390	rs751477326	NC_000017.11:7675081:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.526_528delinsCGG (p.Cys176Arg)	TP53	C17R, C44R, C137R, C176R	Ovarian neoplasm	VCV000634759	17	7578402 - 7578404	17	7675084 - 7675086	634759	622616	rs1567552847	NC_000017.11:7675083:GCA:CCG	Indel	missense variant	Likely pathogenic	Dec 1, 2018	no assertion criteria provided							
NM_000546.6(TP53):c.527G>T (p.Cys176Phe)	TP53	C137F, C176F, C44F, C17F	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000376569	17	7578403	17	7675085	376569	363448	rs786202962	NC_000017.11:7675084:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 30, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.527G>A (p.Cys176Tyr)	TP53	C137Y, C176Y, C44Y, C17Y	Li-Fraumeni syndrome|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|TP53-related disorder|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma	VCV000186451	17	7578403	17	7675085	186451	185371	rs786202962	NC_000017.11:7675084:C:T	single nucleotide variant	missense variant	Pathogenic	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.524G>T (p.Arg175Leu)	TP53	R136L, R175L, R43L, R16L	Li-Fraumeni syndrome	VCV000182963	17	7578406	17	7675088	182963	181010	rs28934578	NC_000017.11:7675087:C:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 6, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.524G>A (p.Arg175His)	TP53	R175H, R136H, R43H, R16H	Li-Fraumeni syndrome|Neoplasm	VCV000012374	17	7578406	17	7675088	12374	27413	rs28934578	NC_000017.11:7675087:C:T	single nucleotide variant	missense variant	Pathogenic	Sep 6, 2024	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.523C>G (p.Arg175Gly)	TP53	R136G, R175G, R43G, R16G	Li-Fraumeni syndrome|Neoplasm	VCV000376649	17	7578407	17	7675089	376649	363528	rs138729528	NC_000017.11:7675088:G:C	single nucleotide variant	missense variant	Pathogenic	Sep 6, 2024	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.518T>C (p.Val173Ala)	TP53	V134A, V173A, V41A, V14A	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376017	17	7578412	17	7675094	376017	362896	rs1057519747	NC_000017.11:7675093:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.517G>T (p.Val173Leu)	TP53	V134L, V173L, V41L, V14L	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000376668	17	7578413	17	7675095	376668	363547	rs876660754	NC_000017.11:7675094:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 16, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.517G>A (p.Val173Met)	TP53	V134M, V173M, V41M, V14M	Li-Fraumeni syndrome|Neoplasm	VCV000233951	17	7578413	17	7675095	233951	232035	rs876660754	NC_000017.11:7675094:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.513G>T (p.Glu171Asp)	TP53	E12D, E132D, E171D, E39D	Acute myeloid leukemia	VCV002446885	17	7578417	17	7675099	2446885	2422010		NC_000017.11:7675098:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic		no assertion criteria provided							
NM_000546.6(TP53):c.512A>G (p.Glu171Gly)	TP53	E132G, E171G, E39G, E12G	Hereditary cancer-predisposing syndrome	VCV001745525	17	7578418	17	7675100	1745525	1802577		NC_000017.11:7675099:T:C	single nucleotide variant	missense variant	Pathogenic	Jan 24, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.503A>C (p.His168Pro)	TP53	H129P, H36P, H168P, H9P	Hereditary cancer-predisposing syndrome	VCV003328154	17	7578427	17	7675109	3328154	3486867		NC_000017.11:7675108:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 14, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.503A>T (p.His168Leu)	TP53	H129L, H168L, H36L, H9L	Hereditary cancer-predisposing syndrome	VCV001744933	17	7578427	17	7675109	1744933	1805779		NC_000017.11:7675108:T:A	single nucleotide variant	missense variant	Pathogenic	Dec 3, 2020	criteria provided, single submitter							
NM_000546.6(TP53):c.494A>T (p.Gln165Leu)	TP53	Q126L, Q165L, Q33L, Q6L	Acute myeloid leukemia	VCV002505496	17	7578436	17	7675118	2505496	2670460		NC_000017.11:7675117:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic		no assertion criteria provided							
NM_000546.6(TP53):c.488A>G (p.Tyr163Cys)	TP53	Y124C, Y163C, Y31C, Y4C	Li-Fraumeni syndrome	VCV000127814	17	7578442	17	7675124	127814	133271	rs148924904	NC_000017.11:7675123:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.481G>A (p.Ala161Thr)	TP53	A122T, A161T, A29T, A2T	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|not provided	VCV000161518	17	7578449	17	7675131	161518	171616	rs193920817	NC_000017.11:7675130:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.476C>A (p.Ala159Asp)	TP53	A120D, A159D, A27D	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV001026335	17	7578454	17	7675136	1026335	1013159	rs1555526131	NC_000017.11:7675135:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.476C>T (p.Ala159Val)	TP53	A120V, A159V, A27V	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Neoplasm	VCV000458545	17	7578454	17	7675136	458545	467544	rs1555526131	NC_000017.11:7675135:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 7, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.473_474delinsTT (p.Arg158Leu)	TP53	R158L, R119L, R26L	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000568285	17	7578456 - 7578457	17	7675138 - 7675139	568285	574635	rs1567553501	NC_000017.11:7675137:GC:AA	Indel	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.473G>T (p.Arg158Leu)	TP53	R158L, R26L, R119L	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided	VCV000528248	17	7578457	17	7675139	528248	531819	rs587782144	NC_000017.11:7675138:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.473G>C (p.Arg158Pro)	TP53	R119P, R158P, R26P	Squamous cell carcinoma of the head and neck|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided|Li-Fraumeni syndrome	VCV000246118	17	7578457	17	7675139	246118	245076	rs587782144	NC_000017.11:7675138:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.473G>A (p.Arg158His)	TP53	R119H, R158H, R26H	Li-Fraumeni syndrome|Glioma susceptibility 1|Bone osteosarcoma|Choroid plexus papilloma|Familial pancreatic carcinoma|Hepatocellular carcinoma|Adrenocortical carcinoma, hereditary|Bone marrow failure syndrome 5|Basal cell carcinoma, susceptibility to, 7|Familial cancer of breast|Li-Fraumeni syndrome 1|Nasopharyngeal carcinoma|Colorectal cancer|Adrenocortical carcinoma, hereditary|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1	VCV000141963	17	7578457	17	7675139	141963	151677	rs587782144	NC_000017.11:7675138:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.472C>A (p.Arg158Ser)	TP53	R119S, R158S, R26S	Li-Fraumeni syndrome	VCV001067910	17	7578458	17	7675140	1067910	1056473	rs587780068	NC_000017.11:7675139:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Sep 13, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.472C>G (p.Arg158Gly)	TP53	R158G, R26G, R119G	Li-Fraumeni syndrome	VCV000856171	17	7578458	17	7675140	856171	846283	rs587780068	NC_000017.11:7675139:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jul 21, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.470_471delinsGT (p.Val157Gly)	TP53	V25G, V157G, V118G	Li-Fraumeni syndrome 1	VCV003148383	17	7578459 - 7578460	17	7675141 - 7675142	3148383	3307631		NC_000017.11:7675140:GA:AC	Indel	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Feb 14, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.470T>G (p.Val157Gly)	TP53	V118G, V157G, V25G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000915695	17	7578460	17	7675142	915695	904019	rs1131691023	NC_000017.11:7675141:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.469G>T (p.Val157Phe)	TP53	V157F, V118F, V25F	Squamous cell carcinoma|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Neoplasm	VCV000012353	17	7578461	17	7675143	12353	27392	rs121912654	NC_000017.11:7675142:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.467G>C (p.Arg156Pro)	TP53	R117P, R156P, R24P	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000634768	17	7578463	17	7675145	634768	622620	rs371524413	NC_000017.11:7675144:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.464C>A (p.Thr155Asn)	TP53	T155N, T116N, T23N	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000406564	17	7578466	17	7675148	406564	402565	rs786202752	NC_000017.11:7675147:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.455C>G (p.Pro152Arg)	TP53	P152R, P20R, P113R	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000824998	17	7578475	17	7675157	824998	814494	rs587782705	NC_000017.11:7675156:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.455C>T (p.Pro152Leu)	TP53	P113L, P152L, P20L	Li-Fraumeni syndrome|Neoplasm	VCV000142766	17	7578475	17	7675157	142766	152480	rs587782705	NC_000017.11:7675156:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Aug 5, 2024	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.451_452delinsAG (p.Pro151Ser)	TP53	P151S, P19S, P112S	Li-Fraumeni syndrome	VCV002700111	17	7578478 - 7578479	17	7675160 - 7675161	2700111	2858963		NC_000017.11:7675159:GG:CT	Indel	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 11, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.451_452delinsTT (p.Pro151Phe)	TP53	P151F, P19F, P112F	Hereditary cancer-predisposing syndrome	VCV000824960	17	7578478 - 7578479	17	7675160 - 7675161	824960	814495	rs1597370899	NC_000017.11:7675159:GG:AA	Indel	missense variant|5 prime UTR variant	Likely pathogenic	Oct 4, 2019	criteria provided, single submitter							
NM_000546.6(TP53):c.452C>G (p.Pro151Arg)	TP53	P112R, P151R, P19R	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376640	17	7578478	17	7675160	376640	363519	rs1057520000	NC_000017.11:7675159:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.451C>G (p.Pro151Ala)	TP53	P112A, P151A, P19A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376641	17	7578479	17	7675161	376641	363520	rs28934874	NC_000017.11:7675160:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.451C>T (p.Pro151Ser)	TP53	P151S, P112S, P19S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1	VCV000012370	17	7578479	17	7675161	12370	27409	rs28934874	NC_000017.11:7675160:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.451C>A (p.Pro151Thr)	TP53	P151T, P112T, P19T	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1	VCV000012369	17	7578479	17	7675161	12369	27408	rs28934874	NC_000017.11:7675160:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.440T>G (p.Val147Gly)	TP53	V108G, V147G, V15G	Li-Fraumeni syndrome	VCV003602769	17	7578490	17	7675172	3602769	3735483		NC_000017.11:7675171:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Feb 4, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.428T>C (p.Val143Ala)	TP53	V104A, V11A, V143A	Li-Fraumeni syndrome	VCV000804214	17	7578502	17	7675184	804214	792574	rs1555526241	NC_000017.11:7675183:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.427G>A (p.Val143Met)	TP53	V104M, V11M, V143M	Breast neoplasm|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Familial cancer of breast|Bone marrow failure syndrome 5|Glioma susceptibility 1|Bone osteosarcoma|Choroid plexus papilloma|Colorectal cancer|Basal cell carcinoma, susceptibility to, 7|Li-Fraumeni syndrome 1|Nasopharyngeal carcinoma|Familial pancreatic carcinoma|Hepatocellular carcinoma|not provided|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000142657	17	7578503	17	7675185	142657	152371	rs587782620	NC_000017.11:7675184:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Dec 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.423C>G (p.Cys141Trp)	TP53	C102W, C141W, C9W	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000376564	17	7578507	17	7675189	376564	363443	rs1057519977	NC_000017.11:7675188:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jul 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.422G>A (p.Cys141Tyr)	TP53	C102Y, C141Y, C9Y	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Neoplasm	VCV000140801	17	7578508	17	7675190	140801	150515	rs587781288	NC_000017.11:7675189:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Nov 22, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.412G>C (p.Ala138Pro)	TP53	A138P, A6P, A99P	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	VCV000012376	17	7578518	17	7675200	12376	27415	rs28934875	NC_000017.11:7675199:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.404G>T (p.Cys135Phe)	TP53	C135F, C3F, C96F	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000376559	17	7578526	17	7675208	376559	363438	rs587781991	NC_000017.11:7675207:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.403T>G (p.Cys135Gly)	TP53	C135G, C3G, C96G	Li-Fraumeni syndrome	VCV000376563	17	7578527	17	7675209	376563	363442	rs1057519975	NC_000017.11:7675208:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.403T>C (p.Cys135Arg)	TP53	C135R, C3R, C96R	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000376560	17	7578527	17	7675209	376560	363439	rs1057519975	NC_000017.11:7675208:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.401T>G (p.Phe134Cys)	TP53	F134C, F2C, F95C	Hereditary cancer-predisposing syndrome	VCV000230477	17	7578529	17	7675211	230477	236493	rs780442292	NC_000017.11:7675210:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Feb 10, 2015	criteria provided, single submitter							
NM_000546.6(TP53):c.400T>A (p.Phe134Ile)	TP53	F95I, F134I, F2I	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000480953	17	7578530	17	7675212	480953	479343	rs267605077	NC_000017.11:7675211:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.398T>C (p.Met133Thr)	TP53	M133T, M1T, M94T	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000012357	17	7578532	17	7675214	12357	27396	rs28934873	NC_000017.11:7675213:A:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Pathogenic	Oct 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.396G>T (p.Lys132Asn)	TP53	K132N, K93N	Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1	VCV000634773	17	7578534	17	7675216	634773	622631	rs866775781	NC_000017.11:7675215:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.396G>C (p.Lys132Asn)	TP53	K132N, K93N	Li-Fraumeni syndrome|Neoplasm	VCV000376624	17	7578534	17	7675216	376624	363503	rs866775781	NC_000017.11:7675215:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Mar 18, 2022	reviewed by expert panel				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.395A>G (p.Lys132Arg)	TP53	K132R, K93R	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Choroid plexus papilloma|Familial pancreatic carcinoma|Hepatocellular carcinoma|Basal cell carcinoma, susceptibility to, 7|Colorectal cancer|Bone osteosarcoma|Adrenocortical carcinoma, hereditary|Glioma susceptibility 1|Li-Fraumeni syndrome 1|Nasopharyngeal carcinoma|Bone marrow failure syndrome 5|Familial cancer of breast|Neoplasm	VCV000376625	17	7578535	17	7675217	376625	363504	rs1057519996	NC_000017.11:7675216:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 4, 2025	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.392A>T (p.Asn131Ile)	TP53	N131I, N92I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000428902	17	7578538	17	7675220	428902	420665	rs1131691037	NC_000017.11:7675219:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.391A>T (p.Asn131Tyr)	TP53	N131Y, N92Y	Hereditary cancer-predisposing syndrome	VCV000141988	17	7578539	17	7675221	141988	151702	rs587782160	NC_000017.11:7675220:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Mar 5, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.389T>A (p.Leu130His)	TP53	L130H, L91H	Hereditary cancer-predisposing syndrome	VCV000824351	17	7578541	17	7675223	824351	814500	rs1131691013	NC_000017.11:7675222:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Mar 28, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.389T>C (p.Leu130Pro)	TP53	L130P, L91P	Hereditary cancer-predisposing syndrome|Bone osteosarcoma|Li-Fraumeni syndrome 1|Bone marrow failure syndrome 5|Adrenocortical carcinoma, hereditary|Hepatocellular carcinoma|Carcinoma of pancreas|Choroid plexus papilloma|Familial cancer of breast|Basal cell carcinoma, susceptibility to, 7|Glioma susceptibility 1|Nasopharyngeal carcinoma|Colorectal cancer	VCV000428873	17	7578541	17	7675223	428873	420666	rs1131691013	NC_000017.11:7675222:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	May 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.380C>A (p.Ser127Tyr)	TP53	S127Y, S88Y	Li-Fraumeni syndrome 1	VCV000656751	17	7578550	17	7675232	656751	646767	rs730881999	NC_000017.11:7675231:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Apr 20, 2021	reviewed by expert panel							
NM_000546.6(TP53):c.380C>G (p.Ser127Cys)	TP53	S127C, S88C	Li-Fraumeni syndrome	VCV000219532	17	7578550	17	7675232	219532	222742	rs730881999	NC_000017.11:7675231:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jul 14, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.380C>T (p.Ser127Phe)	TP53	S127F, S88F	not specified|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|not provided	VCV000182928	17	7578550	17	7675232	182928	181015	rs730881999	NC_000017.11:7675231:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.379T>C (p.Ser127Pro)	TP53	S127P, S88P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000934410	17	7578551	17	7675233	934410	938240	rs1597371694	NC_000017.11:7675232:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Apr 16, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.374C>G (p.Thr125Arg)	TP53	T125R, T86R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Neoplasm	VCV000376667	17	7579313	17	7675995	376667	363546	rs786201057	NC_000017.11:7675994:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 16, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.374C>A (p.Thr125Lys)	TP53	T125K, T86K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000216465	17	7579313	17	7675995	216465	213402	rs786201057	NC_000017.11:7675994:G:T	single nucleotide variant	missense variant	Pathogenic	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.339C>G (p.Phe113Leu)	TP53	F113L, F74L	Li-Fraumeni syndrome	VCV002702402	17	7579348	17	7676030	2702402	2856119		NC_000017.11:7676029:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 20, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.339C>A (p.Phe113Leu)	TP53	F113L, F74L	Li-Fraumeni syndrome	VCV002125367	17	7579348	17	7676030	2125367	2177968		NC_000017.11:7676029:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jul 7, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.338T>G (p.Phe113Cys)	TP53	F113C, F74C	Li-Fraumeni syndrome	VCV000634690	17	7579349	17	7676031	634690	622637	rs1567555667	NC_000017.11:7676030:A:C	single nucleotide variant	missense variant	Pathogenic	Dec 16, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.337T>C (p.Phe113Leu)	TP53	F113L, F74L	Li-Fraumeni syndrome	VCV003634432	17	7579350	17	7676032	3634432	3763655		NC_000017.11:7676031:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 20, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.337T>A (p.Phe113Ile)	TP53	F74I, F113I	Li-Fraumeni syndrome	VCV001469551	17	7579350	17	7676032	1469551	1475500	rs587781642	NC_000017.11:7676031:A:T	single nucleotide variant	missense variant	Pathogenic	Dec 26, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.329_330delinsCC (p.Arg110Pro)	TP53	R110P, R71P	Li-Fraumeni syndrome	VCV000641505	17	7579357 - 7579358	17	7676039 - 7676040	641505	646770	rs1597373700	NC_000017.11:7676038:AC:GG	Indel	missense variant	Pathogenic	Aug 6, 2018	criteria provided, single submitter							
NM_000546.6(TP53):c.329G>T (p.Arg110Leu)	TP53	R110L, R71L	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000406597	17	7579358	17	7676040	406597	402569	rs11540654	NC_000017.11:7676039:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 11, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.329G>C (p.Arg110Pro)	TP53	R110P, R71P	Familial cancer of breast|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome	VCV000233627	17	7579358	17	7676040	233627	236497	rs11540654	NC_000017.11:7676039:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.326T>G (p.Phe109Cys)	TP53	F109C, F70C	Li-Fraumeni syndrome 1	VCV000634784	17	7579361	17	7676043	634784	622638	rs1064796722	NC_000017.11:7676042:A:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 12, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.325T>A (p.Phe109Ile)	TP53	F109I, F70I	Li-Fraumeni syndrome|not provided	VCV002627017	17	7579362	17	7676044	2627017	2794537		NC_000017.11:7676043:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Oct 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.313G>A (p.Gly105Ser)	TP53	G105S, G66S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000428884	17	7579374	17	7676056	428884	420671	rs1060501195	NC_000017.11:7676055:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.313G>C (p.Gly105Arg)	TP53	G66R, G105R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000406574	17	7579374	17	7676056	406574	402601	rs1060501195	NC_000017.11:7676055:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_001377265.1(MAPT):c.14G>T (p.Arg5Leu)	MAPT	R5L	Supranuclear palsy, progressive, 1	VCV000014263	17	44039717	17	45962351	14263	29302	rs63750959	NC_000017.11:45962350:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Sep 13, 2017	no assertion criteria provided							
NM_001377265.1(MAPT):c.1946A>C (p.Lys649Thr)	MAPT	K257T, K574T, K199T, K228T, K592T, K583T, K649T	Pick disease	VCV000014259	17	44073978	17	45996612	14259	29298	rs63750129	NC_000017.11:45996611:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 1, 2000	no assertion criteria provided							
NM_001377265.1(MAPT):c.1972C>G (p.Leu658Val)	MAPT	L266V, L583V, L237V, L601V, L208V, L592V, L658V	Frontotemporal dementia	VCV000014266	17	44074004	17	45996638	14266	29305	rs63750349	NC_000017.11:45996637:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Sep 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_001377265.1(MAPT):c.1991G>T (p.Gly664Val)	MAPT	G272V, G589V, G243V, G607V, G214V, G598V, G664V	Frontotemporal dementia	VCV000014246	17	44074023	17	45996657	14246	29285	rs63750376	NC_000017.11:45996656:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	May 6, 2021	no assertion criteria provided							
NM_001377265.1(MAPT):c.2013T>G (p.Asn671Lys)	MAPT	N279K, N221K, N250K, N596K, N614K, N671K	not provided|Frontotemporal dementia|Progressive supranuclear ophthalmoplegia|Frontotemporal dementia|Pick disease|Parkinson disease, late-onset|Progressive supranuclear palsy-parkinsonism syndrome	VCV000014253	17	44087690	17	46010324	14253	29292	rs63750756	NC_000017.11:46010323:T:G	single nucleotide variant	missense variant|intron variant	Pathogenic	Apr 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_001377265.1(MAPT):c.2077C>G (p.Pro693Ala)	MAPT	P243A, P272A, P301A, P618A, P636A, P693A	Supranuclear palsy, progressive, 1	VCV003075676	17	44087754	17	46010388	3075676	3234972		NC_000017.11:46010387:C:G	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Apr 27, 2023	criteria provided, single submitter							
NM_001377265.1(MAPT):c.2077C>T (p.Pro693Ser)	MAPT	P301S, P243S, P272S, P618S, P636S, P693S	Frontotemporal dementia	VCV000014256	17	44087754	17	46010388	14256	29295	rs63751438	NC_000017.11:46010387:C:T	single nucleotide variant	missense variant|intron variant	Pathogenic	Dec 1, 2005	no assertion criteria provided							
NM_001377265.1(MAPT):c.2078C>T (p.Pro693Leu)	MAPT	P301L, P243L, P272L, P618L, P636L, P693L	Frontotemporal dementia|Pick disease|Parkinson disease, late-onset|Progressive supranuclear palsy-parkinsonism syndrome|Supranuclear palsy, progressive, 1|Frontotemporal dementia|not provided|Progressive supranuclear ophthalmoplegia|Pick disease|Parkinson disease, late-onset|Progressive supranuclear palsy-parkinsonism syndrome|Frontotemporal dementia	VCV000014245	17	44087755	17	46010389	14245	29284	rs63751273	NC_000017.11:46010388:C:T	single nucleotide variant	missense variant|intron variant	Pathogenic	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_001377265.1(MAPT):c.2084G>T (p.Gly695Val)	MAPT	G303V, G620V, G274V, G638V, G245V, G695V	Supranuclear palsy, progressive, 1	VCV000014269	17	44087761	17	46010395	14269	29308	rs63751391	NC_000017.11:46010394:G:T	single nucleotide variant	missense variant|intron variant	Pathogenic	Sep 1, 2005	no assertion criteria provided							
NM_001377265.1(MAPT):c.2090G>A (p.Ser697Asn)	MAPT	S305N, S247N, S276N, S622N, S640N, S697N	Frontotemporal dementia	VCV000014254	17	44087767	17	46010401	14254	29293	rs63751165	NC_000017.11:46010400:G:A	single nucleotide variant	missense variant|intron variant	Pathogenic	Feb 25, 1999	no assertion criteria provided							
NM_001377265.1(MAPT):c.2120T>G (p.Leu707Arg)	MAPT	L632R, L286R, L315R, L650R, L255R, L257R, L284R, L226R, L610R, L707R	not provided	VCV000098226	17	44091637	17	46014271	98226	104118	rs63749855	NC_000017.11:46014270:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic		no assertion criteria provided							
NM_001377265.1(MAPT):c.2126A>T (p.Lys709Met)	MAPT	K317M, K634M, K259M, K288M, K228M, K257M, K652M, K286M, K612M, K709M	Frontotemporal dementia	VCV000014268	17	44091643	17	46014277	14268	29307	rs63750092	NC_000017.11:46014276:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	May 10, 2005	no assertion criteria provided							
NM_001377265.1(MAPT):c.2135C>T (p.Ser712Phe)	MAPT	S320F, S637F, S291F, S655F, S231F, S260F, S262F, S289F, S615F, S712F	Frontotemporal dementia	VCV000014262	17	44091652	17	46014286	14262	29301	rs63750635	NC_000017.11:46014285:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jan 22, 2018	criteria provided, single submitter							
NM_001377265.1(MAPT):c.2179G>A (p.Gly727Ser)	MAPT	G652S, G246S, G277S, G275S, G304S, G306S, G670S, G335S, G630S, G727S	Frontotemporal dementia	VCV000098228	17	44095989	17	46018623	98228	104120	rs63750095	NC_000017.11:46018622:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Feb 1, 2024	criteria provided, single submitter							
NM_001377265.1(MAPT):c.2184G>C (p.Gln728His)	MAPT	Q247H, Q276H, Q336H, Q653H, Q278H, Q307H, Q305H, Q671H, Q631H, Q728H	Frontotemporal dementia	VCV000665222	17	44095994	17	46018628	665222	646113	rs1598408073	NC_000017.11:46018627:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_001377265.1(MAPT):c.2185G>A (p.Val729Met)	MAPT	V337M, V654M, V306M, V308M, V279M, V248M, V277M, V672M, V632M, V729M	Frontotemporal dementia	VCV000014252	17	44095995	17	46018629	14252	29291	rs63750570	NC_000017.11:46018628:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Nov 18, 2020	criteria provided, single submitter							
NM_001377265.1(MAPT):c.2201A>T (p.Glu734Val)	MAPT	E342V, E659V, E282V, E677V, E253V, E313V, E284V, E311V, E637V, E734V	Frontotemporal dementia	VCV000014258	17	44096011	17	46018645	14258	29297	rs63750711	NC_000017.11:46018644:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Dec 1, 2000	no assertion criteria provided							
NM_001377265.1(MAPT):c.2231C>T (p.Ser744Leu)	MAPT	S352L, S669L, S263L, S292L, S321L, S323L, S294L, S687L, S647L, S744L	Supranuclear palsy, progressive, 1	VCV000014267	17	44096041	17	46018675	14267	29306	rs63750425	NC_000017.11:46018674:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Nov 1, 2003	no assertion criteria provided							
NM_001377265.1(MAPT):c.2242T>A (p.Ser748Thr)	MAPT	S267T, S296T, S298T, S325T, S327T, S356T, S651T, S673T, S691T, S748T	not provided	VCV000986870	17	44096052	17	46018686	986870	975481	rs2076339915	NC_000017.11:46018685:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Oct 23, 2020	criteria provided, single submitter							
NM_001377265.1(MAPT):c.2260C>T (p.His754Tyr)	MAPT	H362Y, H679Y, H331Y, H697Y, H302Y, H304Y, H273Y, H333Y, H657Y, H754Y	Alzheimer disease	VCV000599620	17	44096070	17	46018704	599620	590965	rs1568339995	NC_000017.11:46018703:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Feb 1, 2017	criteria provided, single submitter							
NM_001377265.1(MAPT):c.2266C>T (p.Pro756Ser)	MAPT	P275S, P304S, P306S, P333S, P335S, P364S, P659S, P681S, P699S, P756S	Frontotemporal dementia	VCV002573094	17	44096076	17	46018710	2573094	2738036		NC_000017.11:46018709:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jun 27, 2023	criteria provided, single submitter							
NM_001377265.1(MAPT):c.2266C>A (p.Pro756Thr)	MAPT	P304T, P306T, P335T, P275T, P681T, P699T, P333T, P364T, P659T, P756T	Frontotemporal dementia	VCV000807628	17	44096076	17	46018710	807628	798717	rs1598408336	NC_000017.11:46018709:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Mar 2, 2018	criteria provided, single submitter							
NM_001377265.1(MAPT):c.2282A>T (p.Lys761Ile)	MAPT	K369I, K686I, K309I, K280I, K311I, K338I, K340I, K704I, K664I, K761I	Pick disease	VCV000014260	17	44096092	17	46018726	14260	29299	rs63751264	NC_000017.11:46018725:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Oct 1, 2001	no assertion criteria provided							
NM_001377265.1(MAPT):c.2341G>A (p.Gly781Arg)	MAPT	G389R, G706R, G358R, G360R, G300R, G329R, G331R, G724R, G684R, G781R	not provided|Frontotemporal dementia	VCV000014255	17	44101376	17	46024010	14255	29294	rs63750512	NC_000017.11:46024009:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Apr 16, 2021	criteria provided, multiple submitters, no conflicts							
NM_001377265.1(MAPT):c.2392C>T (p.Arg798Trp)	MAPT	R406W, R723W, R375W, R317W, R346W, R741W, R348W, R377W, R701W, R798W	Frontotemporal dementia|Progressive supranuclear palsy-parkinsonism syndrome|not provided|Supranuclear palsy, progressive, 1|Frontotemporal dementia|Pick disease|Parkinson disease, late-onset|Progressive supranuclear palsy-parkinsonism syndrome	VCV000014247	17	44101427	17	46024061	14247	29286	rs63750424	NC_000017.11:46024060:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_005324.5(H3-3B):c.377A>G (p.Gln126Arg)	H3-3B	Q126R	H3-3B-related disorder|Bryant-Li-Bhoj neurodevelopmental syndrome 2	VCV001339275	17	73774710	17	75778629	1339275	1330326	rs2143629984	NC_000017.11:75778628:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_005324.5(H3-3B):c.376C>A (p.Gln126Lys)	H3-3B	Q126K	Bryant-Li-Bhoj neurodevelopmental syndrome 2	VCV002573076	17	73774711	17	75778630	2573076	2738018		NC_000017.11:75778629:G:T	single nucleotide variant	missense variant	Likely pathogenic	May 22, 2023	criteria provided, single submitter							
NM_005324.5(H3-3B):c.365C>G (p.Pro122Arg)	H3-3B	P122R	Bryant-Li-Bhoj neurodevelopmental syndrome 2	VCV001339274	17	73774722	17	75778641	1339274	1330325	rs2143629995	NC_000017.11:75778640:G:C	single nucleotide variant	missense variant	Pathogenic	Feb 2, 2022	no assertion criteria provided							
NM_005324.5(H3-3B):c.155T>A (p.Ile52Asn)	H3-3B	I52N	Bryant-Li-Bhoj neurodevelopmental syndrome 2|Intellectual disability|Brain imaging abnormality|Delayed speech and language development|Short stature|Global developmental delay	VCV001183984	17	73775018	17	75778937	1183984	1173685	rs2143630846	NC_000017.11:75778936:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 2, 2022	no assertion criteria provided							
NM_005324.5(H3-3B):c.103G>A (p.Gly35Arg)	H3-3B	G35R	not provided|Neurodevelopmental disorder	VCV001678706	17	73775153	17	75779072	1678706	1670500	rs2143631260	NC_000017.11:75779071:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_005324.5(H3-3B):c.98C>T (p.Thr33Ile)	H3-3B	T33I	not provided	VCV002571003	17	73775158	17	75779077	2571003	2735960		NC_000017.11:75779076:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 1, 2023	criteria provided, single submitter							
NM_005324.5(H3-3B):c.91C>T (p.Pro31Ser)	H3-3B	P31S	Bryant-Li-Bhoj neurodevelopmental syndrome 2	VCV003376158	17	73775165	17	75779084	3376158	3535339		NC_000017.11:75779083:G:A	single nucleotide variant	missense variant	Likely pathogenic	Oct 16, 2024	criteria provided, single submitter							
NM_005324.5(H3-3B):c.88G>C (p.Ala30Pro)	H3-3B	A30P	Bryant-Li-Bhoj neurodevelopmental syndrome 2	VCV001339273	17	73775168	17	75779087	1339273	1330324	rs2143631293	NC_000017.11:75779086:C:G	single nucleotide variant	missense variant	Pathogenic	Feb 2, 2022	no assertion criteria provided							
NM_005324.5(H3-3B):c.68C>G (p.Thr23Arg)	H3-3B	T23R	Bryant-Li-Bhoj neurodevelopmental syndrome 2	VCV001697246	17	73775188	17	75779107	1697246	1689641	rs2143631320	NC_000017.11:75779106:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 31, 2023	criteria provided, single submitter							
NM_005324.5(H3-3B):c.68C>A (p.Thr23Lys)	H3-3B	T23K	Intellectual disability|Brain imaging abnormality|Delayed speech and language development|Short stature|Global developmental delay	VCV001183983	17	73775188	17	75779107	1183983	1173686	rs2143631320	NC_000017.11:75779106:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jul 15, 2021	no assertion criteria provided							
NM_005324.5(H3-3B):c.52C>T (p.Arg18Cys)	H3-3B	R18C	Bryant-Li-Bhoj neurodevelopmental syndrome 2	VCV002682274	17	73775204	17	75779123	2682274	2843305		NC_000017.11:75779122:G:A	single nucleotide variant	missense variant	Likely pathogenic	Nov 27, 2023	criteria provided, single submitter							
NM_005324.5(H3-3B):c.37G>A (p.Gly13Ser)	H3-3B	G13S	not provided	VCV001682569	17	73775219	17	75779138	1682569	1674469	rs11547391	NC_000017.11:75779137:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jul 6, 2021	criteria provided, single submitter							
NM_005324.5(H3-3B):c.35C>T (p.Thr12Ile)	H3-3B	T12I	Bryant-Li-Bhoj neurodevelopmental syndrome 2	VCV001708061	17	73775221	17	75779140	1708061	1706358		NC_000017.11:75779139:G:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 1, 2022	criteria provided, single submitter							
NM_005324.5(H3-3B):c.31T>C (p.Ser11Pro)	H3-3B	S11P	not provided	VCV001696881	17	73775225	17	75779144	1696881	1689277	rs2143631409	NC_000017.11:75779143:A:G	single nucleotide variant	missense variant	Pathogenic	Jul 15, 2022	criteria provided, single submitter							
NM_005324.5(H3-3B):c.28A>G (p.Lys10Glu)	H3-3B	K10E	Intellectual disability|Brain imaging abnormality|Delayed speech and language development|Short stature|Global developmental delay	VCV001183982	17	73775228	17	75779147	1183982	1173687	rs2143631415	NC_000017.11:75779146:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jul 15, 2021	no assertion criteria provided							
NM_005324.5(H3-3B):c.11C>T (p.Thr4Ile)	H3-3B	T4I	Bryant-Li-Bhoj neurodevelopmental syndrome 2	VCV003374710	17	73775245	17	75779164	3374710	3533899		NC_000017.11:75779163:G:A	single nucleotide variant	missense variant	Likely pathogenic	Nov 6, 2024	criteria provided, single submitter							
NM_014740.4(EIF4A3):c.809A>G (p.Asp270Gly)	EIF4A3	D270G	Richieri Costa-Pereira syndrome	VCV000101503	17	78111999	17	80138200	101503	107249	rs587777204	NC_000017.11:80138199:T:C	single nucleotide variant	missense variant	Pathogenic	Jan 2, 2014	no assertion criteria provided							
NM_001961.4(EEF2):c.2314G>A (p.Glu772Lys)	EEF2	E772K	Spinocerebellar ataxia type 26	VCV001696864	19	3977282	19	3977284	1696864	1689260	rs2145355764	NC_000019.10:3977283:C:T	single nucleotide variant	missense variant	Likely pathogenic	May 25, 2022	no assertion criteria provided							
NM_001961.4(EEF2):c.1787C>A (p.Pro596His)	EEF2	P596H	not provided	VCV000066077	19	3978097	19	3978099	66077	76979	rs587777052	NC_000019.10:3978098:G:T	single nucleotide variant	missense variant	Pathogenic	Dec 6, 2019	criteria provided, single submitter							
NM_004924.6(ACTN4):c.175T>C (p.Trp59Arg)	ACTN4	W59R	Focal segmental glomerulosclerosis 1	VCV001028308	19	39191252	19	38700612	1028308	1018563	rs1968240092	NC_000019.10:38700611:T:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 20, 2020	criteria provided, single submitter							
NM_004924.6(ACTN4):c.236G>A (p.Arg79Gln)	ACTN4	R79Q	Focal segmental glomerulosclerosis 1	VCV000829975	19	39191313	19	38700673	829975	818337	rs759055242	NC_000019.10:38700672:G:A	single nucleotide variant	missense variant	Likely pathogenic	Nov 17, 2019	no assertion criteria provided							
NM_004924.6(ACTN4):c.458T>C (p.Phe153Ser)	ACTN4	F153S	Focal segmental glomerulosclerosis 1	VCV000599130	19	39195634	19	38704994	599130	590330	rs1568723797	NC_000019.10:38704993:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 17, 2018	no assertion criteria provided							
NM_004924.6(ACTN4):c.493G>A (p.Ala165Thr)	ACTN4	A165T	Focal segmental glomerulosclerosis 1	VCV002572429	19	39196692	19	38706052	2572429	2737375		NC_000019.10:38706051:G:A	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_004924.6(ACTN4):c.506T>G (p.Leu169Arg)	ACTN4	L169R	ACTN4-related disorder	VCV003061635	19	39196705	19	38706065	3061635	3218241		NC_000019.10:38706064:T:G	single nucleotide variant	missense variant	Likely pathogenic	Dec 29, 2023	no assertion criteria provided							
NM_004924.6(ACTN4):c.517T>C (p.Cys173Arg)	ACTN4	C173R	Focal segmental glomerulosclerosis 1	VCV003068392	19	39196716	19	38706076	3068392	3227726		NC_000019.10:38706075:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 30, 2024	criteria provided, single submitter							
NM_004924.6(ACTN4):c.584G>T (p.Gly195Val)	ACTN4	G195V	Focal segmental glomerulosclerosis 1	VCV002500724	19	39198768	19	38708128	2500724	2523622		NC_000019.10:38708127:G:T	single nucleotide variant	missense variant	Pathogenic	Feb 2, 2022	criteria provided, single submitter							
NM_004924.6(ACTN4):c.584G>A (p.Gly195Asp)	ACTN4	G195D	Focal segmental glomerulosclerosis 1	VCV000235864	19	39198768	19	38708128	235864	237519	rs878853159	NC_000019.10:38708127:G:A	single nucleotide variant	missense variant	Pathogenic	Feb 8, 2017	no assertion criteria provided							
NM_004924.6(ACTN4):c.608A>C (p.His203Pro)	ACTN4	H203P	ACTN4-related disorder	VCV003035302	19	39198792	19	38708152	3035302	3202517		NC_000019.10:38708151:A:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 5, 2024	no assertion criteria provided							
NM_004924.6(ACTN4):c.718A>G (p.Met240Val)	ACTN4	M240V	Focal segmental glomerulosclerosis 1	VCV003236342	19	39200101	19	38709461	3236342	3395462		NC_000019.10:38709460:A:G	single nucleotide variant	missense variant	Likely pathogenic	Feb 23, 2024	criteria provided, single submitter							
NM_004924.6(ACTN4):c.763A>G (p.Lys255Glu)	ACTN4	K255E	Focal segmental glomerulosclerosis 1|not provided	VCV000005420	19	39200926	19	38710286	5420	20459	rs121908415	NC_000019.10:38710285:A:G	single nucleotide variant	missense variant|intron variant	Pathogenic	Mar 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004924.6(ACTN4):c.776C>T (p.Thr259Ile)	ACTN4	T259I	not provided	VCV000005421	19	39200939	19	38710299	5421	20460	rs121908416	NC_000019.10:38710298:C:T	single nucleotide variant	missense variant|intron variant	Pathogenic	Jan 21, 2019	criteria provided, single submitter							
NM_004924.6(ACTN4):c.784T>C (p.Ser262Pro)	ACTN4	S262P	Focal segmental glomerulosclerosis 1	VCV000005422	19	39200947	19	38710307	5422	20461	rs121908417	NC_000019.10:38710306:T:C	single nucleotide variant	missense variant|intron variant	Pathogenic	Mar 1, 2000	no assertion criteria provided							
NM_014225.6(PPP2R1A):c.96C>G (p.Ile32Met)	PPP2R1A	I32M	Houge-Janssens syndrome 2	VCV002498148	19	52705214	19	52201961	2498148	2473227		NC_000019.10:52201960:C:G	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant	Likely pathogenic	Nov 7, 2022	no assertion criteria provided							
NM_014225.6(PPP2R1A):c.400C>T (p.Arg134Trp)	PPP2R1A	R134W	Houge-Janssens syndrome 2|Neoplasm	VCV003236825	19	52714642	19	52211389	3236825	3395945		NC_000019.10:52211388:C:T	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant	Likely pathogenic	May 2, 2024	criteria provided, single submitter				Uncertain significance	Mar 4, 2025	criteria provided, single submitter	
NM_014225.6(PPP2R1A):c.522C>G (p.Cys174Trp)	PPP2R1A	C174W	Neurodevelopmental disorder	VCV001064777	19	52715957	19	52212704	1064777	1053138	rs2122334423	NC_000019.10:52212703:C:G	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant	Likely pathogenic	Mar 9, 2021	criteria provided, single submitter							
NM_014225.6(PPP2R1A):c.532A>G (p.Thr178Ala)	PPP2R1A	T178A	Houge-Janssens syndrome 2	VCV002430276	19	52715967	19	52212714	2430276	2403784		NC_000019.10:52212713:A:G	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant	Likely pathogenic	Jan 23, 2023	criteria provided, single submitter							
NM_014225.6(PPP2R1A):c.536C>A (p.Pro179His)	PPP2R1A	P179H	not provided|Houge-Janssens syndrome 2	VCV001699184	19	52715971	19	52212718	1699184	1691558	rs786205228	NC_000019.10:52212717:C:A	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_014225.6(PPP2R1A):c.536C>T (p.Pro179Leu)	PPP2R1A	P179L	not provided|PPP2R1A-related neurodevelopmental disorders|Inborn genetic diseases	VCV000190313	19	52715971	19	52212718	190313	188142	rs786205228	NC_000019.10:52212717:C:T	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant	Pathogenic	Nov 30, 2021	criteria provided, multiple submitters, no conflicts							
NM_014225.6(PPP2R1A):c.538A>G (p.Met180Val)	PPP2R1A	M180V, M1V	not provided|Houge-Janssens syndrome 2	VCV001204633	19	52715973	19	52212720	1204633	1195463	rs2122334663	NC_000019.10:52212719:A:G	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Pathogenic	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_014225.6(PPP2R1A):c.539T>G (p.Met180Arg)	PPP2R1A	M180R, M1R	See cases	VCV001098340	19	52715974	19	52212721	1098340	1087098	rs1600167941	NC_000019.10:52212720:T:G	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Likely pathogenic	Apr 26, 2021	criteria provided, single submitter							
NM_014225.6(PPP2R1A):c.539T>C (p.Met180Thr)	PPP2R1A	M180T, M1T	Houge-Janssens syndrome 2|not provided	VCV000684494	19	52715974	19	52212721	684494	672113	rs1600167941	NC_000019.10:52212720:T:C	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Pathogenic	Mar 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_014225.6(PPP2R1A):c.544C>T (p.Arg182Trp)	PPP2R1A	R182W, R3W	not provided|Houge-Janssens syndrome 2|Inborn genetic diseases	VCV000190312	19	52715979	19	52212726	190312	188141	rs786205227	NC_000019.10:52212725:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_014225.6(PPP2R1A):c.545G>A (p.Arg182Gln)	PPP2R1A	R3Q, R182Q	not provided	VCV003649140	19	52715980	19	52212727	3649140	3781149		NC_000019.10:52212726:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Oct 22, 2024	criteria provided, single submitter							
NM_014225.6(PPP2R1A):c.547C>T (p.Arg183Trp)	PPP2R1A	R183W, R4W	Houge-Janssens syndrome 2|not provided	VCV000376505	19	52715982	19	52212729	376505	363384	rs1057519946	NC_000019.10:52212728:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Aug 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_014225.6(PPP2R1A):c.548G>C (p.Arg183Pro)	PPP2R1A	R183P, R4P	Inborn genetic diseases	VCV000985103	19	52715983	19	52212730	985103	974179	rs1057519947	NC_000019.10:52212729:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Nov 28, 2017	criteria provided, single submitter							
NM_014225.6(PPP2R1A):c.548G>A (p.Arg183Gln)	PPP2R1A	R183Q, R4Q	not provided|Houge-Janssens syndrome 2	VCV000376506	19	52715983	19	52212730	376506	363385	rs1057519947	NC_000019.10:52212729:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_014225.6(PPP2R1A):c.656C>T (p.Ser219Leu)	PPP2R1A	S219L, S40L	Inborn genetic diseases|Houge-Janssens syndrome 2|not provided	VCV000521503	19	52716212	19	52212959	521503	512433	rs1555791268	NC_000019.10:52212958:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_014225.6(PPP2R1A):c.658G>A (p.Val220Met)	PPP2R1A	V220M, V41M	not provided	VCV001297557	19	52716214	19	52212961	1297557	1287346	rs2122337413	NC_000019.10:52212960:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Oct 2, 2023	criteria provided, single submitter							
NM_014225.6(PPP2R1A):c.773G>A (p.Arg258His)	PPP2R1A	R258H, R79H	Houge-Janssens syndrome 2|not provided|HP:0000252 (present)|HP:0000664 (present)|HP:0000729 (present)|HP:0000733 (present)|HP:0000758 (present)|HP:0001156 (present)|HP:0001290 (present)|HP:0001999 (present)|HP:0012736 (present)	VCV000217458	19	52716329	19	52213076	217458	214099	rs863225094	NC_000019.10:52213075:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jan 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_014225.6(PPP2R1A):c.1493G>T (p.Arg498Leu)	PPP2R1A	R319L, R498L	Houge-Janssens syndrome 2	VCV002504581	19	52724361	19	52221108	2504581	2669538		NC_000019.10:52221107:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jan 18, 2023	criteria provided, single submitter							
NM_003286.4(TOP1):c.1252G>A (p.Glu418Lys)	PLCG1-AS1|TOP1	E418K	DNA topoisomerase I, camptothecin-resistant	VCV000016774	20	39729937	20	41101297	16774	31813	rs121434562	NC_000020.11:41101296:G:A	single nucleotide variant	missense variant	Pathogenic	Jul 1, 2002	no assertion criteria provided							
NM_003286.2(TOP1):c.[1598A>G;1748G=]	PLCG1-AS1|TOP1	D533G	DNA topoisomerase I, camptothecin-resistant	VCV000016773	20|20	39744958	20|20	41116318	16773	38482|31812	rs267607132|rs267607131	NC_000020.11:41116317:G:G|NC_000020.11:41114114:A:G	Haplotype	no sequence alteration|missense variant	Pathogenic	Jan 11, 1991	no assertion criteria provided							
NM_000484.4(APP):c.2155A>C (p.Thr719Pro)	APP	T588P, T609P, T626P, T644P, T663P, T682P, T695P, T700P, T701P, T719P	Alzheimer disease type 1	VCV001342870	21	27264090	21	25891778	1342870	1334507	rs2146237857	NC_000021.9:25891777:T:G	single nucleotide variant	missense variant	Likely pathogenic	Oct 27, 2021	criteria provided, single submitter							
NM_000484.4(APP):c.2150T>G (p.Val717Gly)	APP	V717G, V607G, V699G, V586G, V624G, V642G, V661G, V680G, V693G, V698G	not provided	VCV000018090	21	27264095	21	25891783	18090	33129	rs63749964	NC_000021.9:25891782:A:C	single nucleotide variant	missense variant	Pathogenic	Oct 27, 2021	criteria provided, single submitter							
NM_000484.4(APP):c.2149G>C (p.Val717Leu)	APP	V717L, V680L, V607L, V642L, V661L, V586L, V624L, V693L, V698L, V699L	not provided	VCV000018105	21	27264096	21	25891784	18105	33144	rs63750264	NC_000021.9:25891783:C:G	single nucleotide variant	missense variant	Pathogenic	Jul 27, 2020	criteria provided, single submitter							
NM_000484.4(APP):c.2149G>T (p.Val717Phe)	APP	V717F, V624F, V661F, V693F, V586F, V607F, V642F, V680F, V698F, V699F	not provided|Alzheimer disease type 1|Alzheimer disease	VCV000018089	21	27264096	21	25891784	18089	33128	rs63750264	NC_000021.9:25891783:C:A	single nucleotide variant	missense variant	Pathogenic	Jul 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000484.4(APP):c.2149G>A (p.Val717Ile)	APP	V717I, V607I, V624I, V661I, V642I, V680I, V693I, V698I, V699I, V586I	not provided|Cerebral amyloid angiopathy, APP-related|Alzheimer disease type 1|Cerebral amyloid angiopathy, APP-related|Alzheimer disease type 1|Alzheimer disease	VCV000018088	21	27264096	21	25891784	18088	33127	rs63750264	NC_000021.9:25891783:C:T	single nucleotide variant	missense variant	Pathogenic	Nov 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000484.4(APP):c.2148C>G (p.Ile716Met)	APP	I585M, I606M, I623M, I641M, I660M, I679M, I692M, I697M, I698M, I716M	not provided	VCV001298879	21	27264097	21	25891785	1298879	1288741	rs145564988	NC_000021.9:25891784:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jul 1, 2021	criteria provided, single submitter							
NM_000484.4(APP):c.2147T>C (p.Ile716Thr)	APP	I716T, I623T, I585T, I660T, I641T, I692T, I697T, I698T, I606T, I679T	Alzheimer disease	VCV000098240	21	27264098	21	25891786	98240	104132	rs63750851	NC_000021.9:25891785:A:G	single nucleotide variant	missense variant	Pathogenic	Nov 27, 2022	criteria provided, single submitter							
NM_000484.4(APP):c.2146A>T (p.Ile716Phe)	APP	I585F, I606F, I623F, I641F, I660F, I679F, I692F, I697F, I698F, I716F	Alzheimer disease|not provided	VCV002498894	21	27264099	21	25891787	2498894	2476871		NC_000021.9:25891786:T:A	single nucleotide variant	missense variant	Pathogenic	May 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000484.4(APP):c.2145_2146delinsTG (p.Ile716Val)	APP	I606V, I692V, I697V, I698V, I585V, I660V, I641V, I679V, I623V, I716V	not provided|Alzheimer disease	VCV001457308	21	27264099 - 27264100	21	25891787 - 25891788	1457308	1478043	rs2146237965	NC_000021.9:25891786:TC:CA	Indel	missense variant	Pathogenic	Dec 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000484.4(APP):c.2146A>G (p.Ile716Val)	APP	I716V, I585V, I641V, I698V, I697V, I606V, I623V, I660V, I679V, I692V	not provided	VCV000018096	21	27264099	21	25891787	18096	33135	rs63750399	NC_000021.9:25891786:T:C	single nucleotide variant	missense variant	Pathogenic	Feb 1, 2020	criteria provided, single submitter							
NM_000484.4(APP):c.2144T>C (p.Val715Ala)	APP	V715A, V622A, V659A, V678A, V697A, V584A, V605A, V691A, V696A, V640A	APP-related disorder	VCV000098238	21	27264101	21	25891789	98238	104130	rs63750868	NC_000021.9:25891788:A:G	single nucleotide variant	missense variant	Pathogenic	Apr 9, 2024	no assertion criteria provided							
NM_000484.4(APP):c.2143G>A (p.Val715Met)	APP	V715M, V622M, V640M, V678M, V584M, V691M, V697M, V605M, V659M, V696M	Alzheimer disease|not provided|Alzheimer disease type 1	VCV000018097	21	27264102	21	25891790	18097	33136	rs63750734	NC_000021.9:25891789:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000484.4(APP):c.2141C>T (p.Thr714Ile)	APP	T714I, T677I, T690I, T604I, T639I, T658I, T621I, T695I, T696I, T583I	Alzheimer disease	VCV000018100	21	27264104	21	25891792	18100	33139	rs63750973	NC_000021.9:25891791:G:A	single nucleotide variant	missense variant	Pathogenic	Apr 25, 2024	criteria provided, single submitter							
NM_000484.4(APP):c.2140A>G (p.Thr714Ala)	APP	T714A, T604A, T639A, T658A, T583A, T696A, T677A, T690A, T621A, T695A	Alzheimer disease|Alzheimer disease type 1	VCV000018102	21	27264105	21	25891793	18102	33141	rs63750643	NC_000021.9:25891792:T:C	single nucleotide variant	missense variant	Pathogenic	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_000484.4(APP):c.2138C>A (p.Ala713Glu)	APP	A582E, A620E, A603E, A638E, A689E, A694E, A713E, A657E, A676E, A695E	Alzheimer disease	VCV003690355	21	27264107	21	25891795	3690355	3820653		NC_000021.9:25891794:G:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 6, 2024	criteria provided, single submitter							
NM_000484.4(APP):c.2137G>A (p.Ala713Thr)	APP	A713T, A620T, A657T, A676T, A694T, A582T, A603T, A638T, A689T, A695T	Cerebral amyloid angiopathy, APP-related|Alzheimer disease|not provided|Primary degenerative dementia of the Alzheimer type, presenile onset	VCV000018094	21	27264108	21	25891796	18094	33133	rs63750066	NC_000021.9:25891795:C:T	single nucleotide variant	missense variant	Likely pathogenic	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000484.4(APP):c.2113C>G (p.Leu705Val)	APP	L705V, L595V, L686V, L687V, L574V, L612V, L630V, L668V, L681V, L649V	Cerebral amyloid angiopathy, APP-related	VCV000018103	21	27264132	21	25891820	18103	33142	rs63750921	NC_000021.9:25891819:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 24, 2024	criteria provided, single submitter							
NM_000484.4(APP):c.2080G>A (p.Asp694Asn)	APP	D563N, D584N, D601N, D619N, D638N, D657N, D670N, D675N, D676N, D694N	not provided|Alzheimer disease	VCV000018101	21	27264165	21	25891853	18101	33140	rs63749810	NC_000021.9:25891852:C:T	single nucleotide variant	missense variant	Pathogenic	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000484.4(APP):c.2078A>G (p.Glu693Gly)	APP	E693G, E562G, E669G, E618G, E583G, E637G, E656G, E600G, E674G, E675G	ABeta amyloidosis, Arctic type|Alzheimer disease type 1	VCV000018098	21	27264167	21	25891855	18098	33137	rs63751039	NC_000021.9:25891854:T:C	single nucleotide variant	missense variant	Pathogenic	Apr 1, 2008	no assertion criteria provided							
NM_000484.4(APP):c.2077G>A (p.Glu693Lys)	APP	E693K, E583K, E600K, E656K, E637K, E669K, E674K, E675K, E562K, E618K	ABeta amyloidosis, Italian type	VCV000018099	21	27264168	21	25891856	18099	33138	rs63750579	NC_000021.9:25891855:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 1, 2010	no assertion criteria provided							
NM_000484.4(APP):c.2077G>C (p.Glu693Gln)	APP	E693Q, E618Q, E637Q, E656Q, E562Q, E583Q, E669Q, E600Q, E674Q, E675Q	Cerebral amyloid angiopathy, APP-related|Alzheimer disease	VCV000018087	21	27264168	21	25891856	18087	33126	rs63750579	NC_000021.9:25891855:C:G	single nucleotide variant	missense variant	Pathogenic	Feb 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_000484.4(APP):c.2075C>G (p.Ala692Gly)	APP	A692G, A655G, A561G, A582G, A617G, A636G, A599G, A668G, A673G, A674G	ABetaA21G amyloidosis|Alzheimer disease type 1	VCV000018091	21	27264170	21	25891858	18091	33130	rs63750671	NC_000021.9:25891857:G:C	single nucleotide variant	missense variant	Pathogenic	May 1, 2001	no assertion criteria provided							
NM_000484.4(APP):c.2061A>C (p.Lys687Asn)	APP	K556N, K577N, K594N, K612N, K631N, K650N, K663N, K668N, K669N, K687N	Cerebral amyloid angiopathy, APP-related|Alzheimer disease type 1	VCV002628367	21	27269888	21	25897576	2628367	2795875		NC_000021.9:25897575:T:G	single nucleotide variant	missense variant	Likely pathogenic	Nov 14, 2023	criteria provided, single submitter							
NM_000484.4(APP):c.2059A>C (p.Lys687Gln)	APP	K556Q, K577Q, K594Q, K612Q, K631Q, K650Q, K663Q, K668Q, K669Q, K687Q	Cerebral amyloid angiopathy, APP-related|Alzheimer disease type 1	VCV003382968	21	27269890	21	25897578	3382968	3542139		NC_000021.9:25897577:T:G	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_000484.4(APP):c.2032G>C (p.Asp678His)	APP	D678H, D568H, D585H, D659H, D622H, D641H, D603H, D654H, D660H, D547H	not provided	VCV000446855	21	27269917	21	25897605	446855	442308	rs63750064	NC_000021.9:25897604:C:G	single nucleotide variant	missense variant	Likely pathogenic	Apr 20, 2017	criteria provided, single submitter							
NM_000484.4(APP):c.2018C>T (p.Ala673Val)	APP	A673V, A654V, A542V, A598V, A580V, A617V, A655V, A563V, A636V, A649V	Alzheimer disease	VCV000018106	21	27269931	21	25897619	18106	33145	rs193922916	NC_000021.9:25897618:G:A	single nucleotide variant	missense variant	Pathogenic	Mar 13, 2009	no assertion criteria provided							
NM_000484.4(APP):c.2010_2011inv (p.Lys670_Met671delinsAsnLeu)	APP		Alzheimer disease|APP-related disorder	VCV000018093	21	27269938 - 27269939	21	25897626 - 25897627	18093	33132	rs281865161	NC_000021.9:25897625:TC:GA	Inversion	missense variant	Pathogenic	Jan 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.29G>C (p.Arg10Pro)	PDHA1	R10P	Pyruvate dehydrogenase E1-alpha deficiency	VCV000010887	X	19362184	X	19344066	10887	25926	rs137853257	NC_000023.11:19344065:G:C	single nucleotide variant	missense variant	Pathogenic	Oct 1, 1995	no assertion criteria provided							
NM_000284.4(PDHA1):c.214C>T (p.Arg72Cys)	PDHA1	R72C, R110C	Pyruvate dehydrogenase complex deficiency	VCV000214938	X	19368151	X	19350033	214938	212004	rs863224148	NC_000023.11:19350032:C:T	single nucleotide variant	missense variant	Likely pathogenic	Oct 25, 2021	reviewed by expert panel							
NM_000284.4(PDHA1):c.225G>T (p.Glu75Asp)	PDHA1	E75D, E113D	Pyruvate dehydrogenase complex deficiency	VCV000627558	X	19368162	X	19350044	627558	615914	rs1569190079	NC_000023.11:19350043:G:T	single nucleotide variant	missense variant	Pathogenic	Nov 28, 2018	criteria provided, single submitter							
NM_000284.4(PDHA1):c.260T>C (p.Ile87Thr)	PDHA1	I125T, I87T	Pyruvate dehydrogenase E1-alpha deficiency	VCV003062013	X	19368197	X	19350079	3062013	3222241		NC_000023.11:19350078:T:C	single nucleotide variant	missense variant	Likely pathogenic	Mar 15, 2024	criteria provided, single submitter							
NM_000284.4(PDHA1):c.262C>T (p.Arg88Cys)	PDHA1	R126C, R88C	not provided|Pyruvate dehydrogenase E1-alpha deficiency	VCV002662437	X	19368199	X	19350081	2662437	2829888		NC_000023.11:19350080:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.313G>A (p.Glu105Lys)	PDHA1	E105K, E112K, E143K	not provided	VCV003337447	X	19369420	X	19351302	3337447	3496109		NC_000023.11:19351301:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 15, 2023	criteria provided, single submitter							
NM_000284.4(PDHA1):c.355C>T (p.Arg119Trp)	PDHA1	R119W, R126W, R157W	not provided|Pyruvate dehydrogenase E1-alpha deficiency	VCV001320219	X	19369462	X	19351344	1320219	1310464	rs2147176072	NC_000023.11:19351343:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.364G>A (p.Gly122Ser)	PDHA1	G122S, G160S, G129S	not provided	VCV000431915	X	19369471	X	19351353	431915	426445	rs1555933643	NC_000023.11:19351352:G:A	single nucleotide variant	missense variant	Likely pathogenic	Oct 15, 2015	criteria provided, single submitter							
NM_000284.4(PDHA1):c.379C>T (p.Arg127Trp)	PDHA1	R127W, R134W, R165W	Pyruvate dehydrogenase E1-alpha deficiency|not provided	VCV000214940	X	19369486	X	19351368	214940	212006	rs199959402	NC_000023.11:19351367:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.380G>A (p.Arg127Gln)	PDHA1	R127Q, R134Q, R165Q	Pyruvate dehydrogenase E1-alpha deficiency|not provided	VCV000871395	X	19369487	X	19351369	871395	860825	rs2063162114	NC_000023.11:19351368:G:A	single nucleotide variant	missense variant	Pathogenic	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.383G>A (p.Gly128Asp)	PDHA1	G135D, G166D, G128D	Pyruvate dehydrogenase E1-alpha deficiency	VCV002737098	X	19369490	X	19351372	2737098	2901795		NC_000023.11:19351371:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jan 2, 2024	criteria provided, single submitter							
NM_000284.4(PDHA1):c.409G>A (p.Glu137Lys)	PDHA1	E137K, E144K, E175K	not provided	VCV000432213	X	19369516	X	19351398	432213	426446	rs1555933663	NC_000023.11:19351397:G:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 16, 2016	criteria provided, single submitter							
NM_000284.4(PDHA1):c.422G>A (p.Arg141Gln)	PDHA1	R141Q, R148Q, R179Q	not provided|Pyruvate dehydrogenase E1-alpha deficiency	VCV000202188	X	19371203	X	19353085	202188	198647	rs794729213	NC_000023.11:19353084:G:A	single nucleotide variant	missense variant	Pathogenic	Jul 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.455C>T (p.Ser152Leu)	PDHA1	S152L, S159L, S190L	Pyruvate dehydrogenase E1-alpha deficiency	VCV000488568	X	19371236	X	19353118	488568	481436	rs1555933954	NC_000023.11:19353117:C:T	single nucleotide variant	missense variant	Likely pathogenic	Dec 7, 2017	criteria provided, single submitter							
NM_000284.4(PDHA1):c.461A>G (p.His154Arg)	PDHA1	H154R, H192R, H161R	Pyruvate dehydrogenase E1-alpha deficiency	VCV000430806	X	19371242	X	19353124	430806	424351	rs1131692230	NC_000023.11:19353123:A:G	single nucleotide variant	missense variant	Likely pathogenic	Jan 12, 2017	criteria provided, single submitter							
NM_000284.4(PDHA1):c.465G>T (p.Met155Ile)	PDHA1	M155I, M162I, M193I	Pyruvate dehydrogenase E1-alpha deficiency	VCV002584338	X	19371246	X	19353128	2584338	2751904		NC_000023.11:19353127:G:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 8, 2023	criteria provided, single submitter							
NM_000284.4(PDHA1):c.476A>T (p.Asn159Ile)	PDHA1	N159I, N166I, N197I	not provided	VCV003257428	X	19371257	X	19353139	3257428	3416182		NC_000023.11:19353138:A:T	single nucleotide variant	missense variant	Likely pathogenic	Jul 1, 2024	criteria provided, single submitter							
NM_000284.4(PDHA1):c.482A>G (p.Tyr161Cys)	PDHA1	Y161C, Y199C, Y168C	not provided|Pyruvate dehydrogenase E1-alpha deficiency	VCV000560929	X	19371263	X	19353145	560929	552255	rs1569190962	NC_000023.11:19353144:A:G	single nucleotide variant	missense variant	Pathogenic	Jan 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.491A>G (p.Asn164Ser)	PDHA1	N164S, N202S, N171S	Pyruvate dehydrogenase E1-alpha deficiency|Pyruvate dehydrogenase complex deficiency|not provided	VCV000488569	X	19371272	X	19353154	488569	481437	rs1555933963	NC_000023.11:19353153:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.499G>A (p.Val167Met)	PDHA1	V167M, V174M, V205M	Neurodevelopmental delay|not provided|Inborn genetic diseases	VCV000985548	X	19371280	X	19353162	985548	974343	rs2063174067	NC_000023.11:19353161:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.506C>T (p.Ala169Val)	PDHA1	A169V, A207V, A176V	Pyruvate dehydrogenase complex deficiency	VCV000214941	X	19371287	X	19353169	214941	212009	rs863224150	NC_000023.11:19353168:C:T	single nucleotide variant	missense variant	Pathogenic	May 6, 2021	reviewed by expert panel							
NM_000284.4(PDHA1):c.511G>A (p.Val171Met)	PDHA1	V171M, V178M, V209M	Pyruvate dehydrogenase E1-alpha deficiency	VCV001806371	X	19372609	X	19354491	1806371	1863380		NC_000023.11:19354490:G:A	single nucleotide variant	missense variant|intron variant	Likely pathogenic	May 6, 2021	criteria provided, single submitter							
NM_000284.4(PDHA1):c.515C>T (p.Pro172Leu)	PDHA1	P179L, P172L, P210L	Pyruvate dehydrogenase E1-alpha deficiency	VCV002737100	X	19372613	X	19354495	2737100	2901797		NC_000023.11:19354494:C:T	single nucleotide variant	missense variant|intron variant	Pathogenic	Jun 17, 2024	criteria provided, single submitter							
NM_000284.4(PDHA1):c.518T>C (p.Leu173Pro)	PDHA1	L173P, L180P, L211P	Pyruvate dehydrogenase E1-alpha deficiency	VCV001804972	X	19372616	X	19354498	1804972	1861987		NC_000023.11:19354497:T:C	single nucleotide variant	missense variant|intron variant	Likely pathogenic	May 6, 2021	criteria provided, single submitter							
NM_000284.4(PDHA1):c.523G>A (p.Ala175Thr)	PDHA1	A175T, A213T, A182T	Pyruvate dehydrogenase E1-alpha deficiency	VCV000561078	X	19372621	X	19354503	561078	552256	rs1569191372	NC_000023.11:19354502:G:A	single nucleotide variant	missense variant|intron variant	Pathogenic	Jul 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.536T>G (p.Leu179Arg)	PDHA1	L179R, L217R, L186R	Pyruvate dehydrogenase E1-alpha deficiency	VCV000488570	X	19372634	X	19354516	488570	481438	rs1555934165	NC_000023.11:19354515:T:G	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Dec 7, 2017	criteria provided, single submitter							
NM_000284.4(PDHA1):c.613T>C (p.Phe205Leu)	PDHA1	F212L, F205L, F174L, F243L	Pyruvate dehydrogenase E1-alpha deficiency	VCV002795237	X	19373476	X	19355358	2795237	2951187		NC_000023.11:19355357:T:C	single nucleotide variant	missense variant	Pathogenic	May 23, 2023	criteria provided, single submitter							
NM_000284.4(PDHA1):c.615C>G (p.Phe205Leu)	PDHA1	F205L, F174L, F212L, F243L	Pyruvate dehydrogenase E1-alpha deficiency	VCV000010882	X	19373478	X	19355360	10882	25921	rs137853254	NC_000023.11:19355359:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 4, 2019	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.616G>A (p.Glu206Lys)	PDHA1	E175K, E206K, E213K, E244K	Pyruvate dehydrogenase E1-alpha deficiency	VCV002584444	X	19373479	X	19355361	2584444	2752007		NC_000023.11:19355360:G:A	single nucleotide variant	missense variant	Pathogenic		criteria provided, single submitter							
NM_000284.4(PDHA1):c.616G>C (p.Glu206Gln)	PDHA1	E206Q, E175Q, E213Q, E244Q	Inborn genetic diseases	VCV000521416	X	19373479	X	19355361	521416	512634	rs1555934336	NC_000023.11:19355360:G:C	single nucleotide variant	missense variant	Likely pathogenic	Dec 15, 2016	criteria provided, single submitter							
NM_000284.4(PDHA1):c.628A>G (p.Met210Val)	PDHA1	M210V, M179V, M217V, M248V	Pyruvate dehydrogenase E1-alpha deficiency	VCV000198412	X	19373491	X	19355373	198412	195573	rs794727843	NC_000023.11:19355372:A:G	single nucleotide variant	missense variant	Pathogenic	Jan 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.640T>G (p.Trp214Gly)	PDHA1	W183G, W214G, W221G, W252G	Pyruvate dehydrogenase E1-alpha deficiency	VCV001804022	X	19373503	X	19355385	1804022	1861047		NC_000023.11:19355384:T:G	single nucleotide variant	missense variant	Likely pathogenic	Apr 25, 2022	criteria provided, single submitter							
NM_000284.4(PDHA1):c.640T>C (p.Trp214Arg)	PDHA1	W214R, W221R, W252R, W183R	not provided	VCV000281060	X	19373503	X	19355385	281060	265297	rs886042089	NC_000023.11:19355384:T:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 5, 2015	criteria provided, single submitter							
NM_000284.4(PDHA1):c.642G>T (p.Trp214Cys)	PDHA1	W214C, W183C, W252C, W221C	Pyruvate dehydrogenase E1-alpha deficiency	VCV000807461	X	19373505	X	19355387	807461	798811	rs1569191659	NC_000023.11:19355386:G:T	single nucleotide variant	missense variant	Pathogenic	Aug 27, 2019	criteria provided, single submitter							
NM_000284.4(PDHA1):c.648A>C (p.Leu216Phe)	PDHA1	L216F, L185F, L223F, L254F	Pyruvate dehydrogenase E1-alpha deficiency	VCV000010893	X	19373511	X	19355393	10893	25932	rs121917898	NC_000023.11:19355392:A:C	single nucleotide variant	missense variant	Pathogenic	Oct 9, 2002	no assertion criteria provided							
NM_000284.4(PDHA1):c.650C>T (p.Pro217Leu)	PDHA1	P217L, P255L, P186L, P224L	not provided	VCV000430118	X	19373513	X	19355395	430118	422448	rs1131691792	NC_000023.11:19355394:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 12, 2018	criteria provided, single submitter							
NM_000284.4(PDHA1):c.653G>A (p.Cys218Tyr)	PDHA1	C187Y, C256Y, C225Y, C218Y	Pyruvate dehydrogenase E1-alpha deficiency	VCV002000808	X	19373516	X	19355398	2000808	2061312		NC_000023.11:19355397:G:A	single nucleotide variant	missense variant	Pathogenic	Nov 28, 2022	criteria provided, single submitter							
NM_000284.4(PDHA1):c.677G>A (p.Arg226His)	PDHA1	R195H, R226H, R233H, R264H	Pyruvate dehydrogenase complex deficiency	VCV003366665	X	19373540	X	19355422	3366665	3525869		NC_000023.11:19355421:G:A	single nucleotide variant	missense variant	Likely pathogenic	Aug 22, 2024	criteria provided, single submitter							
NM_000284.4(PDHA1):c.679T>C (p.Tyr227His)	PDHA1	Y196H, Y227H, Y234H, Y265H	Pyruvate dehydrogenase E1-alpha deficiency	VCV001285483	X	19373542	X	19355424	1285483	1275326	rs2147180839	NC_000023.11:19355423:T:C	single nucleotide variant	missense variant	Likely pathogenic	Dec 8, 2020	criteria provided, single submitter							
NM_000284.4(PDHA1):c.685A>T (p.Met229Leu)	PDHA1	M198L, M229L, M236L, M267L	Pyruvate dehydrogenase E1-alpha deficiency	VCV001324869	X	19373548	X	19355430	1324869	1315133	rs2147180851	NC_000023.11:19355429:A:T	single nucleotide variant	missense variant	Likely pathogenic	Oct 31, 2019	criteria provided, single submitter							
NM_000284.4(PDHA1):c.687G>C (p.Met229Ile)	PDHA1	M267I, M229I, M236I, M198I	Pyruvate dehydrogenase E1-alpha deficiency	VCV000860913	X	19373550	X	19355432	860913	849880	rs2063189233	NC_000023.11:19355431:G:C	single nucleotide variant	missense variant	Pathogenic	Dec 27, 2019	criteria provided, single submitter							
NM_000284.4(PDHA1):c.692C>G (p.Thr231Arg)	PDHA1	T231R, T238R, T269R, T200R	Pyruvate dehydrogenase E1-alpha deficiency	VCV000650357	X	19373555	X	19355437	650357	649924	rs1272572107	NC_000023.11:19355436:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 24, 2020	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.707C>A (p.Ala236Glu)	PDHA1	A236E, A243E, A205E, A274E	not provided	VCV000214933	X	19373570	X	19355452	214933	212011	rs863224145	NC_000023.11:19355451:C:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 8, 2014	criteria provided, single submitter							
NM_000284.4(PDHA1):c.727T>A (p.Tyr243Asn)	PDHA1	Y243N, Y281N, Y212N, Y250N	Pyruvate dehydrogenase E1-alpha deficiency	VCV000010883	X	19373590	X	19355472	10883	25922	rs137853255	NC_000023.11:19355471:T:A	single nucleotide variant	missense variant	Pathogenic	Aug 15, 2017	no assertion criteria provided							
NM_000284.4(PDHA1):c.728A>G (p.Tyr243Cys)	PDHA1	Y212C, Y243C, Y250C, Y281C	Pyruvate dehydrogenase E1-alpha deficiency	VCV001252070	X	19373591	X	19355473	1252070	1242018	rs2147180935	NC_000023.11:19355472:A:G	single nucleotide variant	missense variant	Pathogenic	Apr 29, 2021	no assertion criteria provided							
NM_000284.4(PDHA1):c.733A>G (p.Arg245Gly)	PDHA1	R214G, R245G, R252G, R283G	not provided	VCV003375522	X	19373596	X	19355478	3375522	3534703		NC_000023.11:19355477:A:G	single nucleotide variant	missense variant	Likely pathogenic	May 6, 2024	criteria provided, single submitter							
NM_000284.4(PDHA1):c.735A>C (p.Arg245Ser)	PDHA1	R245S, R283S, R252S, R214S	Inborn genetic diseases	VCV000521121	X	19373598	X	19355480	521121	512635	rs1555934376	NC_000023.11:19355479:A:C	single nucleotide variant	missense variant	Pathogenic	May 31, 2016	criteria provided, single submitter							
NM_000284.4(PDHA1):c.746T>G (p.Ile249Ser)	PDHA1	I249S, I256S, I287S, I218S	not provided	VCV000418402	X	19373609	X	19355491	418402	411238	rs1064793225	NC_000023.11:19355490:T:G	single nucleotide variant	missense variant	Likely pathogenic	May 17, 2013	criteria provided, single submitter							
NM_000284.4(PDHA1):c.748C>A (p.Pro250Thr)	PDHA1	P219T, P257T, P288T, P250T	Pyruvate dehydrogenase E1-alpha deficiency	VCV003598206	X	19373611	X	19355493	3598206	3729691		NC_000023.11:19355492:C:A	single nucleotide variant	missense variant	Likely pathogenic	May 23, 2024	criteria provided, single submitter							
NM_000284.4(PDHA1):c.749C>T (p.Pro250Leu)	PDHA1	P250L, P288L, P219L, P257L	Pyruvate dehydrogenase E1-alpha deficiency	VCV000637039	X	19373612	X	19355494	637039	624873	rs1602227679	NC_000023.11:19355493:C:T	single nucleotide variant	missense variant	Likely pathogenic	May 10, 2018	criteria provided, single submitter							
NM_000284.4(PDHA1):c.754C>G (p.Leu252Val)	PDHA1	L252V, L221V, L259V, L290V	not provided	VCV000432082	X	19373617	X	19355499	432082	426448	rs1555934383	NC_000023.11:19355498:C:G	single nucleotide variant	missense variant	Likely pathogenic	Feb 18, 2016	criteria provided, single submitter							
NM_000284.4(PDHA1):c.773A>C (p.Asp258Ala)	PDHA1	D258A, D265A, D227A, D296A	Pyruvate dehydrogenase E1-alpha deficiency	VCV000010881	X	19373817	X	19355699	10881	25920	rs137853253	NC_000023.11:19355698:A:C	single nucleotide variant	missense variant	Pathogenic	Jun 1, 1994	no assertion criteria provided							
NM_000284.4(PDHA1):c.787C>G (p.Arg263Gly)	PDHA1	R263G, R270G, R301G, R232G	Pyruvate dehydrogenase E1-alpha deficiency|not provided	VCV000010878	X	19373831	X	19355713	10878	25917	rs137853259	NC_000023.11:19355712:C:G	single nucleotide variant	missense variant	Pathogenic	Oct 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.788G>T (p.Arg263Leu)	PDHA1	R232L, R263L, R301L, R270L	Pyruvate dehydrogenase E1-alpha deficiency	VCV002754877	X	19373832	X	19355714	2754877	2909576		NC_000023.11:19355713:G:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 24, 2023	criteria provided, single submitter							
NM_000284.4(PDHA1):c.788G>A (p.Arg263Gln)	PDHA1	R232Q, R263Q, R270Q, R301Q	Pyruvate dehydrogenase E1-alpha deficiency	VCV002717338	X	19373832	X	19355714	2717338	2873163		NC_000023.11:19355713:G:A	single nucleotide variant	missense variant	Pathogenic	Jul 16, 2023	criteria provided, single submitter							
NM_000284.4(PDHA1):c.832G>A (p.Gly278Arg)	PDHA1	G278R, G285R, G316R, G247R	not provided|Pyruvate dehydrogenase E1-alpha deficiency	VCV000384555	X	19375770	X	19357652	384555	379181	rs1057521993	NC_000023.11:19357651:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 1, 2020	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.862C>T (p.Arg288Cys)	PDHA1	R257C, R295C, R288C, R326C	Pyruvate dehydrogenase E1-alpha deficiency	VCV000935969	X	19375800	X	19357682	935969	939521	rs2063213272	NC_000023.11:19357681:C:T	single nucleotide variant	missense variant	Pathogenic	Oct 25, 2019	criteria provided, single submitter							
NM_000284.4(PDHA1):c.863G>A (p.Arg288His)	PDHA1	R288H, R326H, R257H, R295H	Pyruvate dehydrogenase E1-alpha deficiency	VCV000010890	X	19375801	X	19357683	10890	25929	rs137853258	NC_000023.11:19357682:G:A	single nucleotide variant	missense variant	Pathogenic	Jul 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.868C>T (p.His290Tyr)	PDHA1	H259Y, H290Y, H297Y, H328Y	Pyruvate dehydrogenase E1-alpha deficiency	VCV001325820	X	19375806	X	19357688	1325820	1316081	rs2147184502	NC_000023.11:19357687:C:T	single nucleotide variant	missense variant	Likely pathogenic	Nov 4, 2021	criteria provided, single submitter							
NM_000284.4(PDHA1):c.904C>T (p.Arg302Cys)	PDHA1	R302C, R309C, R271C, R340C	PDHA1-related disorder|Inborn genetic diseases|Pyruvate dehydrogenase E1-alpha deficiency|not provided	VCV000010879	X	19377038	X	19358920	10879	25918	rs137853252	NC_000023.11:19358919:C:T	single nucleotide variant	missense variant	Pathogenic	Jul 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.905G>A (p.Arg302His)	PDHA1	R302H, R340H, R271H, R309H	not provided|Pyruvate dehydrogenase E1-alpha deficiency	VCV000419850	X	19377039	X	19358921	419850	411240	rs1064794149	NC_000023.11:19358920:G:A	single nucleotide variant	missense variant	Pathogenic	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.943G>A (p.Asp315Asn)	PDHA1	D315N, D284N, D322N, D353N	not provided	VCV000010884	X	19377077	X	19358959	10884	25923	rs137853256	NC_000023.11:19358958:G:A	single nucleotide variant	missense variant	Likely pathogenic	Oct 23, 2020	criteria provided, single submitter							
NM_000284.4(PDHA1):c.989C>G (p.Ala330Gly)	PDHA1	A330G, A299G, A337G, A368G	Pyruvate dehydrogenase E1-alpha deficiency	VCV002737101	X	19377123	X	19359005	2737101	2901798		NC_000023.11:19359004:C:G	single nucleotide variant	missense variant	Likely pathogenic	Dec 9, 2023	criteria provided, single submitter							
NM_000284.4(PDHA1):c.1025T>G (p.Val342Gly)	PDHA1	V342G, V311G, V380G, V349G	not provided	VCV000388168	X	19377623	X	19359505	388168	379183	rs1057523018	NC_000023.11:19359504:T:G	single nucleotide variant	missense variant	Likely pathogenic	Aug 2, 2016	criteria provided, single submitter							
NM_000284.4(PDHA1):c.1046C>T (p.Ala349Val)	PDHA1	A349V, A356V, A387V, A318V	not provided	VCV000430418	X	19377644	X	19359526	430418	422449	rs1131691952	NC_000023.11:19359525:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 8, 2017	criteria provided, single submitter							
NM_000284.4(PDHA1):c.1060A>C (p.Thr354Pro)	PDHA1	T323P, T392P, T354P, T361P	Pyruvate dehydrogenase E1-alpha deficiency	VCV000816884	X	19377658	X	19359540	816884	805128	rs1157736285	NC_000023.11:19359539:A:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 28, 2018	criteria provided, single submitter							
NM_000284.4(PDHA1):c.1072G>A (p.Glu358Lys)	PDHA1	E327K, E358K, E365K, E396K	not provided	VCV001695287	X	19377670	X	19359552	1695287	1687716	rs2147189180	NC_000023.11:19359551:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 1, 2022	criteria provided, single submitter							
NM_000284.4(PDHA1):c.1100A>T (p.His367Leu)	PDHA1	H336L, H374L, H405L	Pyruvate dehydrogenase E1-alpha deficiency	VCV000992815	X	19377698	X	19359580	992815	980752	rs1131691584	NC_000023.11:19359579:A:T	single nucleotide variant	missense variant	Pathogenic	Jan 13, 2021	no assertion criteria provided							
NM_000284.4(PDHA1):c.1100A>C (p.His367Pro)	PDHA1	H367P, H374P, H405P, H336P	not provided	VCV000429771	X	19377698	X	19359580	429771	422450	rs1131691584	NC_000023.11:19359579:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.1132C>T (p.Arg378Cys)	PDHA1	R378C, R347C, R385C, R416C	Pyruvate dehydrogenase complex deficiency	VCV000214936	X	19377730	X	19359612	214936	212019	rs863224147	NC_000023.11:19359611:C:T	single nucleotide variant	missense variant	Pathogenic	Oct 25, 2021	reviewed by expert panel							
NM_000284.4(PDHA1):c.1133G>A (p.Arg378His)	PDHA1	R378H, R416H, R347H, R385H	See cases|not provided|Inborn genetic diseases|Pyruvate dehydrogenase E1-alpha deficiency	VCV000010873	X	19377731	X	19359613	10873	25912	rs137853250	NC_000023.11:19359612:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000284.4(PDHA1):c.1136G>T (p.Gly379Val)	PDHA1	G348V, G379V, G386V, G417V	Pyruvate dehydrogenase E1-alpha deficiency	VCV001685395	X	19377734	X	19359616	1685395	1677413	rs2147189334	NC_000023.11:19359615:G:T	single nucleotide variant	missense variant	Likely pathogenic	May 4, 2022	criteria provided, single submitter							
NM_001110556.2(FLNA):c.7930G>C (p.Val2644Leu)	FLNA|LOC107988032	V2636L, V2644L	Oto-palato-digital syndrome, type II|Heterotopia, periventricular, X-linked dominant|Frontometaphyseal dysplasia|Melnick-Needles syndrome	VCV002942370	X	153577231	X	154348863	2942370	3100836		NC_000023.11:154348862:C:G	single nucleotide variant	missense variant	Likely pathogenic	Mar 7, 2023	criteria provided, single submitter							
NM_001110556.2(FLNA):c.7732T>C (p.Phe2578Leu)	FLNA|LOC107988032	F2570L, F2578L	Frontometaphyseal dysplasia 1	VCV002692562	X	153577754	X	154349386	2692562	2853560		NC_000023.11:154349385:A:G	single nucleotide variant	missense variant	Likely pathogenic	Oct 2, 2023	criteria provided, single submitter							
NM_001110556.2(FLNA):c.7315C>A (p.Leu2439Met)	FLNA	L2431M, L2439M	Heterotopia, periventricular, with frontometaphyseal dysplasia	VCV000011760	X	153578417	X	154350049	11760	26799	rs2148101204	NC_000023.11:154350048:G:T	single nucleotide variant	missense variant	Pathogenic	Apr 1, 2004	no assertion criteria provided							
NM_001110556.2(FLNA):c.7058T>C (p.Phe2353Ser)	FLNA	F2345S, F2353S	Neurodevelopmental disorder	VCV001321934	X	153579375	X	154351007	1321934	1312252	rs2148102210	NC_000023.11:154351006:A:G	single nucleotide variant	missense variant	Pathogenic	Jun 9, 2021	criteria provided, single submitter							
NM_001110556.2(FLNA):c.6707G>T (p.Gly2236Val)	FLNA	G2228V, G2236V	Prune belly syndrome	VCV000801015	X	153580611	X	154352243	801015	789398	rs1603359091	NC_000023.11:154352242:C:A	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_001110556.2(FLNA):c.6479G>A (p.Cys2160Tyr)	FLNA	C2152Y, C2160Y	Prune belly syndrome	VCV000800568	X	153580944	X	154352576	800568	789169	rs1603359205	NC_000023.11:154352575:C:T	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_001110556.2(FLNA):c.5810A>G (p.Lys1937Arg)	FLNA	K1937R, K1929R	Oto-palato-digital syndrome, type II|Heterotopia, periventricular, X-linked dominant|Frontometaphyseal dysplasia|Melnick-Needles syndrome	VCV002952485	X	153581972	X	154353604	2952485	3112162		NC_000023.11:154353603:T:C	single nucleotide variant	missense variant	Pathogenic	Sep 3, 2024	criteria provided, single submitter							
NM_001110556.2(FLNA):c.5183G>T (p.Gly1728Val)	FLNA	G1720V, G1728V	Melnick-Needles syndrome	VCV001679258	X	153583227	X	154354859	1679258	1671181	rs2148107380	NC_000023.11:154354858:C:A	single nucleotide variant	missense variant	Likely pathogenic	Aug 1, 2021	criteria provided, single submitter							
NM_001110556.2(FLNA):c.5182G>T (p.Gly1728Cys)	FLNA	G1728C, G1720C	Otopalatodigital syndrome spectrum disorder	VCV000011768	X	153583228	X	154354860	11768	26807	rs137853316	NC_000023.11:154354859:C:A	single nucleotide variant	missense variant	Pathogenic	May 15, 2006	no assertion criteria provided							
NM_001110556.2(FLNA):c.4726G>T (p.Gly1576Trp)	FLNA	G1576W	Frontometaphyseal dysplasia 1|not provided	VCV003342232	X	153586596	X	154358228	3342232	3501464		NC_000023.11:154358227:C:A	single nucleotide variant	missense variant	Likely pathogenic	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_001110556.2(FLNA):c.4726G>A (p.Gly1576Arg)	FLNA	G1576R	not provided|Heterotopia, periventricular, X-linked dominant|Oto-palato-digital syndrome, type II|Frontometaphyseal dysplasia|Melnick-Needles syndrome|Cardiac valvular dysplasia, X-linked	VCV000209154	X	153586596	X	154358228	209154	205799	rs797045044	NC_000023.11:154358227:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_001110556.2(FLNA):c.4660G>A (p.Gly1554Arg)	FLNA	G1554R	not provided|Cardiac valvular dysplasia, X-linked|Familial thoracic aortic aneurysm and aortic dissection	VCV000635975	X	153586662	X	154358294	635975	623789	rs1603360542	NC_000023.11:154358293:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_001110556.2(FLNA):c.3668C>T (p.Pro1223Leu)	FLNA	P1223L	Melnick-Needles syndrome|Heterotopia, periventricular, X-linked dominant|Frontometaphyseal dysplasia|Oto-palato-digital syndrome, type II	VCV000405445	X	153588495	X	154360127	405445	404124	rs1060500716	NC_000023.11:154360126:G:A	single nucleotide variant	missense variant	Pathogenic	Jul 27, 2024	criteria provided, single submitter							
NM_001110556.2(FLNA):c.3596C>T (p.Ser1199Leu)	FLNA	S1199L	Melnick-Needles syndrome|Frontometaphyseal dysplasia|Heterotopia, periventricular, X-linked dominant|Oto-palato-digital syndrome, type II|Melnick-Needles syndrome	VCV000011759	X	153588567	X	154360199	11759	26798	rs28935473	NC_000023.11:154360198:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_001110556.2(FLNA):c.3562G>A (p.Ala1188Thr)	FLNA	A1188T	Melnick-Needles syndrome|not provided	VCV000011758	X	153588601	X	154360233	11758	26797	rs28935472	NC_000023.11:154360232:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_001110556.2(FLNA):c.3557C>T (p.Ser1186Leu)	FLNA	S1186L	Melnick-Needles syndrome|Frontometaphyseal dysplasia|Heterotopia, periventricular, X-linked dominant|Oto-palato-digital syndrome, type II|Frontometaphyseal dysplasia 1|Terminal osseous dysplasia-pigmentary defects syndrome|Melnick-Needles syndrome|Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked|Cardiac valvular dysplasia, X-linked|Heterotopia, periventricular, X-linked dominant|FG syndrome 2|Oto-palato-digital syndrome, type I|Oto-palato-digital syndrome, type II|not provided|Oto-palato-digital syndrome, type II|Frontometaphyseal dysplasia 1	VCV000011761	X	153588606	X	154360238	11761	26800	rs137853312	NC_000023.11:154360237:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_001110556.2(FLNA):c.3527G>A (p.Gly1176Glu)	FLNA	G1176E	not provided	VCV001800627	X	153588636	X	154360268	1800627	1857916		NC_000023.11:154360267:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 13, 2022	criteria provided, single submitter							
NM_001110556.2(FLNA):c.3523G>C (p.Ala1175Pro)	FLNA	A1175P	not provided	VCV000432175	X	153588640	X	154360272	432175	426431	rs370202395	NC_000023.11:154360271:C:G	single nucleotide variant	missense variant	Likely pathogenic	May 24, 2016	criteria provided, single submitter							
NM_001110556.2(FLNA):c.3476A>C (p.Asp1159Ala)	FLNA	D1159A	Frontometaphyseal dysplasia 1	VCV000011757	X	153588687	X	154360319	11757	26796	rs28935471	NC_000023.11:154360318:T:G	single nucleotide variant	missense variant	Pathogenic	Jan 5, 2018	no assertion criteria provided							
NM_001110556.2(FLNA):c.2132T>A (p.Val711Asp)	FLNA	V711D	Cardiac valvular dysplasia, X-linked	VCV000011778	X	153592631	X	154364263	11778	26817	rs267606817	NC_000023.11:154364262:A:T	single nucleotide variant	missense variant	Pathogenic	Jan 2, 2007	no assertion criteria provided							
NM_001110556.2(FLNA):c.1910C>T (p.Pro637Leu)	FLNA	P637L	Cardiac valvular dysplasia, X-linked	VCV000931568	X	153593006	X	154364638	931568	919989	rs267606815	NC_000023.11:154364637:G:A	single nucleotide variant	missense variant	Pathogenic	Jan 1, 2016	criteria provided, single submitter							
NM_001110556.2(FLNA):c.1910C>A (p.Pro637Gln)	FLNA	P637Q	Cardiac valvular dysplasia, X-linked	VCV000011776	X	153593006	X	154364638	11776	26815	rs267606815	NC_000023.11:154364637:G:T	single nucleotide variant	missense variant	Pathogenic	Jan 2, 2007	no assertion criteria provided							
NM_001110556.2(FLNA):c.862G>A (p.Gly288Arg)	FLNA	G288R	Melnick-Needles syndrome|Frontometaphyseal dysplasia|Heterotopia, periventricular, X-linked dominant|Oto-palato-digital syndrome, type II|Heterotopia, periventricular, X-linked dominant	VCV000011777	X	153595771	X	154367403	11777	26816	rs267606816	NC_000023.11:154367402:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_001110556.2(FLNA):c.760G>A (p.Glu254Lys)	FLNA	E254K	Frontometaphyseal dysplasia|Oto-palato-digital syndrome, type II|Melnick-Needles syndrome|Heterotopia, periventricular, X-linked dominant|not provided	VCV000011756	X	153595873	X	154367505	11756	26795	rs28935470	NC_000023.11:154367504:C:T	single nucleotide variant	missense variant	Pathogenic	Feb 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_001110556.2(FLNA):c.759C>G (p.Asp253Glu)	FLNA	D253E	not provided	VCV003338826	X	153595874	X	154367506	3338826	3498095		NC_000023.11:154367505:G:C	single nucleotide variant	missense variant	Likely pathogenic	Aug 15, 2023	criteria provided, single submitter							
NM_001110556.2(FLNA):c.682G>T (p.Ala228Ser)	FLNA	A228S	Oto-palato-digital syndrome, type II	VCV001683443	X	153596047	X	154367679	1683443	1675341	rs2148119164	NC_000023.11:154367678:C:A	single nucleotide variant	missense variant	Pathogenic	Apr 1, 2022	criteria provided, single submitter							
NM_001110556.2(FLNA):c.632C>G (p.Pro211Arg)	FLNA	P211R	not provided	VCV000372971	X	153596097	X	154367729	372971	360660	rs1057518109	NC_000023.11:154367728:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 20, 2016	criteria provided, single submitter							
NM_001110556.2(FLNA):c.629G>T (p.Cys210Phe)	FLNA	C210F	Oto-palato-digital syndrome, type II	VCV000011773	X	153596100	X	154367732	11773	26812	rs137853318	NC_000023.11:154367731:C:A	single nucleotide variant	missense variant	Pathogenic	May 15, 2007	no assertion criteria provided							
NM_001110556.2(FLNA):c.622G>T (p.Gly208Cys)	FLNA	G208C	Periventricular nodular heterotopia	VCV003376601	X	153596210	X	154367842	3376601	3535785		NC_000023.11:154367841:C:A	single nucleotide variant	missense variant	Likely pathogenic	May 1, 2020	criteria provided, single submitter							
NM_001110556.2(FLNA):c.622G>C (p.Gly208Arg)	FLNA	G208R	HETEROTOPIA, PERIVENTRICULAR NODULAR, X-LINKED DOMINANT, WITH MELNICK-NEEDLES SYNDROME	VCV000209069	X	153596210	X	154367842	209069	205664	rs797045163	NC_000023.11:154367841:C:G	single nucleotide variant	missense variant	Pathogenic	Jun 1, 2015	no assertion criteria provided							
NM_001110556.2(FLNA):c.620C>T (p.Pro207Leu)	FLNA	P207L	Conductive hearing impairment|Cleft palate|Short stature|Familial thoracic aortic aneurysm and aortic dissection|not provided|FLNA-related disorder|Frontometaphyseal dysplasia|Oto-palato-digital syndrome, type II|Heterotopia, periventricular, X-linked dominant|Melnick-Needles syndrome|Oto-palato-digital syndrome, type I|not specified	VCV000011755	X	153596212	X	154367844	11755	26794	rs28935469	NC_000023.11:154367843:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_001110556.2(FLNA):c.607G>T (p.Asp203Tyr)	FLNA	D203Y	Oto-palato-digital syndrome, type I	VCV000011766	X	153596225	X	154367857	11766	26805	rs137853314	NC_000023.11:154367856:C:A	single nucleotide variant	missense variant	Pathogenic	Jul 15, 2005	no assertion criteria provided							
NM_001110556.2(FLNA):c.586C>T (p.Arg196Trp)	FLNA	R196W	Oto-palato-digital syndrome, type I|Frontometaphyseal dysplasia|Oto-palato-digital syndrome, type II|Melnick-Needles syndrome|Heterotopia, periventricular, X-linked dominant|not provided	VCV000011772	X	153596246	X	154367878	11772	26811	rs137853317	NC_000023.11:154367877:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_001110556.2(FLNA):c.514C>T (p.Leu172Phe)	FLNA	L172F	See cases	VCV001098328	X	153596318	X	154367950	1098328	1087107	rs2148119399	NC_000023.11:154367949:G:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 26, 2021	criteria provided, single submitter							
NM_001110556.2(FLNA):c.415G>C (p.Gly139Arg)	FLNA	G139R	Familial thoracic aortic aneurysm and aortic dissection	VCV000519881	X	153596417	X	154368049	519881	510925	rs1557179684	NC_000023.11:154368048:C:G	single nucleotide variant	missense variant	Likely pathogenic	Feb 10, 2020	criteria provided, single submitter							
NM_001110556.2(FLNA):c.394G>A (p.Gly132Arg)	FLNA	G132R	not provided	VCV000426758	X	153596438	X	154368070	426758	415751	rs1085307783	NC_000023.11:154368069:C:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 21, 2024	criteria provided, single submitter							
NM_001110556.2(FLNA):c.383C>T (p.Ala128Val)	FLNA	A128V	Heterotopia, periventricular, X-linked dominant	VCV000011767	X	153596449	X	154368081	11767	26806	rs137853315	NC_000023.11:154368080:G:A	single nucleotide variant	missense variant	Pathogenic	Mar 1, 2006	no assertion criteria provided							
NM_001110556.2(FLNA):c.373G>A (p.Asp125Asn)	FLNA	D125N	Periventricular nodular heterotopia	VCV001077130	X	153599241	X	154370873	1077130	1065778	rs2148121838	NC_000023.11:154370872:C:T	single nucleotide variant	missense variant	Likely pathogenic	May 12, 2021	criteria provided, single submitter							
NM_001110556.2(FLNA):c.319G>A (p.Val107Met)	FLNA	V107M	not provided	VCV001338339	X	153599295	X	154370927	1338339	1329347	rs2148121877	NC_000023.11:154370926:C:T	single nucleotide variant	missense variant	Likely pathogenic	Apr 10, 2018	criteria provided, single submitter							
NM_001110556.2(FLNA):c.280A>G (p.Asn94Asp)	FLNA	N94D	Heterotopia, periventricular, X-linked dominant|Oto-palato-digital syndrome, type II|Frontometaphyseal dysplasia|Melnick-Needles syndrome	VCV002133410	X	153599334	X	154370966	2133410	2190099		NC_000023.11:154370965:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 15, 2022	criteria provided, single submitter							
NM_001110556.2(FLNA):c.245A>T (p.Glu82Val)	FLNA	E82V	Frontometaphyseal dysplasia|Oto-palato-digital syndrome, type II|Heterotopia, periventricular, X-linked dominant|Melnick-Needles syndrome	VCV000011754	X	153599369	X	154371001	11754	26793	rs28935169	NC_000023.11:154371000:T:A	single nucleotide variant	missense variant	Pathogenic	Apr 7, 2023	criteria provided, single submitter							
NM_001110556.2(FLNA):c.238C>G (p.Leu80Val)	FLNA	L80V	Heterotopia, periventricular, X-linked dominant	VCV001332789	X	153599376	X	154371008	1332789	1323507	rs2148121932	NC_000023.11:154371007:G:C	single nucleotide variant	missense variant	Likely pathogenic		criteria provided, single submitter							
NM_001110556.2(FLNA):c.124A>G (p.Lys42Glu)	FLNA	K42E	FLNA-related disorder	VCV002632816	X	153599490	X	154371122	2632816	2803648		NC_000023.11:154371121:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 14, 2023	criteria provided, single submitter							
NM_001110556.2(FLNA):c.116C>G (p.Ala39Gly)	FLNA	A39G	Heterotopia, periventricular, X-linked dominant	VCV000011765	X	153599498	X	154371130	11765	26804	rs137853313	NC_000023.11:154371129:G:C	single nucleotide variant	missense variant	Pathogenic	Jan 25, 2005	no assertion criteria provided							
NM_001110556.2(FLNA):c.82A>G (p.Met28Val)	FLNA	M28V	Heterotopia, periventricular, X-linked dominant	VCV000488068	X	153599532	X	154371164	488068	481082	rs1557180226	NC_000023.11:154371163:T:C	single nucleotide variant	missense variant	Pathogenic		no assertion criteria provided							
NM_001110556.2(FLNA):c.1A>C (p.Met1Leu)	FLNA	M1L	Melnick-Needles syndrome	VCV003256578	X	153599613	X	154371245	3256578	3415339		NC_000023.11:154371244:T:G	single nucleotide variant	missense variant|initiator_codon_variant	Likely pathogenic	Dec 14, 2023	criteria provided, single submitter							
NM_000117.3(EMD):c.1A>G (p.Met1Val)	EMD	M1V	X-linked Emery-Dreifuss muscular dystrophy|not provided	VCV000011172	X	153607845	X	154379485	11172	26211	rs267606782	NC_000023.11:154379484:A:G	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic	Jun 19, 2019	criteria provided, multiple submitters, no conflicts							
NM_000117.3(EMD):c.2T>G (p.Met1Arg)	EMD	M1R	X-linked Emery-Dreifuss muscular dystrophy	VCV001074958	X	153607846	X	154379486	1074958	1065237	rs2148127941	NC_000023.11:154379485:T:G	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic	Oct 2, 2020	criteria provided, single submitter							
NM_000117.3(EMD):c.3G>A (p.Met1Ile)	EMD	M1I	not provided|X-linked Emery-Dreifuss muscular dystrophy	VCV000281087	X	153607847	X	154379487	281087	265324	rs886044771	NC_000023.11:154379486:G:A	single nucleotide variant	missense variant|initiator_codon_variant	Pathogenic	Jul 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_000117.3(EMD):c.161C>T (p.Ser54Phe)	EMD	S54F	Emery-Dreifuss muscular dystrophy 1, X-linked	VCV002675026	X	153608128	X	154379768	2675026	2834299		NC_000023.11:154379767:C:T	single nucleotide variant	missense variant	Likely pathogenic	Feb 9, 2023	criteria provided, single submitter							
NM_000117.3(EMD):c.547C>A (p.Pro183Thr)	EMD	P183T	X-linked Emery-Dreifuss muscular dystrophy	VCV000011179	X	153609339	X	154380979	11179	26218	rs104894806	NC_000023.11:154380978:C:A	single nucleotide variant	missense variant	Pathogenic	May 1, 1999	no assertion criteria provided							
NM_000117.3(EMD):c.548C>A (p.Pro183His)	EMD	P183H	X-linked Emery-Dreifuss muscular dystrophy	VCV000011178	X	153609340	X	154380980	11178	26217	rs104894805	NC_000023.11:154380979:C:A	single nucleotide variant	missense variant	Pathogenic	Sep 28, 2019	criteria provided, single submitter							
NM_001376.5(DYNC1H1):c.11276G>A (p.Arg3759His)	DYNC1H1	R3759H	not provided	VCV003361938					3361938	3521148			single nucleotide variant	missense variant	Likely pathogenic	Apr 3, 2024	criteria provided, single submitter							
NM_001961.4(EEF2):c.328G>A (p.Asp110Asn)	EEF2	D110N	not provided	VCV003361085					3361085	3520296			single nucleotide variant	missense variant	Pathogenic	Dec 7, 2023	criteria provided, single submitter							
NM_170707.4(LMNA):c.1445G>C (p.Arg482Pro)	LMNA	R274P, R296P, R370P, R383P, R401P, R482P	Familial partial lipodystrophy, Dunnigan type	VCV003359050					3359050	3518266			single nucleotide variant	missense variant	Likely pathogenic	Aug 13, 2024	criteria provided, single submitter							
NM_012479.4(YWHAG):c.532A>G (p.Asn178Asp)	YWHAG	N178D	Developmental and epileptic encephalopathy, 56	VCV003359022					3359022	3518238			single nucleotide variant	missense variant	Likely pathogenic	Jul 24, 2024	criteria provided, single submitter							
